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Chapter 1 
Introduction 
 5 
1.0  Cardiovascular Disease 
Cardiovascular disease (CVD) refers to any abnormal condition characterized by the 
dysfunction of the heart or blood vessels. It includes diseases such as atherosclerosis, 
coronary heart disease, hypertension and cerebrovascular disease. It is the number 
one cause of death in the United States and most European countries, with World 
Health Organisation statistics estimating 16.7 million people per annum around the 
globe die from the disease. This is 29% of all deaths worldwide per year. A study by 
Leal et al. (Leal et al., 2006) revealed that cardiovascular disease costs the economy 
of the European Union €169 billion per year; this includes healthcare costs, lost 
productivity and informal healthcare costs. Figures released by the Irish Heart 
Foundation covering a 50-year period have provided evidence of prolonged high 
mortality rates due to this disease, however it also revealed that progress has been 
made and rates continue to decrease. 
 In 2006, 9,662 people died from cardiovascular diseases in Ireland; figures 
from 1950 show 11,887 deaths from the same group of diseases. While today’s 
numbers remain high, they are in fact declining at a steady rate. For example, 
mortality rates from ischemic heart disease (IHD) reached a peak in the mid 
nineteen-seventies, which continued until 1985, but has been decreasing ever since. 
In fact, approximately 37% fewer men and 30% fewer women are now dying from 
IHD (IrishHeartFoundation, 2001.). 
 The improving figures are due not only to advances in treatment and 
preventative strategies, but also to greater public health awareness. The risk factors 
associated with the development and initiation of cardiovascular disease are well 
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known and heavily advertised. Interestingly, population based studies have 
identified lesions appearing in the right coronary arteries of youths in the 15-19 age 
bracket (Vanhecke et al., 2006). If mortality rates are to decrease significantly, more 
emphasis needs to be placed on targeting this group with information on 
preventative measures and lifestyle choices, which can significantly lessen their 
chances of cardiovascular disease.  
 Risk factors for the disease include: age, gender, smoking, elevated cholesterol 
levels, obesity, high blood pressure, stress, depression and an absence of key 
nutritional elements. Numerous measures can be taken to protect against these 
factors, all of which correspond to a healthier lifestyle: cessation of smoking, regular 
exercise and healthy diet with inclusion of oily fish (Reiner et al., 2007) and olive oil.  
 Much study has focused on the manner of initiation and progression of 
cardiovascular disease, from the effects of blood-flow-associated hemodynamic 
forces (Cunningham and Gotlieb, 2005), cholesterol, and the immune system 
(Cullen et al., 2005, Pasqui et al., 2005) to the role of pathogens (Ando et al., 2006) 
and cell function (Cummins et al., 2007). Central to all of this research are the cells 
that line the vasculature which sense and respond to circulatory conditions (both 
humoral and mechanical)- namely, the endothelial cell monolayer or endothelium. 
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1.1   The Endothelium 
The vascular endothelial monolayer or endothelium is a dynamic cellular interface 
between the vessel wall and bloodstream. In addition to regulating the physiological 
effects of humoral and mechanical stimuli on vessel tone and remodeling (Alexander 
and Elrod, 2002), the endothelium participates in immune and inflammatory 
reactions, presents a non-thrombogenic surface for blood flow, and constitutes a 
highly effective fluid and solute barrier (Sagripanti and Carpi, 2000, Traub and 
Berk, 1998, van Hinsbergh, 2001). 
 The basic structure of the endothelial cell is similar to that of other human cell 
types. The passage of molecules between the blood and sub-endothelial space is 
regulated by intercellular tight junctions and adhesion junctions. Actin stress fibers 
that cross the cytoplasm act to regulate cell morphology in response to blood flow-
associated hemodynamic forces (e.g. in situations of increased flow, and hence shear 
stress, the cells will be flattened and aligned in the direction of flow). The 
endothelium interacts not only with the extracellular matrix (the extracellular part of 
animal tissue that provides structural support for cells and contains proteoglycans, 
collagens, laminins, fibronectin and elastin) but has been shown to indirectly interact 
with other vascular cell types such as smooth muscle cells (SMC) (Cummins et al., 
2007), influencing their behaviour.   
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Fig. 1.1.1 The Human Blood Vessel. Blood vessels function as part of the circulatory system to 
transport blood throughout the body. They are comprised of three main layers Tunica intima: This is 
the innermost layer and consists of a single layer of endothelial cells and a sub-endothelial connective 
tissue containing scattered SMCs. It is separated from the next layer by an internal elastic lamina. 
Tunica media: This layer is comprised of helically arranged SMCs and elastic collagen fibers. The 
external elastic lamina separates it from the next layer. Tunica Adventita: The outermost layer of a 
blood vessel. It contains fibroblasts and elastic collagen fibers.  
 
The human blood vessel is shown in Fig. 1.1.1, and consists of three main layers- the 
tunica intima, tunica media and tunica adventita. The most important function of the 
endothelial cells lining the tunica intima is modulation of vessel tone and 
maintenance of homeostasis. It does so by producing vasodilators, vasoconstrictors, 
pro- and anti-coagulants, pro- and anti-inflammatory molecules, reactive oxygen 
species and anti-oxidants. When endothelial cells lose the ability to control 
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homeostasis, it is indicative of endothelial dysfunction and initiation of a pathologic 
condition may occur (Esper et al., 2006). 
 
1.2  Endothelial Dysfunction 
Vasodilation and vasoconstriction represent the main method of endothelial vessel 
tone control. Central to these mechanisms is the action of nitric oxide (NO), a 
volatile, biologically active gas with a half-life of seconds, which is present in 
virtually all tissue. Importantly, attenuation of NO is one of the earliest biochemical 
changes preceding endothelial dysfunction (Taddei et al., 2006). Three nitric oxide 
synthase (NOS) isoforms have been identified: neuronal NOS (nNOS) and 
endothelial NOS (eNOS) are constitutively expressed, while inducible NOS (iNOS) 
is regulated by cytokine stimulation. NO is produced by the action of NO which 
catalyse the NADPH-dependent conversion of L-arginine and O2 to L-citrulline and 
NO. NO then crosses the endothelial intima to the SMC layer. Here, through 
nitrosilation of the heme moiety from guanylate-cyclase, which subsequently 
converts GTP to cGMP, regulation of cytosolic Ca2+ (by cGMP) is achieved and 
smooth muscle fibre relaxation and vasodilation occur (Loscalzo and Welch, 1995). 
The major stimulation for NO release arises from hemodynamic forces within the 
vessel.  
 The normal functions of endothelial cells include mediation of coagulation 
(Strukova, 2006), platelet adhesion (Celi et al., 1997), immune function (Stoll and 
Bendszus, 2006), and control of volume and electrolyte content of the intra and 
extravascular spaces (Eggermont et al., 2001), in addition to vaso-control of the 
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blood vessel (Lundberg and Weitzberg, 2005). Moreover, maintenance of vascular 
endothelial cell migration, proliferation, angiogenesis and apoptosis in the blood 
vessel is essential to vessel health and prevention of disease. Undisturbed laminar 
blood flow produces a shearing effect or “frictional drag” due to its lateral 
momentum on the endothelium; in this manner, it stimulates production of NO and 
is thus “atheroprotective”. This ability of the endothelium to sense and respond to 
shear is mediated through mechanotransduction signalling mechanism, which 
include integrins, ion channels, G-proteins and Receptor Tyrosine Kinases. 
However, in regions of the vasculature such as arterial bifurcations or vessel 
curvatures, blood flow (and thus, shear) is turbulent and vessel homeostasis becomes 
imbalanced. In these areas, NO production is lowered, resulting in weakened cell-
cell contacts, dysregulation of endothelial growth and functional parameters, platelet 
adhesion, neutrophil infiltration and LDL influx. Thus, locations where perturbed 
shear predominates are implicated in initiation of endothelial dysfunctional 
cardiovascular disease states (e.g. atherosclerosis).  
 In addition to shear, other risk factors are also implicated in plaque initiation 
and progression. The role of infectious agents for example and in particular the 
bacterium Helicobacter pylori has been proposed as a risk factor for atherosclerotic 
lesion formation, by possibly inducing and/or exacerbating endothelial dysfunction.  
  In the following section we will examine the evidence linking shear stress, 
mechanotransduction and H. pylori, to a pro-atherosclerotic cell phenotype. 
Moreover we examine their ability to act in a synergistic fashion, resulting in 
endothelial dysfunction and a disease state.  
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1.2.1     Hemodynamics 
The main components of the circulatory system are the heart, blood and blood 
vessels. Its function is transport of oxygenated blood to all major organs of the body, 
and transport of deoxygenated blood from these organs back to the heart for 
reoxygenation. Blood flowing in this system exerts two major forces on blood 
vessels, namely cyclic strain and shear stress.  
 Cyclic strain is the circumferential stretch, which is exerted tangentially to the 
direction of flow on the vessel wall and is caused by the pulsatile nature of blood 
flow from the heart. It is directly related to blood pressure and vessel dimensions 
and can be described by Laplace’s Law (Laplace, 1899): 
! 
T =
Pr
h  
Where T is the wall tension (or force per unit length of the vessel), P is the blood 
pressure, r is the radius and h is the thickness of the vessel wall. Unlike shear stress 
which impacts exclusively on the endothelium, cyclic strain imparts on both the 
endothelium and smooth muscle layers simultaneously. Endothelium metabolism is 
profoundly affected by cyclic strain, inducing alterations in gene expression that lead 
to changes in cell properties, function and vessel wall homeostasis (Chien et al., 
1998, Patrick and McIntire, 1995). Specifically, cyclic strain regulates the 
production a number of factors which directly impact on the endothelium; NO, NOS 
and cyclooxygenase 2 (Cox-2) (Cheng et al., 2001, Coen et al., 2004, Kito et al., 
1998). These act in modulating vessel diameter; platelet-derived growth factor 
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(PDGF) and vascular endothelial growth factor (VEGF) (Sumpio et al., 1998, Zheng 
et al., 2001)- are central to endothelial proliferation; RGD-dependent integrins, 
monocyte chemotactic protein (MCP)-1 and matrix metalloproteinases (Ulfhammer 
et al., 2005, von Offenberg Sweeney et al., 2004, Wung et al., 1997)- involved in 
cell migration and angiogenesis; intercellular adhesion molecule (ICAM)-1, zonula 
occludens (ZO)-1, and occludin (Collins et al., 2006, Pradhan and Sumpio, 2004)- 
central for cell-cell communication and barrier function. Importantly, physiological 
levels of cyclic strain have been shown to increase both migration (Von Offenberg 
Sweeney et al., 2005) and proliferation (Iba et al., 1991), whilst also decreasing 
apoptosis in aortic endothelial cells (Haga et al., 2003).  
 Blood flow exerts a frictional force on the luminal surface of the endothelium.  
This frictional drag is referred to as shear stress and is defined in terms of blood 
viscosity and velocity and is computationally estimated in units of dyne/cm2. In the 
case laminar flow shear stress is expressed as: 
! 
" =
4µQ
#r3  
 
Where µ is the viscosity, Q the flow rate and r the vessel radius (Lehoux and Tedgui, 
2003). Under normal physiological conditions the mean shear stress to which the 
endothelium is exposed remains a relatively constant value of 10-15 dyne/cm2. 
Under these conditions, endothelial cell stability and survival is promoted, the cells 
align in the direction of flow, and production of anti-thrombotic and vasodilatory 
 13 
factors occur. These factors include prostacyclin, NO, and tissue plasminogen 
activator (tPA). Stimulation leading to production of NO is relatively simple- 
laminar flow opens specialised ion channels within the endothelial cell membrane 
such as Ca2+- activated K+ channels. This hyperpolarises the cell, increasing the 
driving force for Ca2+ entry and activating the NOS III (eNOS) and hence NO 
production. 
 Perturbed or high levels of shear stress (due to turbulent or oscillatory flow), in 
conjunction with known risk factors for cardiovascular disease, can trigger signal 
transduction events leading to endothelial dysfunction and initiation of a 
pathological condition such as atherosclerosis. This type of shear (or altered 
hemodynamic) occurs at curvatures in the blood vessel and in arterial branch ostia 
and bifurcations (Davies et al., 1995, Lehoux and Tedgui, 2003, Traub et al., 1999) 
and results in attenuation of NO production along with increased reactive oxygen 
species (ROS) production.  
 ROS includes oxygen ions, free radicals and peroxides and are highly reactive 
molecules known to play important roles in cell signalling. Under laminar flow 
conditions ROS production is balanced by cellular antioxidant generation, 
preventing oxidant damage to the cell. However a shift in endothelial homeostasis 
due to aberrant shear stress upsets the balance leading to an excess of ROS and an 
oxidative stress state. LDL-cholesterol is easily oxidized when a state of oxidative 
stress exists, giving rise to LDL-ox, a highly immunogenic molecule found in all 
atherosclerotic lesions (Janeway and Medzhitov, 2002, Peiser et al., 2002). 
Moreover LDL-ox is known to increase production of endothelium molecules and 
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monocyte chemoattractants (Li and Mehta, 2000), which have a cytotoxic effect on 
the endothelium, increase proinflammatory gene activation, and promote endothelial 
dysfunction, platelet aggregation, MMP expression and thrombogenesis (Tsimikas 
and Witztum, 2001). In short, excessive ROS production results in an inflammatory 
pro-atherogenic cell phenotype.  
 
 
 
 
 
 
 
 
 
Fig.  1.2.1 The effect of laminar flow on the endothelium (Cunningham and Gotlieb, 
2005). 
1.2.1.1  Mechanotransduction 
The manner in which a cell converts a mechanical signal such as shear stress into 
biochemical activity and subsequent cellular responses is known as 
mechanotransduction (Katsumi et al., 2004, Liu et al., 1996) and many studies have 
focused on the force-dependent signalling mechanisms involved. Current knowledge 
on the endothelial mechanosensors involved and their downstream effects is outlined 
overleaf. 
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1.2.1.2  Integrins 
Integrins are membrane proteins, and comprise a family of over twenty 
transmembrane heterodimers (composed of two distinct chains- denoted alpha (α) 
and beta (β) subunits). They function in attachment of the endothelial cell to both the 
extracellular matrix (ECM) and other cells, in addition to their role in signal 
transduction from the ECM to the cell. The integrin extracellular domain binds to 
ECM ligands such as fibronectin, vitronectin and collagen, whilst the cytoplasmic 
domain interacts with signalling molecules in focal adhesion sites such as focal 
adhesion kinase (FAK) and c-Src (Richardson and Parsons, 1996). These distinctive 
features mean the exterior and interior of the cell are physically linked, allowing for 
bi-directional transmission of mechanical and biochemical signals across the plasma 
membrane. The binding of ECM ligands to integrin receptors results in an activation 
of signalling cascades resulting in cooperative regulation of cell functions such as 
adhesion, migration, growth and differentiation. 
 Cyclic strain of SMCs grown on vitronectin or fibronectin induces integrin-
dependent proliferation, which can be inhibited with anti-β5 or anti-αvβ3 antibodies. 
However, SMCs grown on elastin or laminin do not proliferate under the same 
conditions (Wilson et al., 1995). Conversely, cyclic strain of SMCs on elastin caused 
a down-regulation in expression of c-fos and decreased cell proliferation (Reusch et 
al., 1996). Thus, responses to mechanical force have been shown to be dependent on 
specific integrin-ECM interactions (von Offenberg Sweeney et al., 2004).  
 In endothelial cells shear stress activates endothelial integrins as indicated by 
their clustering (Wang et al., 2002), association with adapter protein Shc (Chen et 
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al., 1999) and binding with WOW-1, an antibody specific to activated αvβ3 (Tzima 
et al., 2001). In addition, shear-induced activation of NF-κB is inhibited by anti-
αvβ3 antibodies (Bhullar et al., 1998). Importantly, blocking integrins using anti-
integrin antibodies or inhibitory RGD peptides, abrogates shear-induced signalling 
and its subsequent role in cellular function (Bhullar et al., 1998, Girard and Nerem, 
1995, Liu et al., 2002). 
 
1.2.1.3  Ion Channels 
Ion channels are membrane protein complexes that enable transport of ions across 
biological membranes and in doing so, establish and control small voltage gradients. 
In this context, they are also involved in cardiac, skeletal and smooth muscle 
contraction, and epithelial nutrient and ion transport. Two different channels have 
been identified in endothelial cells that are responsive to hemodynamic forces- shear 
activated potassium channels and cyclic strain-activated channels (Sackin, 1995).  
 Birukov et al. (Birukov et al., 1995) revealed a role for ion channels in SMC 
mechanotransduction through the use of gadolinium- a specific blocker of the 
stretch-activated (SA) ion channels, which reduced expression of cyclic strain-
induced SMC marker protein. 
 The effect of shear stress on endothelial cells, as noted previously, is to open 
inwardly rectifying K+ channels and outwardly rectifying Cl- ion channels (Barakat et 
al., 2006), thereby increasing Ca2+ influx into endothelial cells (Helmlinger et al., 
1996, Kanai et al., 1995, Yamamoto et al., 2000), with consequences for cell 
signalling and functions. However, the precise mode of action involved in the 
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opening and closing of these channels remains unknown. Complicating this is the 
manner in which shear and cyclic strain can act synergistically or antagonistically, 
through differential activation of ion channels, under both laminar and perturbed 
flow.  
 
1.2.1.4  G-proteins 
G-proteins are so called due to their binding of the guanine nucleotides GDP 
and GTP. They exist as heterotrimers consisting of the three subunits α, β, and γ and 
are located at the inner surface of the plasma membrane associated with 
transmembrane G-protein-coupled receptors. Upon ligand binding, guanosine 
diphosphate (GDP) dissociates from the α-subunit and is replaced by guanosine 
triphosphate (GTP).  Binding of GTP results in release of the βγ and α components, 
which in turn bind to and activate effector molecules (Wieland and Mittmann, 2003).  
Following hydrolyses of GTP by the α subunit, the hetrotrimer reassociates. 
 18 
  
 
 
 
 A 1996 study by Gudi et al. proved that activation of G-proteins in endothelial 
cells can occur as quickly as 1 s after the onset of shear stress, whilst Bao et al. (Bao 
et al., 2001) showed activation of Gαq/α11 and Gαi3/αo proteins was necessary for 
activation of downstream signalling cascades in endothelial cells. Moreover, 
antisense Gαq oligonucleotides can block shear induced Ras-GTPase activity (Gudi 
et al., 2003), whilst treatment of endothelial cells with pertussis toxin (a Gi inhibitor) 
prevented shear stress-mediated activation of ERK 1/2 (Jo et al., 1997).  
 Interestingly, the presence of the γ subunit at integrin-rich focal adhesion sites 
Figure 1.2.2:  Schematic diagram depicting G-protein activation and hydrolyses 
(Colgan, 2006).  
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has been reported (Hansen et al., 1994) - establishing a method not only for a single 
signal to activate two mechanotransduction pathways at once, but also implicating 
G-proteins in mediation of integrin activation. The work of Arcangeli et al. 
(Arcangeli et al., 1993) supports this hypothesis by proving that activation of 
potassium channels stimulated by integrin-dependent cell adhesion to the ECM can 
be blocked by G-protein inhibition. 
 
1.2.1.5  Receptor Tyrosine Kinases 
Receptor tyrosine kinases (RTK) are monomeric, transmembrane cell surface 
receptors composed of between 25-38 amino acids with extracellular N-terminal and 
intracellular C-terminal regions. Extracellular ligands include growth factors, 
cytokines and hormones, binding of which induces dimerisation with adjacent RTKs 
and rapid activation of intracellular (cytoplasmic) kinase domains. In turn the 
activated receptor is auto-phosphorylated on tyrosine residues found at the C-
terminal region, creating binding sites for Src homology 2 (SH2) and 
phosphotyrosine binding (PTB) domain-containing proteins (Pawson, 1995). 
Binding of these proteins results in their phosphorylation and activation with 
initiation of downstream signal transduction pathways (e.g. MAP Kinase pathway) 
(Zwick et al., 2001).  
 Approximately twenty different classes of RTKs have been identified, and in 
many cases both shear stress and cyclic strain implicated in their activation (e.g. 
exposure of SMCs to both hemodynamic forces results in activation and 
phosphorylation of PDGF receptor-α, (Hu et al., 1998). Flk-1 (a VEGF receptor and 
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RTK) is activated in response to shear stress (Zwick et al., 2001) and notably this 
effect is attenuated by the blockage of integrins (Wang et al., 2002).  
 
1.2.1.6 Mechanotransduction Complexity 
 
 Mechanotransduction in response to hemodynamic forces constitutes a major 
area of ongoing research. While much is known about the mechano-sensors involved 
in signal transduction, many classes, sub-classes and families exist within each 
sensor, making elucidation of the components and downstream effects involved a 
lengthy process. Furthermore, interplay between sensors, such as those mentioned 
above (G-proteins and integrins, RTKs and integrins) adds to the complex nature of 
the interactions. Even more interesting still is the argument as to whether these 
molecules are themselves mechano-sensors or merely “mechanosensitive”. It is 
entirely possible that a “primary” mechanosensor located elsewhere in the cell could 
detect hemodynamic forces and induce a signaling cascade resulting in the activation 
of the components mentioned above.  
 
1.2.2                 Endothelial Dysfunction and Cell Behaviour 
  
Generally, “endothelial dysfunction” refers to dysregulation vessel homeostasis and 
nitric oxide/ ROS balance, with the aforementioned hemodynamic forces playing a 
central role in the process (Hayoz and Mazzolai, 2007). One can expand on this view 
and include a cell’s most basic responses in this terminology. Endothelial 
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dysfunction is characterised by dysregulation of endothelial functional processes 
including proliferation, migration, apoptosis and angiogenesis. Moreover, 
hemodynamic imbalance is not the only reason for irregular cell function. The action 
of toxins, bacteria (Grandel and Grimminger, 2003), viruses, direct injury (Versari et 
al., 2007), genetic and dietary factors (van Boven et al., 1994) can all have a 
detrimental impact on endothelial health. It is pertinent therefore to examine 
endothelial cell behaviour in order gain a more complete understanding of its role in 
endothelial dysfunction. 
 
 
1.2.2.1   Apoptosis 
Apoptosis is a carefully regulated process of cell death that occurs as a normal part 
of human development and is distinguished from necrosis, or “accidental” cell death 
by characteristic morphological and biochemical changes. These include nuclear 
chromatin fragmentation and compaction, shrinkage of the cytoplasm and loss of 
membrane asymmetry (Allen et al., 1997, Darzynkiewicz et al., 1997, Lincz, 1998).  
 Ultimately responsible for apoptosis and its related alterations in cellular 
morphology are the caspase family of cysteine proteases that exist in their inactive 
forms within cells (Adams, 2003). Thirteen members have been identified of the 
human caspase family, which have been divided into two sub-groups. The members 
of the first sub-group function as initiators of the cell death process and include 
caspases 8, 9 and 10, while the second sub-group containing caspases 3, 6 and 7 act 
as effectors, cleaving death substrates that result in the cellular changes noted above. 
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In addition to caspases, the Bcl-2 family of proteins also regulate the process of 
apoptosis. The 18 identified members are divided into three sub-groups with the first 
comprising of Bcl-2 and Bcl-xL, both anti-apoptotic proteins. The second and third 
sub-groups contain Bax, Bak, Bid and Bad, all of which function in a pro-apoptotic 
manner.  
 Many stimuli are known to initiate the apoptosis pathway, such as death 
receptor expression, viral infection, ionizing radiation, T-cell recognition and also 
cellular stress. Activation via death receptors activates an extrinsic signalling 
pathway, while other stimuli, in particular cellular stress, result in intrinsic pathway 
activation. Both pathways converge to activate caspases (Danial and Korsmeyer, 
2004). 
 Death receptors are located on the cell surface and transmit apoptotic signals 
intracellularly upon binding of their respective ligands, which include hormones, 
cytokines and cytotoxic T-cells displaying the enzyme granzyme. The receptors 
belong to the tumor necrosis factor (TNF) gene-superfamily and are capable of 
caspase activation within seconds of ligand coupling. The most characterised 
receptors are CD95 (or Fas), TNF receptor-1 (TNFR-1) and the TNF-Related 
Apoptosis Inducing Ligand (TRAIL) receptors DR4 and 5. Their actions are detailed 
in Fig. 1.2.3. 
  Apoptotic pathways result in the activation of the effector caspases 3, 6 and 7. 
They effect cellular chromosomal DNA, and alter nuclear structure and function in 
the following manner: 
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1) Inactivation of enzymes involved in DNA repair: Poly (ADP-ribose) 
polymerase (PARP), is involved in repair of DNA damage. Caspase 3 cleavage of 
the enzyme prevents its action.  
2) Inactivation of enzymes involved in cell replication: Caspases inactivate DNA 
topisomerase II, an enzyme essential to DNA replication 
3) Fragmentation of DNA: Caspase-activated DNase (CAD) is responsible for 
fragmentation of DNA into nucleosomal units. It exists in the cell in the form of the 
inactive ICAD; however, during apoptosis it is cleaved by caspases resulting in 
CAD release. 
4) Breakdown of structural nuclear proteins: Lamins are vital to a cell’s nuclear 
structural integrity. Caspase 6 degrades lamins resulting in chromatin condensation 
and nuclear fragmentation. 
 
Endothelial monolayer homeostasis involves a balance between pro- and anti- 
apoptotic signals, with dysregulation of this balance central to the pathogenesis of 
vascular diseases (Mallat and Tedgui, 2000). Dysfunction of the apoptotic pathway 
resulting in increased cell death is thought to be responsible for conditions such as 
Parkinson’s or Alzheimer’s disease (Jellinger, 2001) and conversely a cell not 
undergoing apoptosis is the hallmark of a cancerous phenotype. Moreover, 
endothelial cell apoptosis is critical in pathological vascular remodeling (Ashton et 
al., 2005) and angiogenesis (Chavakis and Dimmeler, 2002). In vitro studies have 
shown that during the process of apoptosis endothelial cell adherens junction 
proteins are degraded with disruption of barrier function (Bannerman et al., 1998).  
 24 
The same process in vivo would result in detachment of endothelial cells, with their 
subsequent removal into the bloodstream due to shear stress, leading to vascular 
leakage and exposure of the highly thrombogenic subendothelial matrix. This would 
point a role for apoptosis in inflammatory vascular diseases such as atherosclerosis 
(Stoneman and Bennett, 2004). Adding greater depth to this theory are studies by 
Bombeli et al., and Schwartz et al., who have shown apoptotic endothelial cells 
become proadhesive for platelets and leukocytes (Bombeli et al., 1999, Schwartz et 
al., 1999) and also pro-coagulant (Bombeli et al., 1997). Apoptosis is also thought to 
contribute to the pathogenesis of other diseases including heart disease (incubation 
of endothelial cells with serum from patients with heart failure induced apoptosis 
and downregulation of eNOS (Agnoletti et al., 1999)), Emphysema (endothelial 
apoptosis and progression of emphysema were reduced with administration of a 
caspase inhibitor in an experimental model (Voelkel and Cool, 2003)), and 
hypertension (endothelial cells became apoptotic in experimental hypertension in rats, 
(Suematsu et al., 2002)). 
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Fig 1.2.3 The effect of intrinsic and extrinsic stimuli on induction of apoptosis. Extrinsic binding 
of ligands to death receptors results in their trimerisation and clustering of the receptor’s intracellular 
death domains. This allows binding of the adapter molecule Fas-Associated Death Domain protein 
(FADD) and procaspase-8 to the death domain forming a death-inducing signalling complex (DISC) 
and resulting in activation of the initiator caspase 8 (Chen and Goeddel, 2002). Activation of the 
intrinsic pathway due to cell stress results in mitochondrial perturbation and release of cytochrome c 
(whose regulation is controlled by the Bcl-2 family), which binds to apoptotic protease-activating 
factor 1 (Apaf1) (Salvesen and Renatus, 2002). This binding allows the formation of an Apaf1-
caspase 9 complex resulting in activation of the initiator caspase 9.The activated initiator caspases 8 
and 9, in turn activate the effector caspases 3,6 and 7.  
 
 
 
 
 26 
1.2.2.2   Migration 
Cell migration is a highly integrated process that plays vital roles in embryonic 
morphogenesis, tissue repair and regeneration, and contributes greatly to the 
advancement of diseases such as cancer, atherosclerosis and arthritis (Ridley et al., 
2003). Although many aspects of the process are conserved between cell types, great 
variations can occur in the manner in which a cell migrates (Friedl and Wolf, 2003, 
Knight et al., 2000). The steps involved in endothelial cell migration- polarization, 
protrusion, traction and retraction, are outlined below. 
 
1) Polarization: In order for a cell to migrate it must be polarized, meaning the 
molecular processes occurring at the front of the cell will differ from those at the back. 
Upon encountering a chemotactic agent, cells will organize into a frontal forward 
moving section and a rear-retracting portion. Establishment of this polarity along with 
its maintenance is governed by a set of inter-linked positive feedback loops involving 
integrins, microtubules, phosphoinositide 3-kinases (PI3Ks) and the Rho family of 
GTPases. In particular Cdc42 (Itoh et al., 2002), Par proteins and atypical protein 
kinase (aPKC) (Etienne-Manneville and Hall, 2003) initiate the polarization process. 
Cdc42 has been shown to localize the microtuble-organizing center (MTOC) and 
Golgi apparatus in front of the nucleus at the leading migratory edge (Etienne-
Manneville and Hall, 2002, Rodriguez et al., 2003), both of which are cellular 
architectural changes known to accompany polarization. In order to respond 
directionally to a chemotactic stimulus, a small stimulus must be amplified to generate 
a large cellular response, central to this mechanism is production of 
phosphatidylinositol triphosphate (PIP3). PIP3 becomes rapidly produced by PI3Ks 
and localized to the front of a migrating cell, enhancing the polarization (Rodriguez et 
al., 2003).  
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2)  Protrusion: The cell migratory cycle begins with the formation of a protrusion, with 
the actin cytoskeleton playing a central role in the process. Actin filaments are 
themselves polarized, driving membrane protrusion with rapidly growing “barbed” 
ends and slow-moving “pointed” ends. Protrusions can take the form of lamellipodia 
with a branching dendritic network of actin filaments, or filopodia where parallel 
bundles of filaments are formed. Actin polymerization in lamellipodia is controlled by 
the Arp2/3 complex, which is known to bind to the tip or side of actin filaments and 
promote formation of branching daughter filaments. Arp2/3 activation is induced by 
WASP/WAVE family members, which in turn are targets for Cdc42 and Rac. In 
contrast filopodia undergo protrusion in a tread-milling mechanism whereby actin 
filaments elongate at their barbed ends and dissemble at their trailing ends releasing 
actin monomers (Welch and Mullins, 2002).  
3) Traction: In order for the cell to advance, attachment and stabilization of extended 
protrusions must occur to provide the cell with a means of traction to pull itself 
forward. Adhesions and integrins gather at the leading edge of the protrusion and 
provide this traction through ECM interactions. The tractional force required to 
physically move the cell is created at these adhesion sites by the contractile properties 
of myosin II combining with actin filaments and attached integrins (Beningo et al., 
2001, Galbraith et al., 2002, Lauffenburger and Horwitz, 1996).  
4) Retraction: To complete the cell migratory cycle, disassembly of adhesions at the 
rear of the cell and retraction of the cell’s tail is necessary. As with the process of 
traction, myosin II plays an important role in developing a tension between the front 
and rear of the cell. Sufficient tension will open calcium-channels, resulting in 
activation of the protease calpain (Lee et al., 1999), which is responsible for cleavage 
of focal adhesion points, integrins talin, vinvulin and FAK at the rear of the cell.  
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The basic concepts surrounding cellular migration are well understood, however as 
with other cell processes, much research is still required to gain a greater 
understanding of all components of the process. 
  It is important to consider the role of endothelial cell migration in the context 
of vascular disease. Damage or injury to the endothelium resulting from chemical, 
mechanical and biological injury, or from perturbed blood flow has the potential to 
initiate a vascular pathology (Michalik and Wahli, 2006).  In this respect, quick and 
efficient repair of the endothelium is vital in maintaining a healthy vasculature. An 
intricate series of events including inflammation, oxidative stress, immune cell 
recruitment, cell survival, proliferation, migration and differentiation, all act 
synergistically to repair the damaged tissue. Thus, uncontrolled migration (or indeed 
any of the aforementioned events) resulting in failed wound repair can have serious 
consequences including cell death and carcinogenesis. For example, decreased 
endothelial migration and hence wound repair, leaves highly thrombogenic sub-
endothelial layers exposed, increasing the possibility for initiation of a vascular 
pathology (Versari et al., 2007). Moreover, an inflammatory phenotype would 
typically dominate in this situation, which has been shown as central to the 
formation of an atherosclerotic lesion (Barton et al., 2007). 
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1.2.2.3   Proliferation 
The manner in which a cell proliferates is described by a cycle of events leading to 
cellular duplication and division- the cell cycle. It consists of four distinct phases: G1 
phase, S phase, G2 phase (these are collectively known as interphase) and M phase, 
each of which are outlined in Fig. 1.2.4. 
 Regulation of cell cycle progression relies on two classes of molecules- cyclin-
dependent kinases (CDKs) and cyclins. CDKs were first isolated by Paul Nurse in 
1987, following his discovery of a corresponding gene (cdc2) in yeast. When bound 
to cyclin, CDKs become activated and phosphorylate target proteins involved in 
mediating entry into each phase of the cycle. Following a pro-mitogenic signal, G1 
cyclin-CDK complexes are activated and promote expression of transcription 
factors, which act downstream to promote expression of S cyclins and the enzymes 
involved in DNA replication. Moreover, the G1 complex plays a role in degradation 
of molecules that inhibit the S-phase of cell cycle. The mitogen cyclin-CDK 
complexes, which promote initiation of mitosis, are synthesized during the S and G2 
phases. They act by stimulating production of the proteins involved in mitotic 
spindle assembly and chromosome condensation, and in the process, activate 
anaphase-promoting complex (APC). APC is a ubiquitin ligase known to degrade 
not only the mitotic cyclins (to allow cytokinesis to proceed), but also the structural 
proteins associated with the kinetochore (a protein which links the chromosome to 
the mitotic spindle microtuble polymers during mitosis). 
 Proteins that stimulate cell cycle are known are mitogens. They trigger the 
mitogen activated protein (MAP) kinase signaling cascade that regulates various 
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cellular activities such as gene expression, mitosis, differentiation and apoptosis 
(Pearson et al., 2001). MAP kinase activation in mammals occurs primarily through 
binding of growth factors to RTKs and subsequent signal transduction. Growth 
factors known to stimulate this pathway and initiate cell cycle in the endothelium 
include vascular endothelial growth factor (VEGF) (Guo et al., 1995), hepatocyte 
growth factor (HGF) (Wajih and Sane, 2003) and fibroblast growth factor (FGF) 
(Cross et al., 2000). The phases and various components involved in cell cycle are 
outlined diagrammatically below.  
 Similar to the effects of apoptosis, uncontrolled cell proliferation is implicated in 
disease states such as cancer, atherosclerosis, and intimal hyperplasia. Moreover, as 
proliferation plays an important role in vessel repair (Pandya et al., 2006), any 
reduction in its function leads to reduced wound closure following vascular injury.  
This can result (as with decreased migration) in initiation of an inflammatory or 
thrombogenic event and ultimately a disease state such as atherosclerosis. Conversely, 
increased proliferation in organ transplant recipients is considered central to organ 
rejection (Nickel et al., 2006), and much research has focused on treatments to prevent 
this (Chen et al., 2005, Lehle et al., 2005).  
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Fig. 1.2.4 The Cell Cycle. During the M phase of cell cycle the biosynthetic activities of the cell slow 
down considerably. These resume in the G1 phase at a high rate and include production of RNA, 
protein synthesis and an increase in cell size. Next, in order to produce two daughter cells, two sets of 
DNA must be produced. This occurs during the S-phase. The cell then enters the G2 phase where it 
continues to grow and produce new proteins. In the final M phase cells undergo mitosis, where the 
cell’s chromosomes are divided between two daughter cells, and cytokinesis, in which the cell’s 
cytoplasm divides. It is much shorter than interphase, lasting only 1-2 hours before the cell cycle 
begins again with the G1 phase. 
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1.2.2.4   Angiogenesis 
Angiogenesis is a natural process in the body that involves the growth of new blood 
vessels from existing vasculature (Folkman, 2003). It occurs in healthy individuals 
and is necessary for healing wounds and restoring blood flow to tissues after injury. 
Moreover in females, angiogenesis acts during the monthly reproductive cycle (in 
rebuilding the uterus lining and egg maturation during ovulation) and during 
pregnancy (to build the placenta and circulatory system between mother and fetus).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.2.5 The Angiogenic cascade. The above diagram shows the 10 main steps in the angiogenic 
cascade beginning with growth factor production and release, and resulting in formation and 
stabilization of a new blood vessel. (TheAngiogenesisFoundation, 2000) 
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The steps involved in vascular cell angiogenesis encompass all cell functions, 
beginning with proliferation; they are shown diagrammatically in Fig 1.2.5.  
 
• In response to angiogenic stimuli, endothelial cells enter an actively 
proliferating state. Many molecules have been shown to participate in 
angiogenic stimulation including: VEGF (Goto et al., 1993), FGF (Klagsbrun, 
1992), angiopoiteins (Thurston, 2003), platelet derived endothelial growth 
factor (PD-EGF) (Moghaddam et al., 1995) and hepatocyte growth facator 
(HGF) (Rosen et al., 1993).  
 
• Once endothelial cells are activated they need to degrade the ECM to which 
they are attached. Under normal growth conditions the ECM provides 
necessary contacts between endothelial cells and the surrounding tissue, 
adding structural integrity to cells. Endothelial cells are encased in a basement 
membrane of collagen and laminin, and for the angiogenic process to continue, 
the activated endothelium produces potent proteinases to sever the attachments 
between cell and ECM. Proteinases produced include: plasminogen activators 
(such as urokinase plasminogen activator (uPA), MMPs, heparinases. 
chymases, tryptases and cathepsins (Jackson, 2002, Luttun et al., 2000, 
Pepper, 2001).  
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• Once free from the ECM, endothelial cells proliferate into the surrounding 
matrix and connect to neighboring vessels by forming solid sprouts. These 
protrusions respond and travel towards a chemotactic stimuli, which is 
achieved through cell migration with adhesions and integrins providing the 
necessary traction.  
 
• Finally, loops are formed by the protruding sprouts that differentiate and 
become vessel lumen, blood vessel tubes connect to the sprouts to allow for 
circulation, and the vessel is given structural support by smooth muscle cells 
and pericytes (Montesano et al., 1993, Tille and Pepper, 2002, Velazquez et 
al., 2002, Villaschi and Nicosia, 1994).  
 
 Angiogenesis plays a major role in the pathogenesis of cancerous tumor 
formation. Tumors release VEGF to stimulate production of new blood vessels, 
which supply the nutrients necessary for tumor metastasis. Clinical experiments 
have now yielded the first drug aimed specifically at inhibiting tumor angiogenesis 
by preventing the action of VEGF using monoclonal antibodies (Ruegg and Mutter, 
2007). As previously noted, maintenance of the endothelial monolayer and its 
functions are crucial for the prevention of cardiovascular disease (Versari et al., 
2007). The process of angiogenesis is central to maintaining a healthy vasculature, in 
particular after vessel injury to repair and close a wounded endothelium. Known 
cardiovascular risk factors have been shown to impact on an endothelial cell’s 
angiogenic ability- smoking (Su et al., 2004), high blood pressure (Sane et al., 
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2004), and bacterial infection (Pearce et al., 2004) all reduce endothelial 
angiogenesis. Thus, reduced endothelial repair can be viewed as an important early 
indicator of a cardiovascular disease state and the necessity for healthy angiogenic 
response to injury is clear.  
 
1.2.3   Shear Stress and Endothelial Function 
The effect of shear on endothelial function in the context of NO has previously been 
discussed, however many links have also been established between endothelial 
dysfunction and shear stress.  
 Laminar shear stress causes a dose-dependent reduction of endothelial cell 
proliferation (Levesque et al., 1990) and a lower level of DNA synthesis over a 
sustained period, than cells growing under static conditions (Akimoto et al., 2000). 
Conversely, perturbed shear stress results in a higher turnover rate of cells than those 
in static conditions (Davies et al., 1986) and increased DNA synthesis (Chiu et al., 
1998).  
 Endothelial cell migration is enhanced during conditions of laminar flow 
(Sprague et al., 1997, Wu et al., 1995), and it is believed that this up-regulated 
directional migration in response to shear is related to lamellipodia and focal 
adhesion remodeling (Davies et al., 1994, Li et al., 2002). In turn, this remodeling is 
regulated by the Rho family of small GTPases (Wojciak-Stothard and Ridley, 2003).  
 Animal models have shown that endothelial cells exposed to perturbed shear 
have a junction permeability that is four times greater than that of laminar sheared 
cells (Schwenke and Carew, 1989). Moreover, endothelial tight junction proteins 
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ZO-1 and occludin are upregulated following shear (Colgan et al., 2007a).  
 A potent apoptotic suppression effect has been shown in cells exposed to 
physiological levels of laminar shear stress. This suppression is continued 
throughout exposure to pro-apoptotic stimuli such as TNF-α, oxygen radicals, 
oxidized LDL and serum depletion (Dimmeler et al., 1997). Furthermore, this effect 
can be attenuated by the inhibition of NO (Dimmeler et al., 1997). Laminar shear 
stress exerts an athero-protective effect on the endothelium; however as previously 
noted disturbed levels of shear have the opposite effect, with increased ROS 
production leading to an inflamed and pro-atherogenic cell phenotype (Cunningham 
and Gotlieb, 2005).  
 
1.3        Atherosclerosis 
The term cardiovascular disease refers to a number of blood vessel and arterial 
pathologies including cerebrovascular disease, coronary heart disease and 
atherosclerosis. Of these, atherosclerosis is perhaps the best studied, and much is 
known about the initiation and progression of the disease through both in vitro and 
in vivo research, making it an ideal experimental model. 
  Atherosclerosis is a complex, multi-step process involving many different 
aspects of vascular biology, with endothelial dysfunction playing a central role in the 
initiation and progression of the disease. Animal studies have provided much 
clarification of the events leading to and during atherosclerotic plaque formation, 
with apolipoprotein E knockout mice used most commonly in genetic and 
physiological studies (Tamminen et al., 1999).  
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 As noted previously many factors are known to contribute to an atherosclerotic 
pathology. In regions of the arteries where disturbed flow predominates, such as 
arterial branching or curvature, endothelial cell shape and alignment differs greatly 
to that of cells under laminar flow. Perturbed flow regions show greater endothelial 
permeability to macromolecules such as low-density lipoprotein (LDL) and are 
preferential sites for initiation of atherosclerotic lesions (Gimbrone, 1999a). 
Moreover, a cell phenotype with increased ROS and decreased NO expression 
dominates in these areas, with marked endothelial dysfunction also present due to 
decreased mechanotransducer control and the influence of cardiovascular risk 
factors. 
  In these conditions, LDL accumulates in the sub-endothelial matrix and 
undergoes minimal oxidation by ROS. Oxidised LDL stimulates production of pro-
inflammatory molecules such as adhesions (including ICAM, PCAM, VCAM, P-
selectin and E-selectin), growth factors (e.g. macrophage colony stimulating factor), 
and chemotactic proteins (e.g. monocyte chemotactic protein-1, MCP-1). 
Furthermore, oxidised LDL can inhibit production of NO (Rosendorff, 2002), and 
increase ROS formation (Sukhanov et al., 2006). Expression of adhesions 
(Frostegard et al., 1991), chemoattractants and growth factors result in monocyte 
influx to the sub-endothelial layer, mediated in particular by ICAM and selectins 
(Collins et al., 2000, Dong et al., 1998). Monocytes “roll” along the endothelial 
surface and undergo firm adhesion to the cells, followed by diapedesis into the sub-
endothelial layer through cell junctions. This action is governed by junction 
adhesion molecules (JAMs) (Chavakis et al., 2004) with MCP-1 acting as a strong 
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chemoattractant.  
 Extensive modification of LDL in the sub-endothelial space results in highly 
oxidised LDL, which is rapidly taken up by macrophage, forming foam cells- so 
called due to their appearance under magnification. This heavy oxidation relies not 
only on ROS, but also on the action of numerous enzymes including 
myeloperoxidase (Podrez et al., 2000), sphingomyelinase (Marathe et al., 1999) and 
phospholipase (Ivandic et al., 1999), while the LDL uptake by macrophage is 
mediated by the scavenger receptors SR-A and CD36 (Febbraio et al., 2000, Suzuki 
et al., 1997). The death of foam cells releases extracellular lipids and other cell 
debris, which becomes a growing mass, forming a necrotic core in the 
atherosclerotic plaque.  
 Macrophages within the sub-endothelial space of the plaque, along with T-
cells, secrete cytokines and growth factors that stimulate SMC migration, 
proliferation and extracellular matrix production. One such cytokine is expressed on 
macrophages and is termed CD40. Engagement of CD40 with its ligand CD40L 
results in the production of pro-inflammatory cytokines, adhesion molecules and 
matrix degrading enzymes (Schonbeck et al., 2000). Moreover, known 
cardiovascular risk factors, such as elevated homocysteine levels are known to 
contribute to the development of fibrous lesions by also stimulating SMC migration 
and proliferation (Gerhard and Duell, 1999). In this manner the sub-endothelial 
spaces becomes a milieu of enzymes, foam cells, SMCs (secreting extracellular 
matrices) and a necrotic core, giving rise to a complex, atherosclerotic plaque with a 
thin fibrous cap. The process of atherosclerosis is shown in Fig. 1.3.1. 
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Fig 1.3.1. Progression of Atherosclerosis Over time, lipid accumulation, SMC migration and 
proliferation and matrix synthesis within the lesion narrow the arterial lumen, ultimately leading to 
myocardial ischemia. However, rupture of an atherosclerotic plaque is a far more serious matter, with 
the thrombogenic response capable of severely restricting blood flow to the heart resulting in 
myocardial infarction. (TheMayoClinic, 2000)  
 
There are three main determinants of a plaque’s vulnerability to rupture (Naghavi et 
al., 2003): 1) The core size and consistency- a larger core of soft lipid-rich 
atheromatous gruel is highly unstable. 2) Thickness of the fibrous plaque- cap 
thinning increases a plaque’s ability to rupture. 3) Cap inflammation and repair- a 
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cap that is slow to heal due to decreased SMC presence, or an inflamed cap due to 
macrophage influx is more likely to rupture.  
 Much progress has been made in identifying the factors contributing to the 
formation of an atherosclerotic lesion and in particular the risk factors involved in 
the disease. Hence, it is important to note that shear stress is not the only factor 
involved. Smoking has been shown to decrease HDL whilst increasing LDL 
cholesterol levels (Dautzenberg, 2005), obesity also results in higher cholesterol 
levels and increases blood pressure (Bray and Bellanger, 2006) and increased 
homocysteine levels have been shown to damage the arterial lining as well as 
promoting the formation of blood clots (Castro et al., 2006). Moreover, research has 
yielded an ever-increasing list of these factors including depression and other 
behavioural traits (Glassman and Shapiro, 1998), systemic inflammation (Kugiyama 
et al., 1999) and metabolic syndrome, along with the other risk factors of 
cardiovascular disease previously referred to. Non-traditional factors are also being 
explored with many promising results, in particular the role of infectious diseases in 
initiation and pathogenesis of atherosclerosis appears plausible. The oncogenic, 
Gram-negative bacterium, Helicobacter pylori (H. pylori), is one such pathogen. 
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1.4       Helicobacter Pylori 
In 1875 when German scientists discovered a spiral shaped bacterium colonizing the 
mucus layer of the human stomach, an inability to grow the bacteria meant their 
findings were forgotten and ignored (Blaser, 2005). Subsequent references to this 
“spiral bacteria” by Giulio Bizzozero (1892) and Professor Walery Joworski (1899) 
also went largely unnoticed (Konturek, 2003). However in 1984 our understanding 
of Helicobacter pylori began in earnest as Nobel Prize winners Robin Warren and 
Barry Marshall suggested that gastric “curved bacilli” were associated with gastritis 
and peptic ulceration (Marshall and Warren, 1984). Our knowledge on this 
bacterium is now vast with over 1,700 publications a year for the last decade. 
Outlined below is our current understanding of the important aspects associated with 
H. pylori. 
 
 
 
 
 
 
 
 
Fig. 1.4.1. Helicobacter pylori under high magnification. (Kelly D. J., 2006) 
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1.4.1       Characteristics and Epidemiology 
H. pylori is a Gram-negative, micro-aerophillic, spiral-shaped, bacterium that 
colonises the human gastric epithelium and is strongly implicated in chronic 
gastritis, peptic ulcer disease and gastric carcinoma (Dunn et al., 1997, Hatakeyama, 
2004, Kuipers, 1997, Suerbaum and Michetti, 2002). The bacterium is about 3 µm 
long and 0.5 µm in diameter with 4-6 flagella, and is the only known bacterium to 
thrive in the harsh acidic conditions of the stomach. Utilizing the enzyme urease, H. 
pylori converts urea- of which there is an abundant supply, into bicarbonate and 
ammonia, thus neutralizing any acid in the surrounding area and providing the 
bacteria with optimum pH neutral growth conditions at 37°C.  It produces two major 
virulence factors, Cytotoxin-Associated Gene A (CagA) and Vacuolating Toxin A 
(VacA), which are responsible for the many deleterious effects associated with the 
bacteria (Ernst et al., 2006, Radosz-Komoniewska et al., 2005).  
The prevalence of H. pylori varies according to numerous factors including 
geographic location, race, age, sex and socio-economic status. However, greater 
levels of infection are found in developing countries with emerging economies 
(typically 80-90% of the population will be H. pylori positive) as opposed to 
developed countries with a strong economy (approximately 10% will test positive) 
(Frenck and Clemens, 2003, Parsonnet, 1995). Of those infected, only 10-15% will 
ever require medical treatment with 1% progressing to adenocarcinoma and fewer 
experiencing gastric mucosa-associated lymphoid tissue lymphoma. Irish figures for 
infection reveal the overall prevalence for H. pylori in Northern Ireland was as high 
as 50.5% in 1997. These figures are well outside the expected ranges for a 
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developing country. Numerous risk factors for H. pylori infection have been 
explored and their relevance evaluated: a link between smoking (Lin et al., 1998) 
and the bacteria does not appear likely based on the literature; the anti-microbial 
effect of alcohol (Brenner et al., 1997) may reduce the risk/severity of H. pylori; and 
the preparation of food in unsanitary conditions may be a mode of transmission for 
the bacterium. In addition water-borne exposures (Zhang et al., 1996), hygiene 
practices (Goodman et al., 1996) such as sharing a toothbrush or cup with an 
infected individual, high population density/overcrowding (Hammermeister et al., 
1992) and a family history of gastric disease (Brenner et al., 2000) have all been 
implicated as H. pylori risk factors. Transmission of the bacteria may occur through: 
person-to-person contact (i.e. saliva, vomitus, feces); contaminated drinking water 
(H. pylori may live days in milk or tap water); from animals such as cats or pigs; and 
the use of endoscopy techniques to examine gastric disorders (endoscopes can be 
difficult to disinfect due to their complex shape).  
 
1.4.2       Genome and Genetic Diversity 
The publication of two complete genomic sequences for H. pylori strains 26695 and 
J99 (Alm et al., 1999, Tomb et al., 1997), provided valuable information regarding 
the toxins, lipoproteins, and adhesions present in the bacteria along with details on 
well developed systems for motility, scavenging iron and DNA restriction and 
modification. Importantly it was also shown that H. pylori is likely to use 
recombination and slipped-strand mis-pairing within repeats as mechanisms for 
antigenic variation and adaptive evolution. This is based on the large number of 
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sequence-related genes encoding outer membrane proteins and the presence of 
homopolymeric tracts and dinucleotide repeats in coding sequences- traits displayed 
by other diverse bacteria. This would in part explain how H. pylori could remain 
alive in the human body for the duration of an individual’s life causing chronic 
gastritis and gastric lymphoma.  
 
 
1.4.3       Secretions 
Once present in the stomach, the secretions of H. pylori are vital for its survival and 
successful colonization of the gastric epithelium (Andrutis et al., 1995, Eaton et al., 
1991, Pugsley, 1993). These secretions enable the bacteria to fight the harsh acidic 
conditions of the gastric mucosa, and are known to contribute greatly to the 
pathogenesis of H. pylori-related diseases. Factors released such as VacA have been 
shown to significantly effect not only cellular morphology, but also cell processes 
such as apoptosis, proliferation, angiogenesis and migration (Blaser, 1992, Crabtree 
et al., 1991, Pearce et al., 2004). Secretions such as urease and heat shock proteins, 
which also have confirmed roles in gastric cell function, are confined exclusively to 
the cytoplasm of other bacteria, yet they are released into the extracellular space by 
H. pylori. This has led to studies of the mechanisms by which the bacterium secretes 
its known virulence factors, proteins and enzymes. Three such secretion methods 
have been identified: 
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1) A specific, selective release of proteins including VacA- through a type V secretion 
system, and CagA- injected into the host cells by means of a type IV secretion 
system (Cui and Shao, 2007, Nguyen et al., 2001). 
2) Non-selective entry of H. pylori proteins through bacterial autolysis, (this was 
concomitant with gradual decrease in the optical density and bacterial viability in 
broth cultures studies). Moreover, autolysis accounts for the surface localization of 
proteins such as urease and heat shock protein B (HspB). A detailed description of 
which is outlined below (Fujita et al., 2005). 
3) Many extracellular proteins are thought to be released in membrane vesicles or 
blebs, with several studies supporting this hypothesis (Fiocca et al., 1999). 
 
Of these mechanisms, bacterial autolysis accounts for the bulk of secretion, whilst to 
Phadnis et al. propose it as a method for expression of cytoplasmic proteins on the 
bacterial cell surface (Phadnis et al., 1996). Urease and HspB are examples of such 
proteins, and are strictly expressed in the cytoplasm of H. pylori during log phase 
growth. The mechanism of autolysis is presented in Fig. 1.4.2.  
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Fig 1.4.2 Autolysis in H. pylori. 1) Autolysis is thought to occur under appropriate environmental 
conditions (such as favourable pH, temperature and nutrient availability), releasing proteins along 
with putative virulence or mutagenic factors. 2) Adsorption of Urease and HspB onto the surface of 
remaining intact bacteria follows, at which point the bacteria can either 3)/ 4) divide to form daughter 
cells (with the surface absorbed proteins intact), or 5) undergo autolysis. 
 
Autolysis and subsequent adsorption has other functions during pathogenesis of H. 
pylori-associated disease: 
 
- Release of many antigenic factors at once overwhelms the immune system and 
makes evasion of host defences easier. Similarly, intrinsic outer membrane proteins 
can be masked from the immune system by the presence of adsorbed urease and 
HspB.  
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- It allows the bacteria to present virulence factors and antigens to the gastric mucosa 
and immune system in vivo (significant humoral responses are induced against 
Urease and HspB). 
- It likely influences the specificity and magnitude of the interaction of H. pylori and 
gastric cells. 
 
Supplementary to the knowledge on the mechanisms involved in secretion is the 
contribution made by numerous studies on the identification of the released factors. 
Schraw et al., Kim et al. and Cao et al. all conducted such experiments focusing on 
proteins released in culture broth by H. pylori (Cao et al., 1998, Kim et al., 2002, 
Schraw et al., 1999). The proteins identified along with their function and known 
effects are outlined below.  
 
1.4.3.1       Vacuolating Cytotoxin A 
Five secretions systems (Type I-V) have been characterised for Gram-negative 
bacteria (Saier, 2006). Briefly, Type I Protein Secretory Pathway exporters (ISP) 
belong to the ATP-binding cassette ABC superfamily, of which 65 members are 
known. Two cytoplasmic domains that hydrolyze ATP molecules and two integral 
membrane channel-forming domains feature in this pathway. Transport is limited by 
the size and ease of unfolding of the protein being exported. Type II pathways (IISP) 
involve a two-step mechanism of transport, and are responsible for the export of 
numerous proteins across the cytoplasmic membrane by means of a general 
secretory (Sec) system (through the main terminal branch of the general secretory 
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pathway). Type III one-step systems are associated with pathogenicity in Gram-
negative bacteria and allow secretion of cytoplasmically synthesized proteins across 
the cell membrane. Type IV systems are termed conjugation and virulence related 
pathways (IVSP) and consist of a number of subunits that span the membrane of the 
Gram-negative bacterial cell. They are capable of transporting proteins and DNA 
from the bacterial cell into the cytoplasm of the recipient cell (e.g. Bordetella 
pertussis). Finally, the Type V secretion system, often referred to as a sub-section of 
IISP, (due to its use of the Sec system) is an auto-transporter system (Henderson et 
al., 2000). VacA secretion falls into this last category and is examined below.  
 Following the discovery of H. pylori, it was noted that a protein present in 
broth cultures could induce formation of large vacuoles in cultured mammalian 
cells- the vacuolating cytotoxin A protein, (encoded by a chromosomal gene known 
as VacA) was found to be responsible (Leunk et al., 1988, Cover and Blaser, 1992). 
VacA is made up of an A-subunit that has enzymatic activity and a B-subunit that is 
responsible for recognising and binding to receptors on the target cell surface. Thus, 
it falls into the category of an AB group toxin. It is synthesized as a 140 kDa pro-
toxin, which is cleaved at both the N-terminal signal sequence and C-terminal 
domain to yield an 88 kDa mature toxin, which is secreted into the extracellular 
space via a Type V auto-transporter secretion system (Telford et al., 1994, Nguyen 
et al., 2001) - this process is represented in Fig 1.4.3. Reyrat et al. demonstrated that 
the mature toxin is then proteolytically cleaved resulting in a 55 kDa C-terminal 
fragment, which binds to host cell receptors. This is then followed by internalisation 
of the remaining the 33 KDa N-terminal fragment, leading to vacuolation (Reyrat et 
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al., 1999). The structure of the 140 kDa protoxin along with its proteolytic 
processing and secretion is characteristic of other Gram-negative bacterial auto-
transporter proteins. Apart from the aforementioned N-terminal signal sequence (or 
leader sequence), these characteristics also include a region that becomes the mature 
cytotoxin (often termed a passenger domain- the 88 kDa fragment secreted toxin 
noted previously), and a C-terminal domain with the ability to form β-strands, which 
aid translocation by inserting into in outer membrane in a β-barrel structure 
(Henderson et al., 2000).  
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Fig 1.4.3. The Autotransporter System of H. pylori  (a) 140 KDa protein is synthesised and 
exported through the bacterial cytoplasmic membrane via Sec machinery. (b) Once through the 
membrane, the signal sequence is cleaved and the c-terminal β-domain inserts into the outer 
membrane of H. pylori in a barrel structure, forming a pore through the membrane. (c) The passenger 
domain is then inserted into this pore and is translocated to the bacterial cell surface for further 
proteolytic cleavage. 
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 It is important to note here that much diversity exists between VacA alleles 
of differing H. pylori strains and is at its most prominent in two distinct regions of 
the gene- namely the signal sequence region (s-region) and, in the middle of the 
passenger domain (mid region) (Fig 1.4.4). Two distinct sequences have been 
identified in the s-region, S1 and S2. Similarly, differing M1 and M2 sequences are 
found in the mid region. Strains containing the gene sequence for S1/M1 toxins are 
far more virulent, (and more widely studied) than those of S2/M1 or S2/M2 
(Atherton et al., 1997, Atherton et al., 1995).  
 
 
 
 
 
 
 
Fig 1.4.4 Genetic Diversity in H. pylori The cleavage site for S1 and S2 sequences is not the same, 
resulting in an extra 12 amino acid hydrophilic extension in S2 alleles. Only when this extension is 
absent will VacA exert its vacuolating activity. Reciprocally, when the toxin includes an M1 
sequence, it’s vacuolating effects are greater than with M2. 
 
 Once secreted from the bacteria the mature 88 kDa VacA toxin exists as a 
monomer capable of oligomerising to form a six- or seven-sided flower-like 
structure approximately 12 nm in height and 30 nm in diameter. Under acidic pH, it 
returns to its monomer form, an action associated with marked increase in 
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vacuolating activity (Cover, 1998). VacA is classified as a multi-functional toxin, 
capable of binding to many receptors and as such interactions of the toxin with host 
cells are poorly understood. It has been shown to bind to various lipids (Moll et al., 
1995, Molinari et al., 1998, Czajkowsky et al., 1999), epidermal growth factor 
(EGF) receptor (Seto et al., 1998), heparan sulphate (Utt et al., 2001), RTPTα and 
RTPTβ (Yahiro et al., 2003, Padilla et al., 2000). The latter remains the best 
described.  
 Phosphorylation of proteins on tyrosine residues is necessary for 
transmission of the signals responsible for cell growth, proliferation and 
differentiation. Protein tyrosine phosphatases (PTPs) in conjunction with protein 
tyrosine kinases (PTKs) regulate this phosphorylation. While much is known on the 
subject of PTKs, little characterisation has been performed on PTPs, however basic 
information is available. PTPs are classified into two main groups- cytoplasmic 
proteins and transmembrane receptor proteins (Johnson and Van Vactor, 2003, 
Bixby, 2001). These receptor proteins (RPTPs) bear a resemblance to cell adhesion 
molecules and are hence believed to function in cell-cell communication. RTPTs 
comprise of an extracellular and transmembrane domain along with a cytoplasmic 
portion that contains one or two tyrosine phosphatase domains. RTPTβ is distinct 
from other RTPTs as a sequence within its extracellular domain bears homology to 
the enzyme carbonic anhydrase (Barnea et al., 1993).  
 Cells resistant to vacuolation by VacA become sensitized when transfected 
with plasmids encoding RTPTβ. In addition, VacA’s cytotoxic effects on AZ-521 
gastric cells is inhibited with RTPTβ antisense oligonucleotides (Schraw et al., 
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2002, Padilla et al., 2000). This data suggests that binding RTPTβ is necessary or at 
least has an important role, for host cell vacuolation. Other known effects of VacA 
binding of RTPTβ include activation of the signalling pathways resulting in Git 1 
tyrosine phosphorylation (Git 1 is involved in pathways responsible for growth 
factor signal transduction), and detachment of primary murine gastric epithelial from 
a reconstituted basement membrane (Fujikawa et al., 2003).  
 Much remains to be learned about binding of VacA to host cells and of the 
receptors involved. Complicating the issue, S1/M1 strains of H. pylori have different 
binding patterns and target different receptors in comparison to S2/M2 bacterial 
strains. Moreover, the targeted cell surface receptors may vary from one cell type to 
the next (Ji et al., 2000, Pagliaccia et al., 1998, Wang et al., 2001).  
 
1.4.3.1.2       Cellular Effects Associated with VacA 
 
1) Vacuolation: The most recognisable effect VacA on cells is the formation of 
vacuoles throughout the cell body. Following binding of VacA to the cell surface, it 
is internalised into the cell and formation of anion-selective VacA channels in the 
membranes of late endocytic compartments occurs (Tombola et al., 1999, Szabo et 
al., 1999, Morbiato et al., 2001, Czajkowsky et al., 1999). Due to increased chloride 
conduction through these channels, intra-luminal chloride concentrations are 
increased and to compensate, vacuolar ATPase activity rises, resulting in an upsurge 
in proton pumping and a reduction in intra-lumenal pH. Weak bases such as 
ammonia diffuse and become trapped in the late endocytic compartments, with 
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subsequent osmotic swelling of these compartments leading to vacuolation. 
Interestingly, vacuolated cells exclude trypan blue (Leunk et al., 1988), indicating 
that the process is not lethal to the host cell. 
2) Mitochondrial Effects: In addition to VacA’s presence within cell 
membranes, several studies report mitochondrial localisation (Willhite and Blanke, 
2004, Galmiche et al., 2000). VacA was shown not only to decrease mitochondrial 
membrane permeability, but also to stimulate cytochrome C release- a process 
leading to caspase-3 activation and cell apoptosis (Willhite et al., 2003, Kimura et 
al., 1999).   Concomitantly, a reduction of cellular ATP concentrations and impaired 
cell cycle progression has been shown following exposure to VacA (Kimura et al., 
1999). Notably NPPB (5-nitro-2- (3-phenylpropylamino) benzoic acid) - which 
prevents the formation of vacuoles by blocking the chloride channels through which 
VacA operates, inhibits the aforementioned mitochondrial effects (Willhite et al., 
2003, Willhite and Blanke, 2004).  
3) Signal Transduction Effects: VacA induces activation of MAP kinases p38 and 
ERK1/2 in conjunction with the activating transcription factor 2 (ATF2) signalling 
pathway. However, this activity has no effect on vacuole formation or cytochrome C 
release- indicating that VacA activation of the p38 pathway is independent of these 
(Nakayama et al., 2004). As of yet, no downstream function of this activation has 
been assessed and no surface receptors leading to their activation have been 
identified.  
4) Paracellular Permeability Effects: Papin et al. have shown a decrease in 
transepithelial electric resistance (TER) owing to an increase in paracelllular 
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permeability to low molecular mass molecules following exposure to VacA (Papini 
et al., 1998). Again, mechanisms involved in this effect are not well understood.  
 
From its secretion method to cell surface interactions and subsequent effects on cell 
function, much remains unclear about H. pylori VacA. Recent studies have shown 
similar effects in vascular endothelial cell lines (Jenkinson et al., 2002, Pearce et al., 
2004), suggesting a putative role in vascular disease and in particular, endothelial 
dysfunction. However this hypothesis requires much experimental exploration and 
consolidation.  
 
1.4.3.2       Cytotoxin Associated Gene A 
The CagA gene of H. pylori is recognised as a marker for increased risk of peptic 
ulcer disease and gastric cancer when present in bacterial strains (Blaser and 
Crabtree, 1996, Kuipers et al., 1995, van Doorn et al., 1999). Early research into 
differences between variant H. pylori strains and isolates led to the association of 
CagA- positive status with increased pathogenicity and the ability to induce 
numerous morphological and biochemical changes in human gastric cells (Leunk et 
al., 1988). The gene is present in 50 to 70% of strains (Ching et al., 1996, Dore et 
al., 2001) and is located at one end of the Cag pathogenicity island (PAI), a 40 bp 
DNA segment, which encodes 31 genes (Akopyants et al., 1998, Censini et al., 
1996, Covacci et al., 1993). Eighteen of these genes are involved in the formation of 
the Type IV secretion system (T4SS), whose syringe-like structure is capable of 
penetrating and translocating bacterial macromolecules into the host cell (Asahi et 
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al., 2000, Christie and Vogel, 2000). The CagA protein (encoded by the CagA gene) 
is one such macromolecule, and acts as a substrate for the T4SS.  
 As previously mentioned, the Type IV secretion system is one of 5 such 
systems that exist in Gram-negative bacteria. It has a generic role in transporting 
toxins and DNA or protein-DNA complexes to host cells. The T4SS of 
Agrobacterium tumefaciens is the most studied model (Li et al., 1998), and 
comparison to the H. pylori system reveals a homologous structure, which is 
outlined in detail below. It consists of three distinct sub-structures: the coupling 
protein (CP) homo-multimer; a transenvelope protein complex; and the conjugative 
pilus. Mating-pore-formation (Mpf) proteins are assembled from the latter two 
substructures (Fischer et al., 2001). The three structures most likely act cohesively 
as one supramolecular organelle to mediate the stages of translocation: 1) 
Recruitment of DNA and protein substrates to the transfer machine; 2) Transfer of 
substrates across the cell envelope; and 3) Delivery to target cells. The function of 
each element of the T4SS is as follows: (Fig. 1.4.5) 
 
Coupling protein:  
VirD4 - recruitment of DNA and protein substrates to the Mpf complex (VirB1-
VirB11);  
Energy components:  
VirB4 and B11 - ATPase homomultimer, provides energy for substrate export and 
pilus biogenesis. 
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Channel subunits:  
VirB3 - function unknown.  
VirB6 - assembly factor.  
VirB8 - assembly factor and bridge between subcomplexes. 
VirB9 - outer membrane pore signal peptide, which is cleaved by peptidase.  
VirB10 - bridge between inner and outer membrane subcomplexes.  
T pilus:  
VirB2 – A cyclized pilin subunit signal peptide that is cleaved by peptidase. It starts 
as inner membrane protein until the periplasmic end is cleaved and undergoes 
cyclization and polymerization to form the T-pilus.  
ViB5 – A pilus subunit chaperone. 
VirB7 - A lipoprotein involved in pilus assembly. 
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Fig. 1.4.5 The Type IV Secretion System 
 
Once translocated into the endothelial cell the CagA protein is known to interact 
with numerous pathways and to stimulate a host of cellular responses. Upon 
injection, the vast majority of the protein (approximately 80%) localizes at the 
plasma membrane and undergoes tyrosine phosphorylation at the CagA EPIYA 
motif (a five amino-acid sequence that is present in the carboxy-terminal variable 
region of the protein) by the host cell Src family protein tyrosine kinases (SFK) 
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(Selbach et al., 2002, Stein et al., 2002). Once phosphorylated, membrane integrated 
CagA then binds to a cytoplasmic SRC homology 2 domain (SH2), which contains a 
protein tyrosine phosphatase (PTP) called SHP2 (Feng and Pawson, 1994). This 
results in a conformational change of SHP2 and continuous PTP activation 
(Hatakeyama and Higashi, 2005).  
 CagA-activated SHP2 can stimulate extracellular signal-regulated kinase 
(Erk) in a Ras- dependent manner- resulting in cell scattering and inducing a 
morphological change known as “humming bird” phenotype in endothelial cells 
(Maroun et al., 2000, Neel et al., 2003). This phenotype is characterised by cell 
elongation and alteration of the actin cytoskeleton. Moreover, CagA-activated SHP2 
has also been shown to dephosphorylate focal adhesion kinase (FAK) with 
subsequent elevation of cell motility due to reduction of active focal adhesions 
(Tsutsumi et al., 2006). 
 To prevent excessive CagA cytotoxic activity, a negative feedback loop is 
initiated upon translocation of the protein. Approximately 20% of phosphorylated 
CagA forms a complex by interacting with the carboxy-terminal Src kinase (Csk), 
which in turn inhibits the activity of SFK by tyrosine phosphorylation (Murakami et 
al., 2006). A similar inhibition effect has been shown for CagA that has not been 
SFK phosphorylated.  
 Numerous CagA interactions are known to occur without a need for 
phosphorylation of the protein. As previously mentioned, CagA localises to the host 
cell plasma membrane, where it can interact with the cell junction proteins zonola 
occludens-1 (ZO-1) and junction adhesion molecule (JAM) through recruitment of 
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SHP2, resulting in a weakened endothelial barrier and monolayer leakage (Amieva 
et al., 2003). CagA has also been shown to bind to growth factor receptor bound 
protein 2 (Grb2) and form a complex with son of sevenless (Sos) resulting in Ras 
activation and subsequent alterations in cell scattering and proliferation (Mimuro et 
al., 2002). In addition, CagA’s ability to stimulate reactive oxygen species (ROS) 
production through mitochondria interactions elicits the same cellular effects (Handa 
et al., 2006). A morphological change to humming bird phenotype can be induced 
through CagA interacting with C-Met hepatocyte growth factor receptor (similar to 
activation of ERK) (Churin et al., 2003). Finally, recent data has proven CagA’s 
ability to activate the nuclear factor of activated T cells (NFAT) in gastric epithelial 
cells- thus inhibiting progression of cell cycle (Yokoyama et al., 2005). 
 In summary, the cytotoxin-associated protein of H. pylori is responsible for 
many of the known pathogenic effects of the bacterium and can influence many 
aspects of cellular morphology and cycle. Studies of its secretion mechanism and 
subsequent pathway activations have revealed a diverse, multifunctional protein. 
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Fig. 1.4.6. CagA induced signal transduction. Translocation of CagA into the cell occurs through the 
Type IV secretion system. Its subsequent interactions can be tyrosine phosphorylation-dependent or -
independent. Csk, C-terminal Src Kinase; SHP2, Src homology 2 (SH2) domain- containing tyrosine 
phosphatase; Erk, extracellular signal-regulated kinase; FAK, focal adhesion kinase; Grb2, growth 
factor receptor bound protein 2; JAM, junctional adhesion molecule; MEK, mitogen-activated protein 
kinase; NFAT, nuclear factor of activated T cells; ROS, reactive oxygen species; SFK, Src family 
kinase; Sos, son of sevenless; ZO-1, zonola occludens-1. 
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1.4.3.3       Urease 
The enzyme urease accounts for approximately 10% of the total protein content of 
H. pylori, making it the bacterium’s most abundant protein and virulent factor. As 
previously mentioned, VacA forms pores in cell membranes inducing the release of 
urea and anions from host cells. Urease converts this urea into ammonia and 
bicarbonate, aiding gastric colonization of the stomach by neutralizing the acidic 
conditions (Burne and Chen, 2000). Urease activity varies greatly between H. pylori 
strains despite being present in all (Contreras et al., 2003), and it has the ability to be 
reabsorbed by the bacterial cell surface through an autolytic mechanism (see section 
1.4.3) or to exist in the bacterial cytoplasm (Phadnis et al., 1996). The ammonia 
produced has been shown to have cytotoxic effects on epithelial cells, thus 
promoting pathogenesis of the bacterium. In addition Fan et al. have reported a 
urease-dependent induction of apoptosis in gastric epithelial cells and it is known to 
activate monocytes and stimulate inflammatory cytokine production (Fan et al., 
2000). 
 
1.4.3.4       Heat Shock Proteins 
All organisms respond to environmental stress with an upregulation of heat shock 
proteins (Hsp). The Hsp’s are part of a group of approximately 24 proteins that are 
highly conserved across species and have been classified into 6 families based on 
molecular size: Hsp 100, 90, 70 60, 40 and small (Jolly and Morimoto, 2000). They 
function as chaperones to: facilitate the folding and unfolding of proteins and 
resolubilisation of protein aggregates, aid transmembrane molecular transport, and 
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are implicated in loading immunogenic peptides onto major histocompatibility 
complex for T-cell presentation (Schlesinger, 1990).  
 Characterisation of a 58-kDa protein secreted by H. pylori, which is also 
present on the bacterial surface, showed homology to Hsp’s, and was hence named 
HspB- often referred to as H. pylori Hsp60 homologue (Dunn et al., 1992). HspB 
has been shown to have a role in adherence and attachment of H. pylori to the gastric 
epithelium and induce Interleukin-8 (Il-8) secretion, leading to gastric inflammation 
and increasing the risk of gastric carcinoma (Hayashi et al., 1998, Kawahara et al., 
1999). The secretion of HspB (along with CagA, VacA and Urease positivity) is 
associated with a more virulent form of the bacterium. However, unlike the other H. 
pylori secreted factors, few studies have been carried out on HspB and little is 
known of its functions and host cell interactions.  
 
1.4.3.5   Other Secretions  
In culture H. pylori has also been shown to secrete the potent chemotactic factor 
Diethyl Phthalate, which has been shown to stimulate monocyte migration (Keire et 
al., 2001). 
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1.4.3.6  Adhesions and Other Outer Membrane Proteins 
While secreted proteins form the major virulence factors of H. pylori and contribute 
greatly to the pathogenesis of diseases associated with the bacterium, adhesion to 
host cells is necessary for prolonged gastric colonisation. Furthermore, CagA T4SS 
requires cell adherence to function, and many adhesions are themselves virulent 
factors- influencing inflammation and stimulating host immune responses. Complete 
genome sequencing of two strains (J99 and 26695) have led to identification of one 
major outer membrane family of 33 genes which encode the H. pylori outer 
membrane proteins (OMP) (Alm et al., 1999, Tomb et al., 1997). Two sub-groups of 
this family have been identified- the Hop (H. pylori outer membrane protein) and 
Hop-related Hor families. Here we focus on adhesions and the Hop family, as little 
experimental data is available on Hor.  
 
1) BabA (HopS): A 78 kDa protein encoded by the babA gene, it represents the 
best-characterised adhesion protein of H. pylori. It mediates binding to fucosylated 
Lewis b (Leb) blood group antigens on host cells (Boren et al., 1993). BabA is 
suggested to have a role in pathogenesis of the bacteria as one of its alleles (babA2) 
is linked with peptic ulcer disease and gastric carcinoma (Gerhard et al., 1999).  
2) OipA (HopH): A 34 kDa protein, which may function in adhesion as well as 
being a pro-inflammatory response-inducing protein (Yamaoka et al., 2000). 
Conjointly, experimental data reveals OipA expression is concurrent with increased 
Il-8 expression in vitro and in vivo (Ando et al., 2002).  
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3) SabA (HopP): During H. pylori gastric colonisation and inflammation, non-
sialylated Lewis antigens are replaced with sialylated Lewis antigens. The role of 
SabA is to mediate binding to sialic acid-containing glycoconjugates (Mahdavi et 
al., 2002).  
4) Lipopolysaccharide (LPS): LPS is a large molecule, and forms the major 
component of the gram-negative bacteria cell wall. It is comprised of three parts: 
polysaccharide (O) side chains, core oligosaccharide, and lipid A. It gives structural 
integrity to the bacteria and protects it from some chemicals. H. pylori LPS contains 
fucosylated oligosaccharide antigens that are similar to Lewis antigens structurally 
and immunologically. Thus, they are thought to contribute to immune evasion 
(Lozniewski et al., 2003). Unlike LPS of other bacteria, this molecular mimicry 
means only a weak innate immune response is stimulated.  
5) H. pylori-neutrophil activating-protein (HP-NAP): HP-NAP is a 200-kDa 
highly symmetrical dodecameric molecule that belongs to the Dps (DNA-binding 
proteins from starved cells) protein family. These proteins are generally expressed 
by bacteria under environmental stress to protect DNA against oxidative damage. It 
adheres to gastric epithelium and, upon crossing the epithelial lining, recruits 
monocytes and neutrophils to the site of infection. Moreover, it has the ability to 
survive under oxidative stress conditions, play a role in the pathogenesis of H. pylori 
infection by acting as a major antigen and inducing an immune response, and acts as 
an adhesion for the bacteria (Evans et al., 1995, Montemurro et al., 2001, 
Montemurro et al., 2002). 
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6) AlpA and B: Inactivation of the AlpA and B genes reduce adherence of H. 
pylori to gastric epithelial cells.  
7) Flagella: H. pylori has 4-6 flagella, which are essential for motility and 
colonization of the gastric epithelium. Similar to LPS, it does not induce a strong 
immune response, hence aiding evasion of the host immune system. 
 
1.4.4   The Immune Response to H. pylori 
The immune system is a collection of mechanisms within an organism that protects 
against infection by identifying and killing pathogens. Two immune systems operate 
in concert within the human body, the innate and acquired systems. Innate immunity 
refers to the antigen-nonspecific defense mechanisms that a host uses immediately 
or within a number of hours after exposure to almost any antigen (Janeway Charles; 
Paul Travers, Stvrtinova, 1995). Adaptive immunity on the other hand, refers to 
antigen-specific defense mechanisms that take several days to become protective and 
are designed to react and remove a specific antigen; this type of immunity continues 
to develop throughout life (Alberts, 2002, Janeway CA, 2005). The immune 
response to H. pylori involves both innate and acquired immunity, with various 
bacterial molecules inducing the response.  
 Innate immunity to bacterial molecules centers on Toll-like receptors (TLRs) 
expressed on antigen-presenting cells (APCs) such as monocytes and dendritic cells 
(DCs). Secretion of pro-inflammatory cytokines interleukin (IL)- 1β and IL-8, along 
with tumor necrosis factor-α (TNF-α) is induced following bacterial contact with 
APCs. In turn, these cytokines induce granulocytic infiltration in a chemotactic 
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manner (Crabtree, 1996b). In general, innate studies have focused on LPS of H. 
pylori and TLR-4, as the LPS of gram-negative bacteria elicit a strong immune 
response. However, as previously noted, the H. pylori LPS does not stimulate innate 
immunity due to its similarity to Lewis antigens. This fact was reflected in 
experimental data with gastric cells lines showing no response to the LPS (Backhed 
et al., 2003). As TLR2 and 5 are also known to respond to gram-negative LPS and 
flagella, studies were conducted to determine whether they could recognize and 
respond to H. pylori. Data revealed that epithelial cell cultures infected with the 
bacteria induced nuclear factor-κB (NF-κB) activity in cells transfected with TLR2 
and 5, but not TLR4 (Smith et al., 2003). However conflicting reports show TLR5 
evasion by H. pylori flagella in flagellin-responsive cell lines (Gewirtz et al., 2004). 
In vitro and in vivo studies consistently demonstrate that cell contact with H. pylori 
results in increased NF-κB and AP-1 expression (in a MAP Kinase- dependent 
manner), with a subsequent increase in IL-8 secretion (Aihara et al., 1997, Keates et 
al., 1997, Sharma et al., 1998). 
 The Adaptive immune cellular response is triggered primarily by attachment 
of H. pylori to epithelial cells and production of the antigenic HSPs, LPS and urease- 
all of which activate T-cells (following macrophage processing) (Di Tommaso et al., 
1995). Attachment results in continuous gastric inflammation, with neutrophils, 
lymphocytes, plasma cells and macrophage all playing a role in attempting to rid the 
body of the bacteria. Mentioned previously was the effect of H. pylori on cellular 
junctions. This disruption enhances antigen presentation and greatly increases the 
immune response, resulting in increased IL-1, IL-6 IL-8 and TNF-α production 
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(Crabtree, 1996a, Fan et al., 1995). These cytokines are indicative of a Th1 response 
phenotype, and induction of interferon-γ (IFN-γ) and its related genes supports this 
(Tummala et al., 2004). Notably, host genetics also plays an important role in 
cellular adaptive immunity as the IL-1B gene encodes IL-1β- a major contributor to 
amplifying the H. pylori-associated inflammation (Noach et al., 1994).  
 Despite a strong systemic and local antibody release, binding of IgG to H. 
pylori, thereby stimulating phagocytosis and bacterial susceptibility to the process of 
complement, the humoral adaptive immune response is highly ineffective. In 
actuality, the response may aid pathogenesis of H. pylori, as shown by Israel and 
Peek et al., when delivery of the antibodies directed against the bacteria into mice 
induced gastritis (Israel and Peek, 2001). The failure of this system is largely put 
down to the gastric mucus in which H. pylori resides, as it provides a protective 
layer making the bacteria inaccessible to specific antibodies.  
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Fig. 1.4.7  The immune response to H. pylori. (Portal-Celhay and Perez-Perez, 2006) 
 
1.4.5   Diagnosis, Treatments and Vaccines 
Diagnosis of H. pylori has improved vastly in recent years and many non-invasive 
tests are now available. However, a combination of both invasive and non-invasive 
methods is still the gold standard for accurate identification of the bacteria 
(Dzierzanowska-Fangrat et al., 2006, Ricci et al., 2007, Vaira and Vakil, 2001). 
Each of the tests are outlined below: 
 
Non –Invasive Methods 
1) Urea breath test: This is a rapid diagnostic test. Patients swallow urea labeled 
with an uncommon isotope- either radioactive carbon-14 or non-radioactive carbon 
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13.  Ten to thirteen minutes later, detection of isotope- labeled carbon dioxide in 
exhaled breath indicates that the urea was split through the action of H. pylori 
urease, and thus presence of the bacteria is confirmed (Surveyor et al., 1989).  
2) Stool Antigen Test: This test utilizes polyclonal anti-H. pylori antibody adsorbed 
to microwells.  Diluted patient samples and a peroxidase-conjugated polyclonal 
antibody are added to the wells and incubated for one hour at room temperature. A 
wash is performed to remove unbound material. Substrate is added and incubated for 
ten minutes at room temperature. Colour develops in the presence of bound 
enzyme. A stop solution is added and the results are interpreted visually or 
spectrophotometrically. Any laboratory can perform the test in less than 90 minutes, 
since no special equipment is needed (Koletzko, 2005).  
3) Antibody testing: This is a similar principle to the stool antigen test, anti-H. 
pylori antibodies are used in an ELISA and patient’s blood is added to the wells to 
detect bacterial presence. 
 
Invasive Methods 
1) Endoscopy: with subsequent biopsy. Testing of biopic samples can occur in 
numerous ways: (a) Slide with a colour change indicator if urea is broken down- 
indicating a positive reaction for H. pylori. (b) Performing nested PCR with primers 
specific to conserved sequences only found in H. pylori strains. (c) Culturing the 
sample and testing using antibodies in a Western blot or immunocytochemical 
format (Ricci et al., 2007). 
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Invasive methods have the advantage of a definitive positive or negative result, and 
estimation of bacterial load. However the nature of endoscopy is a drawback due to 
its discomfort. While non-invasive methods are quick, generally in-expensive and 
cause minimal discomfort, results can be hampered by factors such as smoking and 
alcohol, or other pharmaceuticals, which alter the pH of the stomach briefly and 
decrease the number of bacteria present. This can lead to incorrect estimation of 
bacterial load or even a negative test result.  
 
The recommended H. pylori eradication therapy continues to be triple therapy with a 
proton pump inhibitor (PPI) and two antibiotics of clarithromycin, amoxicillin or 
metronidazole for seven days (Della Monica et al., 2002). PPI’s inhibit gastric acid 
secretion by blocking the hydrogen/potassium adenosine triphosphatase enzyme 
system (proton pump) of the gastric cell. Clarithromycin prevents bacterial protein 
synthesis, thus inhibiting growth. Amoxicillin inhibits the synthesis of bacterial cell 
wall and metronidazole selectively disrupts nucleic acid synthesis in anaerobic 
bacteria.  
 However, in 20% of cases this therapy fails and hence the requirement exists 
for continued revision and updating of treatments. For this reason the top six 
treatment regimes have been identified. Failure of one to eradicate H. pylori means 
moving down the list to the next best and rigorous treatment.  
 
1) Clarithromycin, amoxicillin, and PPIs for seven days. (This is the 1st line defense, 
and works in 80% of cases). 
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2) Longer duration of therapy. 
3) A Quadruple therapy- PPI, Bismuth, tetracycline and metromidazole. 
4) Sequential treatment: Five day PPI, amoxicillin, followed by five day PPI, 
clarithromycin and metromidazole. 
5) Adjuvant therapy 
6) New anti-microbial-based therapies: Seven day PPI triple regime with 
levofloxacin and amoxicillin. 
 
As with most diseases, prevention is preferential to curing an established infection. 
For this reason, the development of a vaccine against H. pylori is underway and 
while none are commercially viable at the moment, clinical trials suggest it is only a 
matter of time. Immunization with H. pylori urease subunit in conjunction with the 
mucosal adjuvants cholera toxin (CT) or heat labile toxin of Escherichia coli, into 
oral (Michetti et al., 1994, Weltzin et al., 1997), nasal (Weltzin et al., 1997), or 
rectal (Kleanthous et al., 1998) passageways, can impart protection against H. pylori 
infection in mice and ferrets (Cuenca et al., 1996). Moreover, due to gastric mucosal 
colonization by the bacteria, mucosal vaccinations have also been explored in 
humans. Unfortunately these studies revealed weak urease immunogenicity, 
although the safety of recombinant urease was confirmed (Kreiss et al., 1996, 
Michetti et al., 1999, Banerjee et al., 2002). The main conclusion taken from these 
studies was that it is necessary to increase our knowledge on the mechanisms by 
which H. pylori is cleared following vaccination, hence creating a better 
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understanding of the host defense systems involvement, leading to improvements in 
future vaccine design. 
 
1.5   H. pylori and Atherosclerosis 
Recently, a considerable number of studies have focused on whether any correlation 
exists between H. pylori infection and the complex process of atherosclerosis. To 
this end, research has concentrated on whether bacterial positivity affects known 
atherosclerotic lesion markers such as plasma levels of cytokines, fibrinogen, lipids 
and C-reactive protein (CRP)- a marker of inflammation. Much controversy 
surrounds this field with many studies reporting findings for, or against, the 
association. These data are presented below.  
 Higher levels of all these lesion markers were shown in patients with 
coronary heart disease (CHD) and H. pylori infection than in controls (Pieniazek et 
al., 1999). Zito et al. (1999) reported elevated fibrinogen levels and Hoffmeister et 
al. (2001) showed decreased HDL cholesterol, both in H. pylori positive patients. 
Similar positive associations were shown by Majka et al. (2002) when examining 
plasma levels of cholesterol, LDL-cholesterol, fibrinogen and IL-8. In addition, 
separate studies reveal seropositivity to H. pylori correlates with higher levels of 
tumour necrosis factor alpha (TNFα) and fibrinogen in patients with coronary artery 
disease (CAD)  (Schumacher et al., 2002). A polymerase chain reaction and 
immunohistochemical examination of 38 atherosclerotic plaques by Ameriso et al. 
(2001) found H. pylori DNA present in 20 plaques, with 10 of these testing positive 
for immunohistochemical staining. Similarly, Kowalski et al. (2002) provided 
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evidence of H. pylori-related DNA in 47.8% of patients with CAD. Previously 
mentioned was the role of adhesion molecules in the initiation and pathogenesis of 
atherosclerosis. Interestingly, soluble ICAM-1 and VCAM-1 levels have been found 
to be associated with IgA seropositivity to H. pylori (Maciorkowska et al., 2005). 
Moreover, mean anti- Hsp65 titers (Hsp is secreted by H. pylori), which correlate to 
the severity and extent of coronary atherosclerosis, decreased in 100 patients 
following eradication of the bacteria (Birnie et al., 1998). Finally, many studies have 
addressed the role of CagA- positive H. pylori strains (associated with a more 
virulent infection) in cardiovascular disease, with Pasceri et al. (2008), Franceschi et 
al. (2002) and Mayr et al. (2003) all confirming an association of CagA with 
atherosclerosis, and significantly in the case of Mayr et al. increased expression of 
C-reactive protein was found in individuals infected with CagA- positive strains 
versus CagA- negative. 
An interesting argument is the manner in which H. pylori may interact with 
endothelial cells. Immune function would dictate that if the whole bacterium were to 
vacate the stomach through an ulcer or other means, it would immediately be 
destroyed. This has lead to suggestions that the bacterium influences progression of 
the disease through the damaging influence of its products (i.e. cytokines, 
endotoxins, cytotoxins and other virulence factors), with many of the above studies 
supporting this hypothesis.  
 Much evidence exists against the association between H. pylori and 
atherosclerosis. Ridker et al., Wald et al. and Biagi et al. all reported no association 
between H. pylori seropositivity and myocardial infarction (MI) (Ridker et al., 
 75 
2001), IHD (Wald et al., 1997) and CHD respectively (Biagi et al., 2000).  In 
addition, numerous studies have rejected the links between increased atherosclerotic 
markers such as CRP, fibrinogen, oxidized LDL, leukocyte counts and pro-thrombin 
in response to H. pylori infection (Brenner et al., 1999, Hoffmeister et al., 2001, 
Koenig et al., 1999, Parente et al., 2000, Rothenbacher et al., 2001, Schweeger et 
al., 2000, Singh et al., 2002, Whincup et al., 2000, Yusuf and Mishra, 2002). Lastly, 
research focusing on the role of CagA- positive H. pylori strains in IHD, and 
detection of bacterial DNA in atherosclerotic plaques found no such links (Danesh et 
al., 1999, Danesh and Peto, 1998, Danesh et al., 2000, Koenig et al., 1999, Pellicano 
et al., 2002, Whincup et al., 2000).   
 In order to clarify the putative role of H. pylori in vascular disease and in 
particular atherosclerosis, it is necessary to examine the effect of the bacteria on the 
central mediator of lesion formations- the endothelium. Several in vitro studies 
describe profound effects of H. pylori-derived components on vascular endothelial 
properties and function. Incubation of microvascular endothelial cells with H. pylori 
extracts, or co-culture with the bacterium, has been shown to decrease cell viability 
(Kalia et al., 2001) and inhibit angiogenesis (Kalia et al., 2001, Jenkinson et al., 
2002) A recent study by Pearce et al. (2004) has shown that H. pylori extracts can 
inhibit proliferation in both human dermal microvascular endothelial cells 
(HDMvECs) and human umbilical vein endothelial cells (HUVECs). Moreover, 
Kurosawa et al. also demonstrate that H. pylori extracts inhibit proliferation, whilst 
inducing apoptosis in HUVECs, in a CagA/VacA-independent manner (Kurosawa et 
al., 2002). Other recent studies have also shown that H. pylori co-culture and H. 
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pylori-conditioned medium significantly increase recruitment and transendothelial 
migration of neutrophils (Brisslert et al., 2005, Innocenti et al., 2002).  
 In summary, cardiovascular disease refers to dysfunction of the heart and 
blood vessels and accounts for approximately one third of global deaths annually. 
Maintenance of a healthy endothelium is central in preventing the onset of 
cardiovascular disease and its development to a pathologic condition. Regions of the 
vasculature where blood-flow is perturbed, such as arterial bifurcations or vessel 
curvature, are preferential initiation sites for occlusive pathologies. At these 
locations, owing to reduced endothelial function and the presence of cardiovascular 
disease risk factors an inflammatory, pro-atherogenic phenotype predominates. 
However, traditional risk factors can only account for approximately 50% of 
atherosclerotic cases, and thus, research has focused on identifying other factors 
involved in the disease. Following discovery of its DNA in atherosclerotic plaques, 
the Gram-negative bacterium Helicobacter pylori, has been proposed as one such 
non-traditional risk factor. Numerous studies point to a positive association between 
H. pylori infection and markers of atherosclerosis such as C-reactive protein and 
adhesion molecule expression. Moreover, toxins secreted by the bacteria have 
known effects in promoting immune and inflammatory responses and importantly, 
disrupting endothelial function.  
 Whilst studies have examined the putative role of H. pylori in this respect, cell 
models employed thus far are quite diverse, and provide little or no information on 
cells of aortic or coronary artery origin where atherosclerotic plaque formation 
predominates. To address this knowledge deficit, the effects of H. pylori 60190 (a 
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strain positive for VacA, CagA and Urease) on apoptosis, proliferation, tube 
formation, migration, and tight junction integrity, was investigated, all in a single 
aortic endothelial cell model (BAEC). Moreover, as previously noted by the author, 
the major secreted virulence factor of the bacterium in culture is the VacA cytotoxin. 
To this end, the role of VacA on endothelial cell nitrite production- an early 
indicator of endothelial dysfunction was examined.  
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Chapter 2 
Materials and Methods 
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2.0 Material & Methods: 
 
All reagents used in this study were of the highest purity commercially 
available and were of cell culture standard when applicable. 
 
2.1 Materials: 
The American Type Culture Association (ATCC), (Middlessex, England) 
Helicobacter pylori Strain 60190 (ATCC 49503) 
 
AGB Scientific (Dublin, Ireland) 
Syringe Filters 
96-well white plates 
 
Amersham Pharmacia Biotech (Buckinghamshire, UK) 
Anti-rabbit 20antibody, HRP-conjugated 
BIOMOL Gmbh (Hamburg, Germany) 
E-coli BL21 strain 
 
Coriell Cell Repository (Camden, New Jersey) 
Bovine Aortic Endothelial Cells 
 
DakoCytomation (Glostrup, Denmark) 
Polyclonal Rabbit Anti-Human Von Willebrand Factor 
Fluorescent Mounting Media 
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Fisher Scientific (Leicestershire, UK) 
Buffer Solution pH 4 (phthalate) 
Buffer Solution pH 7 (phosphate) 
Buffer Solution pH 10 (borate) 
 
Millipore (Cork, Ireland) 
6-well Millicell® Hanging Cell Culture Insert 
 
Molecular Probes (Oregon, USA) 
Alexa Fluor® 488 F (ab’)2 fragment of goat anti-mouse IgG (H+L) 
Alexa Fluor® 488 F(ab’)2 fragment of goat anti-rabbit IgG (H+L) 
Alexa Fluor 546 Phalloidin 
Vybrant® Apoptosis Assay Kit 
Vybrant® CFDA-SE Cell Tracer Kit 
 
Nalgene (Rochester, New York) 
Cryogenic Vials 
Cryo Freezing Container 
 
Pierce Chemicals (Cheshire, UK) 
BCA Protein Assay Kit 
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Roche (Dublin, Ireland) 
Complete Protease Inhibitor  
 
Sarstedt (Wexford, Ireland) 
1.5 mL micro tube with safety cap 
10, 200 and 1000 µL pipette tips  
15 and 50 mL falcon tubes 
25 mL sterilin tubes 
5, 10 and 25 mL serological pipettes  
6-well tissue culture plates 
T-175 tissue culture flasks 
T-25 tissue culture flasks 
T-75 tissue culture flasks 
 
Sigma Chemical Company (Poole, Dorset, England) 
2-propanol 
2,3 Diaminonapthalene 
Ac-DEVD-pNA 
AEBSF 
Aproprotinin 
Ammonium Persulfate 
Agarose 
Acridine orange/Ethidium Bromide dual stain 
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Bovine Serum Albumin 
Brightline Haemocytometer 
Bromophenol Blue 
Chloroform 
Collagen, Type 1 Rat Tail 
Fetal Bovine Serum 
FITC-Dextran (FD-40) 
Formaldehyde 
Glycine 
Hanks Balanced Salt Solution 
HEPES 
Hydrochloric Acid 
Lauryl Sulfate (i.e. Sodium Doecyl Sulphate (SDS)) 
Leupeptin 
Mitomycin C 
Penicillin-Streptomycin (100x) 
Phosphate Buffered Saline 
pNitroanilide 
Ponceau S Solution 
Protease Inhibitor Cocktail 
Potassium Chloride 
Potassium Phosphate 
Potassium Phosphate-Dibasic Trihydrate 
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Potassium Hydroxide 
RPMI 1640 
Sodium Chloride 
Sodium Deoxycholate 
Sodium Nitrite 
Sodium Orthovanadate 
Sodium Phosphate-Dibasic (anhydrous) 
Sodium Phosphate-Monobasic (anhydrous) 
S-nitroso-N-acetylpenicillamine 
Triton® X-100 
Trizma Base 
Trypan Blue 
Trypsin-EDTA (10x) 
Tween® 20 
 
Zymed Laboratories (CA, USA) 
Mouse anti-ZO-1 Monoclonal Antibody 
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2.2      Cell Culture Methods 
 
 All cell culture procedures were carried out under clean, sterile conditions 
using a Bio Air 2000 MAC laminar flow unit.  Cells were monitored daily using and 
Olympus CK30 phase contrast microscope. 
 
2.2.1      Culture of Bovine Aortic Endothelial Cells (BAECs)  
 
 Cryopreserved passage four Bovine Aortic Endothelial Cells (BAEC) were 
obtained from Coriell Cell Repositories, (catalogue no. AG08500) New Jersey, 
USA. Cells were routinely grown in RPMI-1640 media, supplemented with 10% 
(v/v) foetal calf serum (FCS), 100 U/mL penicillin and 100 µg/mL Streptomycin to 
give RPMI-complete media. Cells were maintained in a humidified atmosphere of 
5% CO2/95% air at 37°C and cultured in T25 cm2, T75 cm2 and T175 cm2 flasks and 
6 well plates. All experiments were carried out on cells between passage 5 – 15. 
 
2.2.2      Trypsinization of BAECs  
 
 As BAECs are an adherent cell line, trypsinization was required for their 
sub-culture.  Briefly, growth media was removed by aspiration and the cells washed 
in Hank’s balanced salt solution (HBSS) to remove α-macroglobulin, a trypsin 
inhibitor present in FCS.  An appropriate volume of trypsin/ethylenediamene 
tetracetic acid (10% v/v Trp/EDTA in HBSS) was subsequently added to the cells 
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and incubated for 1 – 2 min at 370C, until the cells were rounded, but not fully 
detached, and then tapped briefly to detach them from the growth surface.  Growth 
media containing FCS was added to prevent further trypsinization and cells removed 
from suspension by centrifugation at 1,000 g for 5 min at 40C.  Cells were 
resuspended in growth media (or freeze media) and either counted using a bright line 
haemocytometer for experiments, split at a 1:5 ratio for further subculturing or 
cryopreserved. 
 
2.2.3      Cryogenic Preservation and Recovery of Cells 
 
 For long-term storage of cells, BAECs were stored in a commercial liquid 
nitrogen cryofreezer unit. Following trypsinization, cells were centrifuged at 1,000 x 
g for 5 min at 40C and supernatant was removed.  The resultant pellet was 
resuspended in an appropriate volume of freezing media (RPMI-1640 media 
containing 20% v/v FCS, 10% DMSO- Dimethyl sulfoxide, and antibiotics), 
transferred as 1 mL aliquots to Nalgene cryogenic vials and frozen in a -800C freezer 
at a rate of -10C/min in a Nalgene cryo-freezing container.  Cryovials were stored in 
the cryofreeze unit until required.  For recovery of cells, cryovials were heated 
rapidly in a 370C water bath and added to a T 75cm2 flask containing 15 mL of 
growth media to dilute the DMSO. After 24 h (approximately 80-90% plating 
efficiency), the media was removed and the cells were washed in HBSS and fresh 
growth media added.  
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2.2.4      Cell Counts 
 
Following trypsinization, cell counts were performed using a brightline 
haemocytometer in conjunction with Trypan blue staining to assess cell viability.  20 
µL of trypan blue was added to 100 µL of cell suspension and incubated at room 
temperature for 2 min.  10 µL of this suspension was added to the counting chamber 
of the haemocytometer (Brightline, Sigma) and visualized under phase contrast 
microscopy.  Dead cells stained blue, whilst viable cells excluded the dye and 
appeared colourless.  The number of viable cells was calculated according to the 
equation:  
Avg. cell no. x 1.2 (dilution factor) x 1x104 (area under coverslip) = Viable cells/mL 
 
2.2.5      Bacterial Growth and Fraction Generation 
 
  H. pylori 60190 (ATCC 49503- supplied as dessicate) was cultured on Pylori 
Agar Plates (BioMérieux®, Marcy l’Etoile, France) at 37oC under microaerophillic 
conditions (using Oxoid gas generating kit) and incubated for 7 days to allow 
sufficient growth to occur. For conditioned media preparation; (Forsyth and 
Cover, 2000) bacterial colonies were scraped off and re-suspended in 3 mL 
phosphate buffered saline (PBS). The optical density (OD) of the suspension was 
determined at 600 nm and adjusted to a final OD of 1.0 in PBS, corresponding to 
5X109 H. pylori bacteria/mL. (Innocenti et al., 2002). Exactly 2.5 ml of bacterial 
suspension was added to a T25 tissue culture flask containing 40 mls of RPMI 
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complete media and incubated at 37oC under microaerophillic (low oxygen) 
conditions for 24 h. Following this, conditioned media was sterile filtered using a 0.2 
µM filter to yield H.pylori-conditioned media (HPCM). Dilutions of HPCM in 
RPMI complete media were routinely prepared for individual experiments (i.e. 
undiluted = 100%, 1:2 dilution = 50% etc.). E-coli and 60190:VacA negative (kindly 
gifted by Prof. John Atherton, Nottingham University) conditioned media was 
prepared in a similar manner. Experiments typically involved exposure of BAECs to 
either 1 ml/well (i.e. migration, tube formation, 24-well format) or 2 ml/well (i.e. 
apoptosis, proliferation, immunocytochemistry, 6-well format) of control or test 
media. The chloride channel inhibitor NPPB (100 µM) benzoic acid (Gojova and 
Barakat, 2005), Urease (10 µg/mL) (Enarsson et al., 2005), S-nitroso-N-
acetylpenicillamine (SNAP) and L-NAME (nitrite inhibitor) were included in 
HPCM when required. 
 Outer membrane protein extraction was carried out according to the method 
of Utt et al. (Utt et al., 2002). Bacterial colonies were harvested by applying 1.5 mLs 
of sterile PBS pH 7.2 to each plate and gently scraping the cells from the plate 
surface. Subsequently, cells were washed once using PBS and re-suspended in 0.2 M 
glycine hydrochloride (pH 2.2) at a concentration of 4 g cells/100 mL. This 
suspension was then stirred at 20°C for 15 min and supplemented with complete 
protease inhibitors (Roche, Dublin, Ireland). Cells and cell debris were removed by 
centrifugation at 12000 x g for 15 min at 8°C. NaOH was added to the resultant 
supernatant to neutralise the acidity generated by the glycine-hydrochloride.  This 
solution was dialysed against PBS for 18 h at 4°C to yield a concentrated OMP 
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fraction. Following BCA assay for protein concentration, appropriate concentrations 
of OMP were added to RPMI complete media (typical additions were 0-8 µg/mL). 
E-coli outer membrane proteins were prepared in a similar manner. Both HPCM and 
outer membrane protein fractions were routinely stored at -80°C and thawed as 
required.  
 
2.2.6      Laminar Shear Stress Studies 
 
 For laminar shear stress studies, BAECs were seeded at 1 x 104 cells/cm2 in 6 
well plates and allowed to come to confluency, typically 2 – 3 days.  Following this, 
media was removed and replaced with 4 mL of fresh growth media.  Cells were then 
exposed to 0-10 dyne/cm2 of shear stress for 24 h on an orbital shaker (Stuart 
Scientific Mini Orbital Shaker OS) set to the appropriate RPM as determined by the 
following equation (Hendrickson et al., 1999). 
 
   
! 
ShearStress =" #n(2$f )3  
 
 Where  α = radius of rotation (cm) 
   ρ = density of liquid (g/L) 
n = 7.5 x 10-3 (dyne/cm2 at 370C) 
f = rotation per second 
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Figure 2.2.1:  Apparatus used in non-pulsatile laminar shear stress studies. 
2.2.7 Cyclic Strain Using the Flexercell® System 
2.2.8  
The Flexercell Strain Unit (Dunn Labortechnik, Germany) is an innovative 
microprocessor-driven instrument that regulates pressure to flexible bottomed 
Pronectin-coated BioFlex® plates to mechanically challenge cells in culture. It 
allows vascular cells to be exposed to a defined physiological level of cyclic strain in 
vitro. These two unique, novel, complementary technologies allow vascular 
endothelial cells to be examined under conditions of physiological pulse pressure 
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and cyclic strain and therefore scientific findings will realistically reflect the 
behaviour of the vasculature in response to haemodynamic forces. 
 
 
 
Fig 2.2.2a (above)- Effect of the Flex system on cells 
Fig 2.2.2b (below)- The Flexercell® System 
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Flexercell® Procedure 
 
BAECs were trypsinised and counted as described earlier. Each BioFlex® well 
is seeded with 1 x 105 cells and left to grow to confluency for 48 hours. After the 
cells have come to approximately 60-70% confluency the BioFlex® plate is mounted 
into the Flexercell® system, by gluing the loading post to the flexible membrane. 
The computer program corresponding to 10% strain is initiated and left running for 
exactly 24 hours, during this period the cells are kept incubated at 37°C with 5% CO2 
with humidity. A second BioFlex® plate, seeded as a control, remains unflexed (thus 
exposing it to 0% cyclic strain). Once the time course has finished the BioFlex® 
plate is removed from the baseplate and gasket, with subsequent excision of 
BioFlex® membranes for immunocytochemical staining.  
 
 
2.2.7      Immunocytochemistry 
 
 In order to visually monitor the expression and/or subcellular localization of 
proteins, cells were prepared for immunocytochemical analysis as previously 
described (Groarke et al., 2001) with minor modifications.  Cells were washed twice 
in phosphate buffered saline (PBS) and fixed with 3% (v/v) formaldehyde for 15 
min.  Cells were subsequently washed, permeabilised for 15 min with 0.2% (v/v) 
Triton X-100 and blocked for 30 min in 5% (w/v) BSA solution.  Following 
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blocking, cells were incubated with the appropriate primary anti-serum or stain as 
indicated in table 2.2.7.1, followed by 1 h incubation with 1:400 dilution of either 
Alexa Fluor 488-conjugated anti-mouse or anti-rabbit secondary anti-serum.  Nuclear 
DAPI staining was routinely performed by incubating cells with 0.5 x 10-6 µg/mL 
DAPI for 3 min.  Cells were sealed with coverslips using DAKO mounting media 
(DAKO Cytomation, Cambridgeshire, UK) and visualized by standard fluorescent 
microscopy (Olympus BX50). 
 
Primary Antiserum/Stain Concentration/Dilution Time (h) 
Rhodamine Phallodin 
(actin stain) 
1:200 1 
anti-Von-Willebrand 
(endothelial marker) 
1:1000 3 
anti-ZO-1 
(tight junction marker) 
0.25 µg/mL 2 
 
Table 2.2.1: Primary anti-sera and protein stains. 
 
2.2.8      Permeability Studies 
 
 To measure barrier function in BAECs, a permeability assay was employed. 
Following laminar shear stress studies in 6-well plates, cells were trypsinized and 
replated into Millipore-Clear Inserts at 2.5 x 105 cells/cm2.  After 24 h when cells 
were confluent, transendothelial permeability was measured as previously described 
(Collins et al., 2006).  At t=0, 40 kDa fluorescein isothiocyanate (FITC)-labelled 
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dextran was added to the abluminal chamber (to give a final concentration of 250 
µg/mL) and diffusion of dextran across the monolayer allowed to proceed at 37°C 
for 2 h. Media samples (30 µL) were collected every 30 min from the subluminal 
compartment and monitored in triplicate (7 µL sample + 93 µL media) for FITC-
dextran fluorescence at excitation and emission wavelengths of 490 and 520 nm, 
respectively (Perkin-Elmer Luminescence Spectrometer LS50B with microplate 
reader attachment). RPMI-complete media without FD40 dextran was used as a 
blank. % Trans Endothelial Exchange (%TEE) of FITC-dextran 40 kDa is expressed 
as the total subluminal fluorescence at a given time point (from 0-120 min) 
expressed as a percentage of total abluminal fluorescence at t=0 min. 
 
2.2.9      Preparation of Whole Cell Lysates 
 
 Post- treatment confluent BAEC monolayers in 6-well dishes were washed 
three times with HBSS and solubilised by the addition of 0.25 mL/well lysis buffer 
and incubation at 4°C for 1 h with agitation. Lysis buffer was a modified 
radioimmunoprecipitation assay (RIPA) buffer (49.92 mM HEPES- pH 7.5, 149.76 
mM NaCl, 1% v/v Triton X-100, 0.5% w/v sodium deoxycholate and 0.1% w/v 
SDS) supplemented with 0.1 M NaF, 5 mM EDTA- pH 8, 0.01 M NaPO4, 1.04 mM 
AEBSF, 0.08 µM aprotinin, 0.02 mM leupeptin, 0.04 mM bestatin, 0.015 mM 
pepstatinA, 0.014 mM E-64. Insoluble material was pelleted by centrifugation for 15 
min at 12,000 x g and the supernatant removed to fresh microfuge tubes. BCA 
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protein assay was performed, following which samples were stored at -80ºC until 
analysis was carried out.  
 
 
2.2.10 Caspase-3 Assay 
 
Caspase-3 activity, an index of apoptosis, was monitored according to the 
method of Sweeney et al. (Sweeney et al., 2004). 10 µl of Caspase-3 substrate (2 
mM Ac-DEVD-pNA containing 10% DMSO in 20 mM HEPES, 0.1% CHAPSO, 5 
mM DTT and 2 mM EDTA) was added to 10 µl cell lysates and diluted in assay 
buffer (20 mM HEPES, 0.1% CHAPSO, 5 mM DTT and 2 mM EDTA) to a final 
volume of 100µl. Samples were incubated for 90 min and the absorbance measured 
at 405nm using a Biotek® ELx800 plate reader. Appropriate negative controls and 
blanks were included in the assay. A pNitroanilide (pNA) standard curve (0-200 
µg/µl) was used for calculation of Caspase-3 specific activity worked out in µg 
substrate cleaved/ min/ µg protein at 37°C and converted to fold change relative to 
control for data presentation. 
 
2.2.11      Acridine Orange/Ethidium Bromide Cell Staining  
 
The staining of BAEC’s with the Acridine Orange/Ethidium Bromide 
(AO/EtBr) dual stain (10 µg/mL) allows concurrent determination of viable, 
apoptotic and necrotic cells. Procedures were carried out as per Sweeney et al. 
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(Sweeney et al., 2004). Post- treatment, BAECs were washed twice in PBS and 
fixed in ice cold isopropanol for 5 min. Cells were then rehydrated in 1x PBS for 8 
min, and stained with the AO/EtBr dual nuclear stain for 5 min, rinsed with PBS and 
visualized by standard fluorescent microscopy (Olympus BX50). 
 
2.2.12      FACS Analysis  
 
Post treatment, both apoptotic and proliferative BAEC phenotypes were 
monitored using flow cytometery as described by Gao et al., (Gao et al., 2007). 
Apoptosis: BAEC monolayers were washed once in HBSS and harvested by 
trypsinisation. Cells were pelleted by centrifugation at 1000 x g for 5 min and the 
supernatant removed. Cell pellets were washed by the addition of 1 mL ice-cold 1X 
PBS containing 0.1% BSA and resuspended by gentle pipeting. This was followed 
by centrifugation at 1000 x g for 5 min. Supernatant was discarded and the cells 
resuspended in 100 µl of 1X Annexin-Binding Buffer (10 mM HEPES, 140 mM 
NaCl, 2.5 mM CaCL2, pH 7.4). Propidium Iodide (0.4 µl from 100 µg/mL working 
solution) and AlexaFluor 488 Annexin V (1 µl of 25 mM HEPES, 140 mM NaCl, 1 
mM EDTA, pH 7.4 plus 0.1% BSA) were added to the cell suspension and 
incubated at room temperature for 15 min. Following incubation, a further 100 µl of 
1X Annexin-Binding buffer was added to the cells with gentle mixing. 
 Proliferation: 2X104 BAEC’s were seeded into 6-well plates and allowed to 
grow for 24 h. Subsequently the growth media was removed and cells were washed 
once with HBSS. A working solution of 5 µM CFDA SE (carboxy-fluorescein 
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diacetate succinimidyl ester) was prepared in an appropriate volume of HBSS to 
allow the addition of 1 mL CFDA-HBSS per well. CFDA-HBSS was added to the 
wells and cells incubated for 15 min at 37°C. Following incubation, the CFDA-
HBSS was removed and replaced with fresh, pre-warmed media and cells were 
allowed to recover for 12 h before overnight quiescence. Cells were treated with 
HPCM (0-25% dilutions) or OMP and harvested every 24 h for 5 days, pelleted by 
centrifugation at 1000 x g for 5 min and the supernatant removed. Cells were 
washed with 1 mL ice-cold 1X PBS containing 0.1% BSA and resuspended by 
gentle pipeting. This was followed by centrifugation at 1000 x g for 5 min before 
being resuspended in 100 µl of ice-cold 1X PBS containing 0.1% BSA.  
 Both apoptotic and proliferative samples were then placed on ice and 
analysed using a Becton Dickinson FACSCAN flow cytometer.  
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Fig. 2.2.3 Typical FACS analysis for apoptosis. R2= healthy cells (green), R3= Early apoptotic cells 
(purple), R4= Late apoptotic cells (blue), R5= Necrotic cells (orange). Apoptotic values for healthy 
BAEC ranged from approximately 1-4%.  
 
2.2.13      Wound Heal Assay 
 
  Wound heal assay was carried out as described by de Jonge et al (de Jonge et 
al., 2002). BAEC’s were seeded at 5x104 cells/well of a 24-well plate and allowed to 
grow for 24 h, following which they were quiesced overnight and treated with 
R1
File: Data.007 Sample ID: Ctrl BAEC 1.3
Acquisition Date: 11-Jan-06 Gated Events: 9946
Total Events: 10293
Region Events % Gated % Total
R1 9946 100.00 96.63
R2 9371 94.22 91.04
R3 306 3.08 2.97
R4 164 1.65 1.59
R5 111 1.12 1.08
R2
R3
R4
R5
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HPCM or OMP containing mitomycin C (2.5 µg/mL). In vitro wounds were created 
by scraping BAEC monolayers with a yellow tip. After injury, the wound was 
photographed at 2 distinct positions every 2 h and the distance between the two 
wound edges calculated using the Macintosh Free Ruler Version 1.6 program. 
BAEC migration was assessed by comparing distance between wound edges before 
and after treatment. 
 
 
Fig. 2.2.4 A typical tube formation assay. Distance (A) is measured at t=0 h and distance (B) at t=6 h, 
thus A-B= distance migrated.  
 
 
2.2.14      2,3-Diaminonaphthalene (DAN) Assay: 
 
This assay measures the concentration of nitrite (downstream product of NO 
pathway), which accumulates in conditioned media in vitro (Misko et al., 1993).  In 
vivo, NO is scavenged rapidly and undergoes a series of reactions leaving final 
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products nitrite (NO2-) and nitrate (NO3-). Nitrite can subsequently be reacted with 
2,3-diaminonaphthalene under acidic conditions to form a fluorescent product 
naphthalenetriazole. 100 μL of media sample or Nitrite Standards (0-100 pM) was 
added to a fluorometric plate with 10 μL DAN (0.05 mg/mL in 0.62 M HCl), and 
incubated for 20 min at 20oC. 5 μL of 2.8 M NaOH was subsequently added to 
provide the alkaline pH necessary for measuring naphthalenetriazole fluorescence.  
Fluorescence was measured using Excitation wavelength: 365nm, Emission 
wavelength: 450nm and at Slit widths Ex: 10 nm, Em: 7.5 nm using the Perkin 
Elmer LS50B Luminescent Spectrophotometer model (with plate reader 
attachment).   
 
 
2.2.15      Tube Formation Assay 
 
Collagen gels were prepared as previously described (Zheng et al., 2001).  
Briefly, a neutralized collagen mixture was prepared by mixing stock 1.5 mg/mL 
type I rat tail collagen (in 10 mM acetic acid), with growth medium and 1N NaOH.  
Typical mixture: 600 µl of collagen + 60 µl of culture medium + 50 µl of 1N NaOH.  
The mixture was pipetted into 24-well tissue culture plate (100 µl/well) and allowed 
to gel in an incubator containing 5% CO2-95% air at 37°C for 1 h. After 
polymerization the gels were then incubated with growth medium overnight at 37°C 
before use. 
Following 24 h treatment with HPCM (0-25% dilutions) or OMP, BAECs 
were trypsinized, cell counts were performed and 1.5X104 cells were resuspended in 
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RPMI complete media and seeded in each well of collagen gel. Cells were incubated 
overnight for 16-18 hours and tube formation monitored using an Olympus SP-350 
digital camera. Four random fields of vision were photographed from each gel and 
length of tube formation was quantified by measuring the length of the network of 
connected cells in each well (Von Offenberg Sweeney et al., 2005) using Olympus 
Cell* Imaging software for Life Sciences and Microscopy.  
 
 
Fig. 2.2.5 A typical tube formation assay. (A) Example of tube length in untreated cells (B) Example 
of tube length in treated cells. Arrows indicate tubes typically measured. 
2.2.16      Statistical Analysis 
 Results are expressed as mean ±SEM of a minimum of three independent 
experiments (n=3) unless otherwise stated.  Statistical comparisons were performed 
using unpaired Student’s t-test or Two-Way ANOVA with replication, where 
applicable. *P≤0.05, **P≤0.005, ***P≤0.0005, §P≤0.05, §§P≤0.005, §§§P≤0.0005 
were considered significant.  
A B 
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3.1 Introduction  
 
H. pylori is a Gram-negative, micro-aerophillic, spiral-shaped bacterium that 
colonises the human gastric epithelium and is strongly implicated in chronic 
gastritis, peptic ulcer disease, and gastric carcinoma (Hatakeyama, 2004). It 
represents one of the most widespread human infectious diseases. Central to the 
progression of infection and gastric colonization is the bacterium’s ability to bind 
and interact with the epithelial cell surface (Yamaoka et al., 2002). Much research 
has focused on the how these interactions occur, leading to the identification and 
characterization of 33 outer-membrane proteins. These proteins are  not only 
responsible for host cell binding, but many have been recognised as virulence factors 
responsible for the progression of gastric disease.  
Recent evidence suggests that infection with H. pylori is associated with 
atherosclerotic plaque formation (Haim Shmuelya  et al., 2005, Yamaoka et al., 
2002). Injury to the arterial wall resulting in endothelial dysfunction is considered 
pivotal to the pathogenesis of athersosclerosis, with angiogenesis and apoptosis 
prominent in plaque formation and rupture. Following the discovery of H. pylori 
DNA in atherosclerotic plaques (Ameriso et al., 2001), it has been postulated that 
that the OMP’s of H. pylori  may play a role in the progression of atherosclerosis by 
contributing to endothelial dysfunction.  
In this chapter, it was attempted to elucidate the putative contribution of H. pylori 
to endothelial dysfunction by investigating the angiogenic and apoptotic 
phenotype of vascular endothelial cells in response to exposure to H. pylori 
OMP’s in vitro. 
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3.2       Results 
 
3.2.1 Morphology of BAECs, H. pylori Outer Membrane Proteins have no 
effect on the BAEC cytoskeleton 
 
BAEC’s were monitored by phase-contrast microscopy (Fig. 3.2.1 a i) and 
Von Willebrand Factor VIII expression by immunocytochemistry. (Fig. 3.2.1 a ii) 
Cell’s were found to be of typical size and shape with characteristic “cobblestone” 
morphology, and tested positive for Von Willebrand Factor VIII.  
Following BAEC exposure to H. pylori OMP (8 µg/mL) for 24 h, no 
difference was observed in cytoskeletal formation (Fig. 3.2.1 b iii-iv) when 
compared to untreated control cells (Fig. 3.2.1 b i-ii), as determined 
immunocytochemically by F-actin staining with rhodamine phalloidin. 
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Fig. 3.2.1: Characterization on BAECs and the effect of H. pylori OMP on 
BAEC Cytoskeletal Formation: (a) (i) Endothelial “cobblestone” morphology 
(ii) Von Willebrand Factor VIII expression (green) (iii) Von Willebrand negative 
control- no primary antibody (b) Following exposure of BAECs to 8 µg/mL OMP 
for 24 h, Rhodamine Phallodin expression was examined as above. DAPI stained 
nuclei are shown in blue. Images are representative.  
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3.2.2 H. pylori Outer Membrane Proteins have no effect on BAEC apoptosis 
 
Following BAEC exposure to increasing concentrations of H. pylori OMP 
(0-8 µg/mL) for 24 h, flow cytometry indicated no increase in apoptosis relative to 
control (based on positive Annexin V and negative PI binding). Hydrogen peroxide 
(25 µM) was included as positive control and increased apoptosis by 4.13±0.03 fold 
relative to control (Fig. 3.2.2a). 
Following BAEC exposure to increasing concentrations of H. pylori OMP 
(0-8 µg/mL) and E. coli OMP (1 pg) for 24 h no increase in apoptosis relative to 
control was observed, as determined by Acridine Orange/Ethidium Bromide 
(AO/EtBr) dual stain. Cells show characteristic green fluorescence (Fig. 3.2.2b i-v), 
whereas positive apoptotic control cells (Fig. 3.2.2b vi), fluoresce a dark orange 
colour.  
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Fig. 3.2.2a: Effect of H. pylori OMP on BAEC apoptosis. Following BAEC 
exposure to OMP (0-8 µg/mL) for 24 h, cells were monitored for apoptosis by (a) 
FACS analysis. Histograms represent fold change relative to control and are 
averaged from seven independent experiments ±SEM. Hydrogen peroxide (25 µM 
H202) included as positive control. ***P≤0.005 versus control. 
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Fig. 3.2.2b: Effect of H. pylori OMP on BAEC apoptosis. Following BAEC 
exposure to H. pylori OMP (0-8 µg/mL) for 24 h, cells were monitored for apoptosis 
by AO/EtBr staining. (i-iv) Increasing OMP concentrations (v) E. coli OMP (1 ng) (vi) 
Positive apoptotic control. Images are representative. 
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3.2.3 H. pylori Outer Membrane Proteins decrease BAEC migration whilst 
increasing tube formation 
 
Following BAEC exposure to H. pylori OMP (0-1 µg/ml) for 24 h, cells were 
monitored for migration and tube formation. BAEC migration was reduced to 
0.71±0.049 and 0.62±0.069 of control at 0.5 and 1 µg/mL H. pylori OMP 
respectively (Fig. 3.2.4 a).  
BAEC tube formation was increased to 1.46±0.3 and 1.96±0.58 fold of 
control at 0.25 and 0.5 µg/mL H. pylori OMP respectively (Fig. 3.2.4 b).  
 
3.2.4 H. pylori Outer Membrane Proteins have no effect on BAEC 
proliferation. 
 
Following BAEC exposure to H. pylori OMP (8 µg/mL) for 24 h, no change 
in BAEC proliferation was observed, as monitored by either FACS analysis (Fig. 
3.2.4 a ii) or cell counts (Fig. 3.2.4 b).  
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Fig. 3.2.3: Effect of H. pylori OMP on BAEC migration and tube formation. 
Following BAEC exposure to OMP (0-1 µg/mL) for 24 h, cells were monitored for 
(a) Migration and (b) Tube formation. E. coli OMP (1 ng/mL) was included as 
positive bacterial control. Histograms represent fold change relative to control and 
are averaged from three independent experiments ±SEM. ***P≤0.005 versus 
control. 
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Fig. 3.2.4: Effect of H. pylori OMP on BAEC Proliferation. Following BAEC 
exposure to OMP (8 µg/mL) for 24 h, cells were monitored for proliferation by (a) 
FACS Analysis- (i) Typical shift in cell body following 4 days proliferation (ii) - 
grey shaded area represents untreated control cells overlayed with black line 
representing OMP (b) Cell counts. Histograms represent fold change relative to 
control and are averaged from three independent experiments ±SEM.  
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3.2.5 H. pylori Outer Membrane Proteins have no effect on BAEC ZO-1 
localisation. 
Following 24 h culture of BAECs in the presence of H. pylori OMP (8 
µg/mL) and under conditions of 10 dyne/cm2 laminar shear (upregulates endothelial 
barrier formation), subcellular localization of ZO-1 within BAEC monolayers was 
monitored by immunocytochemistry. In sheared cells, OMP treatment saw no 
change in continuous ZO-1 immunoreactivity along the cell- cell border (3.2.5)  
 
3.2.6 H. pylori Outer Membrane Proteins have no effect on BAEC 
permeability and nitrite production. 
Following BAEC exposure to H. pylori OMP (8 µg/mL) and 10 dyne/cm2 
laminar shear for 24 h no increase in permeability relative to control (0 µg/mL) was 
observed, as determined by permeability assay. Unsheared BAECs were included as 
a positive control and demonstrated slightly increased FD40 Dextran flux of 2.7±0.2 
% relative to sheared control cells (Fig. 3.2.6a) 
Similarly, no increase in sodium nitrite production (an indicator of cell 
function) was observed in BAECs incubated with 8 µg/mL OMP for 24 h, as 
determined by DAN assay. Shearing of BAECs increased sodium nitrite production 
2.2±0.07 fold over unsheared control (Fig. 3.2.6b). 
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Fig. 3.2.5: Effect of H. pylori OMP on BAEC ZO-1 membrane localization. 
Following exposure of cyclically strained BAECs to 8 µg/mL OMP for 24 h, cells 
were immunocytochemically monitored for ZO-1 localization (i) 0 µg/mL OMP (ii) 
Unsheared control (iii) 8 µg/mL (iv) Negative control (no primary antibody). White 
arrows indicate plasma membrane localization of ZO-1. DAPI-stained nuclei (Blue) 
are clearly visible. Images are representative. 
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Fig. 3.2.6: Effect of H. pylori OMP on BAEC Permeability and Nitrite 
production. Following BAEC exposure to OMP (8 µg/mL) and shear for 24 h, 
cells were monitored for (a) Permeability. Histograms represent transendothelial 
permeability to Dextran after 3 h, and are averaged from three independent 
experiments ±SEM. (b) Nitrite production. L-Name (1 mM) included as positive 
control. Histograms represent fold change relative to control and are averaged 
from three independent experiments ±SEM. ***P≤0.005 versus control. 
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3.3 Discussion 
 
The outer membrane proteins of H. pylori display many properties not commonly 
found in other bacteria. Its Lipopolysaccharide (Lps) contains fucosylated 
oligosaccharide antigens that are similar to Lewis antigens, allowing molecular 
mimicry and eliciting only a weak immune response. In contrast, the Lps of E. coli is 
the governing factor in initiating a strong host immune response (Knapp et al., 
2003). Outer inflammatory Protein A (Oip A) acts not only as an adherence protein, 
but also induces inflammation (Yamaoka et al., 2002). Even the flagella of H. pylori 
differ from many bacteria. Similarly to Lps, they induce only a weak immune 
response. Importantly, many OMPs are also thought to contribute to gastric injury, 
and even to the progression of gastric diseases (Cover, 2006). While the function of 
many of the 33 OMPs are known (see table 3.3.1), much research remains on 
establishing all effects associated with the proteins. For the above reasons, the OMPs 
represent an interesting area of study with many possibilities and potential roles in 
not only altering the cell to which they interact with, but also inducing disease states. 
 Numerous studies have reported a link between H. pylori and atherosclerosis 
(Grabczewska et al., 2006, Grebowska et al., 2006, Kaplan et al., 2006, Triantafilou 
et al., 2007). Central to these studies is the possibility that endothelial dysfunction, 
resulting from an interaction between the bacterium and the endothelium, can initiate 
and even progress the formation of an atherosclerotic plaque. To the author’s 
knowledge little or no research has been carried out on the effect of H. pylori OMP’s 
directly on endothelial cells. To this end, endothelial properties and function were 
investigated following exposure to a H. pylori OMP fraction. 
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Table 3.3.1. Adhesions and virulence-associated proteins of H. pylori. (Kusters et al., 2006) 
 
Initial investigations focused on whether OMP has any effect on the BAEC 
cytoskeleton by examining actin expression. Since actin participates in a host of 
cellular functions such as muscle contraction, cell division, cell signalling, cell 
junction maintenance and cell shape, any alteration in actin dynamics may indicate a 
change in cell function. However, no such alteration was observed in response to 
OMP treatment. Previous studies have indicated that both the CagA and VacA 
proteins of the bacterium are responsible for actin rearrangements in gastric cells 
(Hennig et al., 2005, Selbach et al., 2003). Hence, this result potentially points to the 
purity of our OMP preparation, with no VacA or CagA present. We next determined 
whether OMP had any effect on BAEC apoptosis, but similar to results found in 
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epithelial cells (Toyoda et al., 2005), no effect was shown with concentrations of up 
to 8 µg/mL OMP.  
 In order to examine the angiogenic phenotype of our cells in response to H. 
pylori we looked at BAEC migration and tube formation, processes that are central 
not only in angiogenesis, but to maintenance of a healthy endothelium. Interestingly, 
incubation with OMP decreased BAEC migration, whilst increasing tube formation, 
In an atherosclerotic phenotype for example, where endothelial dysfunction 
predominantes and the endothelium is unable to sufficiently repair a vascular injury, 
it would be expected that both tube formation and migration are decreased. Due to 
lack of comparable data, it can only be speculated as to why we observed opposing 
effects. One possibility may be that the integrins involved in migration (as discussed 
in Section 1.2.2.2) are not sufficiently stimulated after 24 h to initiate migration. Cell 
migration speed is limited by the rate of integrin attachment at the front of the cell 
and detachment at the cell rear. Since integrin activation, binding and disassociation, 
follow a bell-shaped curve (Palecek et al., 1999), it is conceivable that after 6-8 h, 
the integrins, following an “all or nothing” migratory response may not yet have 
reached their peak rate of disassociation and thus no positive migration relative to 
control is occurring, however this does not explain the decrease we have observed. 
A second theory is the possibility that, as many functions of the outer membrane 
proteins remain unclear there may simply be anti-migratory or pro-angiogenic 
stimuli in the fraction preparation. Finally, as this model was conducted in an in 
vitro system which would differ to the exact manner in which OMP’s might come 
into contact with the endothelium in vivo the result may be artifactual. Further 
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studies may clarify whether any of these theories are correct. An experiment 
examining the activation profile of the integrins involved in migration over time 
should yield a clearer answer on their involvement. Moreover, isolation and testing 
the functions of individual OMP’s in an in vivo model, would greatly enhance our 
understanding of their actions and may allow determination of which protein(s) in 
particular are causing these opposing effects. 
 Further investigation also revealed that OMP has no effect on BAEC 
proliferation. This is similar to the findings of Toyoda et al., where OMP was shown 
to have no effect on cell cycle of gastric cancer cell lines (MKN45 cells) (Toyoda et 
al., 2005). In addition to the examination of cell properties, the effect of OMP on 
vascular endothelial barrier integrity was also monitored. Previous work by our 
group has demonstrated endothelial barrier up-regulation in response to cyclic 
circumferential strain and shear stress, in BAECs (Collins et al., 2006) and bovine 
brain microvascular endothelial cells (BBMvECs) (Colgan et al., 2007b), 
respectively. For these studies, immunoreactivity of tight junction zonnula 
occludens-1 (ZO-1) along the cell-cell border was successfully employed as an 
index of barrier integrity. Following incubation of BAECs with OMP, ZO-1 
localization was well defined and continuous along the cell-cell border in both 
untreated and treated cells. These results indicate an intact and fully functional 
barrier. Consistent with these ZO-1 stain findings, an FD-40 Dextran permeability 
assay was also employed and flux of FD40 across a cell monolayer did not change in 
response to OMP treatment.  
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The role of both proliferation and barrier function in atherosclerosis has been 
well documented. In particular, a weakened barrier resulting in an influx of 
lipoproteins, is a hallmark of atherosclerotic plaque initiation (Peters et al., 2007). 
Since no change in either proliferation or permeability is occurring following 
incubation with OMP, it would suggest that these proteins may not contribute to the 
endothelial dysfunction associated with vascular disease. To add further weight to 
this, nitrite production by BAECs was examined following incubation with OMP. 
As previously discussed (section 1.2), attenuation of NO is one of the earliest 
biochemical changes preceding endothelial dysfunction. No change in BAEC nitrite 
levels was found after incubation with OMP.  
These results, when viewed collectively suggest that H. pylori OMP has 
relatively minor effects on BAEC properties and function in vitro. This further 
suggests a limited role for these proteins with respect to endothelial dysfunction in 
vivo. While it is possible that OMP’s directly interact with the endothelium, there 
was no evidence they interfere with a cell’s functional properties in a pro-
atherogenic manner in vitro. Moreover, it may be necessary for the intact bacterium 
to be present forming an integrated response for OMP virulence to be fully realised. 
However, it is important to note that studies have identified other mechanisms by 
which OMPs could in fact contribute to the progression of an atherosclerotic 
phenotype. OipA is one such mechanism, as it has been shown to promote 
inflammation (Yamaoka et al., 2000)-  a key event in atherosclerosis. In addition, 
Triantafilou et al. have indicated that the Lps from H. pylori can induce 
inflammatory responses through toll-like receptor 2 in human endothelial cells 
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(Triantafilou et al., 2007). Alp A and B have been identified as important in 
adherence to epithelial cells resulting in gastric colonization and have even been 
identified for use in vaccines against H. pylori (de Jonge et al., 2004).  
 In conclusion, H. pylori OMPs have the ability to influence BAEC migration 
and tube formation, without affecting proliferation, apoptosis or barrier function. 
From published data, it is possible that if OMPs are involved in atherosclerosis they 
may play two key roles. Firstly, they facilitate adherence of the bacterium to 
endothelial cells (as they do in epithelial cells). Following adhesion, the bacteria can 
inject highly virulent molecules such as CagA, or secrete VacA, both of which have 
profound effect on the endothelium. Secondly, OMP’s have the ability to stimulate 
production of inflammatory cytokines such as Il-8 (Yamaoka et al., 2002), hence 
exacerbating or even initiating a vascular lesion. It is also worth noting that H. pylori 
has the ability to “shed” its OMPs. This means that the bacteria itself would not have 
to be in contact with the endothelium, but its released components could travel in the 
bloodstream and interact with the vessel wall. This, coupled with the ability of 
OMPs to induce inflammation and govern adherence to host cells, means a role for 
H. pylori OMP’s in atherosclerotic plaque initiation or development cannot be 
discounted. However, from these studies the link appears unlikely.  
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4.1 Introduction 
 
Seroepidemiological and eradication data suggest a casual relationship between H. 
pylori infection and atherosclerosis/coronary heart disease (Ando et al., 2006, 
Grabczewska et al., 2006). Elevated levels of homocysteine (Corrado and Novo, 
2005), asymmetric dimethylarginine (Marra et al., 2005) and serum lipids (Laurila et 
al., 1999) associated with H. pylori infection have all been presented as possible 
contributors to atherogenesis. Importantly, H. pylori-specific DNA and VacA cross-
reactive antigens have been detected in atherosclerotic plaques (Kowalski et al., 
2002), suggesting a direct interaction of the bacterium with vessel wall, and 
potentially the initiation of an atherosclerotic phenotype.  
Studies indicate that the role of H.pylori in atherosclerosis may derive from 
its effects on endothelial cell fate and barrier function. Incubation of microvascular 
endothelial cells with H.pylori extracts, or direct co-culture with the bacterium, has 
been shown to decrease cell viability (Kalia et al., 2001) and inhibit angiogenesis 
(Jenkinson et al.). A recent study by Pearce et al. has shown that H.pylori extracts 
can inhibit proliferation in both human dermal microvascular endothelial cells 
(HDMvECs) and human umbilical vein endothelial cells (HUVECs) (Pearce et al., 
2004), whilst studies by Kurosawa et al. demonstrate that H.pylori extracts inhibit 
HUVEC proliferation and induce apoptosis in a CagA/VacA-independent manner 
(Kurosawa et al., 2002). Other recent studies have also shown that H.pylori-
conditioned medium and co-culture significantly increase neutrophil recruitment and 
transendothelial migration (Enarsson et al., 2005). 
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Despite these observations, the issue of H.pylori infection and atherosclerosis 
is still controversial, the precise mechanism(s) of microbial translocation from 
gastric epithelium to arterial lumen as yet to be determined. Vascular endothelial cell 
models employed are quite diverse, yielding data of limited mechanistic value. 
Moreover, to our knowledge, no studies of this type have been performed in 
endothelial cells of aortic or coronary artery origin, where atherosclerosis typically 
predominates.  
 
In this chapter, to help address this knowledge deficit, the effects of H.pylori 
conditioned medium on bovine aortic endothelial cell (BAEC) properties and 
function was investigated. 
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4.2 Results 
 
4.2.1 HPCM alters BAEC morphology and causes cell vacuolation. 
 
Following BAEC exposure to HPCM (0-100%) for 24 h, cell morphology 
and vacuolation were examined by phase-contrast microscopy. Incubation of BAECs 
with HPCM concentrations of 50% and greater induced extensive vacuole formation 
(Fig. 4.2.1 iii-viii), and a change in cell shape to an elongated phenotype- commonly 
referred to as a “hummingbird” phenotype. These effects were not present at or 
below HPCM concentrations of 25% (Fig. 4.2.1 ix-x). 
 
4.2.2 H. pylori Conditioned Media alters BAEC cytoskeletal formation. 
 
Following BAEC exposure to HPCM (0-100%) for 24 h, actin cytoskeletal 
formation was examined immunocytochemically by staining with rhodamine 
phalloidin. Incubation of BAECs with HPCM concentrations of 25% and greater 
(Fig. 4.2.2 iii-x) revealed significant increase in actin expression and stress fibre 
distribution.  
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Fig. 4.2.1: Effect of HPCM on BAEC morphology. Following BAEC exposure 
to HPCM (0-100%) for 24 h, cell morphology was examined by phase contrast. (i-
ii) 0% HPCM (iii-x) Decreasing HPCM dilutions. Black arrows indicate 
vacuolation. Images are representative. 
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Fig. 4.2.2: Effect of HPCM on BAEC cytoskeletal formation. Following BAEC 
exposure to HPCM (0-100%) for 24 h, actin cytoskeletal formation was examined 
by Rhodamine-Phallodin expression using standard fluorescent microscopy. (i-ii) 
0% HPCM (iii-x) Decreasing HPCM dilutions. White arrows indicate actin- 
filaments. Images are representative. 
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4.2.3 HPCM  increases BAEC apoptosis in a dose-dependent manner. 
 
Following BAEC exposure to HPCM (100%) for 24 h, apoptosis increased 
by 8.05±0.65 fold over control, as determined by flow cytometry. This figure 
decreased dose-dependently to 2.75±0.1 fold at 50% HPCM, whilst lower 
concentrations showed no significant increase (Fig. 4.2.3 a).  
Similar dose-dependent trends were observed by Caspase-3 assay, with 
2.37±0.38 and 1.14±0.06 fold increases in apoptosis over control at 100% and 50% 
HPCM respectively (Fig. 4.2.3 b). 
Following BAEC exposure to HPCM (0-100%) for 24 h, BAEC apoptosis 
was examined by AO/EtBr staining. HPCM concentrations of 25% and above 
displayed a dose-dependent increase in orange fluorescence- an apoptotic indicator 
(Fig. 4.2.4 iii-iv). For subsequent experiments HPCM dilutions at or below 25% 
were employed. 
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Fig. 4.2.3: Effect of HPCM on BAEC apoptosis. Following BAEC exposure to 
HPCM (0-100%) for 24 h, cells were monitored for apoptosis by (a) FACS 
analysis and (b) Caspase-3 assay. Histograms represent fold change relative to 
control and are averaged from three independent experiments ±SEM. Hydrogen 
peroxide (5, 10 and 25 µM H202) included as positive control. *P≤0.05 versus 
control. **P≤0.005 versus control. ***P≤0.0005 versus control. 
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Fig. 4.2.4: Effect of HPCM on BAEC apoptosis. Following BAEC exposure to 
HPCM (0-100%) for 24 h, cells were monitored for apoptosis by AO/EtBr staining. 
(200x). (i) 0% HPCM, (ii) 100% HPCM, (iii) 25% HPCM, (iv) 8.33% HPCM. White 
arrows indicate vacuoles. Images are representative. 
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4.2.5 HPCM decreases BAEC migration and tube formation in a dose-
dependent manner. 
 
Following BAEC exposure to HPCM (0-25%) for 24 h, cells were monitored 
for migration and tube formation. BAEC migration was dose-dependently reduced to 
0.69±0.02 fold of control at 25% HPCM (Fig. 4.2.5 a), whilst BAEC tube formation 
was dose-dependently reduced to 0.67±0.04 fold and 0.37±0.02 fold of control at 
12.5 and 25% HPCM, respectively (Fig. 4.2.5 b). E. coli- conditioned media was 
included in both experiments as a Gram-negative bacterial control and had no effect 
on migration or tube formation. 
 
4.2.6  HPCM decreases BAEC proliferation in a dose-dependent manner. 
 
Following BAEC exposure to HPCM (0-25%), cells were monitored for 
proliferation over 4 days. A dose-dependent decrease in BAEC proliferation with 
increasing HPCM concentration was observed by FACS analysis (Fig. 4.2.6a). 
Similarly, at 25% HPCM, BAEC proliferation decreased to 0.57±0.01 fold of 
control, as determined by cell counts (Fig. 4.2.6b). E. coli- conditioned media was 
included in both experiments as a gram-negative bacterial control and had no effect 
on proliferation. 
 
 130 
a
b) 
Ca
sp
as
e-
3 
as
sa
y- 
Fig. 4.2.5: Effect of HPCM on BAEC Migration and Tube Formation. 
Following BAEC exposure to HPCM (0-25%) for 24 h, cells were monitored for 
(a) Migration and (b) Tube formation. E. coli conditioned media was included as 
gram-negative bacterial control. Histograms represent fold change relative to 
control and are averaged from three independent experiments ±SEM. *P≤0.05 
versus control. **P≤0.005 versus control. ***P≤0.0005 versus control. 
control. 
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Fig. 4.2.6a: Effect of HPCM on BAEC Proliferation. Following BAEC exposure 
to HPCM (0-25%) for 4 days, proliferation was monitored by FACS Analysis. (i) 
Arrow shows shift in cell population after 4 days (ii) 0 vs. 8.33% (iii) 0 vs. 10% (iv) 
0 vs. 12.5% (v) 0 vs. 16.67% (vi) 0 vs. 25% (vii) 0 vs. E. coli. Grey shaded area 
represents untreated control cells whilst black line represents HPCM treated cells. 
E. coli conditioned media was included as gram-negative bacterial control. Curves 
are representative. 
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Fig. 4.2.6b: Effect of HPCM on BAEC Proliferation. Following BAEC exposure 
to HPCM (0-25%) for 4 days, proliferation was monitored by cell counts. E. coli 
conditioned media was included as a gram-negative bacterial control. Histograms 
represent fold change relative to control and are averaged from three independent 
experiments ±SEM. ***P≤0.005 versus control. 
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4.2.7 NPPB blocks the HPCM-mediated decrease in BAEC tube formation 
and migration. 
 
 Following BAEC exposure to 25% HPCM for 24 h in the absence and 
presence of NPPB, cells were monitored for migration and tube formation. NPPB is 
an inhibitor known to selectively block the chloride channels through which VacA 
elicits its effects. Exposure of cells to NPPB reduced baseline migration to 
0.95±0.08 fold of control, whilst 25% HPCM reduced tube formation to 0.75±0.011 
fold of control. Exposure of BAECs to 25% HPCM in the presence of NPPB 
completely reversed the effect of HPCM on BAEC migration (Fig. 4.2.7 a). 
Furthermore, exposure of cells to 25% HPCM also reduced tube formation to 
0.39±0.008 fold of control, an effect that was completely reversed by treatment with 
NPPB (Fig. 4.2.7 b). Urease (which is also found in HPCM) was included in both 
experiments to elucidate its role on BAEC function. No effect was observed 
following incubation with the enzyme on BAEC migration or tube formation. 
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Fig. 4.2.7: Effect of NPPB on HPCM-induced changes in BAEC tube 
formation and migration. Following BAEC exposure to 25% HPCM for 24 h in 
the absence and presence of 100 mM NPPB, cells were monitored for (a) Tube 
formation and (b) Migration. Histograms are averaged from three independent 
experiments ±SEM. ***P≤0.005 versus control. §P≤0.005 versus 25% HPCM. 
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4.2.8 NPPB blocks the HPCM-mediated decrease in BAEC 
proliferation. 
 
Following BAEC exposure to 25% HPCM in the absence and presence of 
NPPB, cells were monitored for proliferation over 2 days by FACS Analysis. As 
previously shown, 25% HPCM reduced proliferation relative to control, however 
inclusion of NPPB in 25% HPCM completely reversed the effect of HPCM on 
BAEC proliferation. Urease had no effect on proliferation (Fig 4.2.8a). 
Similarly, cell counts revealed that exposure of cells to NPPB reduced 
baseline proliferation to 0.82±0.01 fold of control, whilst 25% HPCM reduced 
proliferation to 0.64±0.01 fold of control. Exposure of BAECs to 25% HPCM in the 
presence of NPPB completely reversed the effect of HPCM on BAEC proliferation. 
Urease had no effect on proliferation relative to control (Fig 4.2.8b). 
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(ii) 
0% vs NPPB 
(iii) 
0% vs 25% 
(iv) 
0% vs 25% + NPPB 
(v) 
0% Day 1 vs 0% Day 2 
(i) Cell Body 
Shift 
  
Fig. 4.2.8a: Effect of NPPB on HPCM-induced changes in BAEC proliferation. 
Following BAEC exposure to 25% HPCM for 48 h in the absence and presence of 100 
mM NPPB, cells were monitored for proliferation by FACS Analysis. (i) Arrow shows 
shift in cell body after 2 days (ii) 0 vs. Urease (iii) 0 vs. NPPB (iv) 0 vs. 25%, arrow 
indicates shift in cell body (v) 0 vs. NPPB. Grey shaded area represents untreated 
control cells whilst black line represents HPCM treated cells. Curves are representative. 
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Fig. 4.2.8b: Effect of NPPB on HPCM-induced changes in BAEC proliferation. 
Following BAEC exposure to 25% HPCM for 24 h in the absence and presence of 
100 mM NPPB, cells were monitored for proliferation by cell counts. Histogram 
represents fold change relative to control and is averaged from three independent 
experiments.  ±SEM. ***P≤0.005 versus control. §P≤0.005 versus 25% HPCM. 
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4.2.9  NPPB blocks the HPCM-mediated decrease in BAEC barrier        
function. 
 
Following exposure of sheared BAECs to 25% HPCM for 24 h in the 
absence and presence of NPPB, cells were immunocytochemically monitored for 
ZO-1 localization, as described previously. Consistent with an intact endothelial 
barrier, ZO-1 immunoreactivity exhibited a continuous, well-defined pattern of 
localization along the cell-cell border under untreated conditions in the absence or 
presence of NPPB, Urease and E. coli conditioned media (Fig. 4.2.9 i-iii, vii). 
Following 25% HPCM treatment however, ZO-1 membrane localization became 
highly discontinuous and jagged along the cell-cell border, an effect that was 
prevented by treatment with NPPB (Fig. 4.2.9 vi).  
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Fig. 4.2.9: Effect of NPPB on HPCM-induced changes in BAEC ZO-1 
membrane localization. Following exposure of cyclically strained BAECs to 25% 
HPCM for 24 h in the absence and presence of 100 mM NPPB and Urease (10 
µg/mL), cells were immunocytochemically monitored for ZO-1 localization. White 
arrows indicate plasma membrane localization of ZO-1. (i) 0% (ii) 0% + Urease (iii) 
0% + NPPB (iv) Unsheared Control (v) 25% HPCM (vi) 25% HPCM + NPPB (vii) 
E. coli (viii) Negative control with DAPI stained nuclei. Images are representative. 
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4.2.10  VacA- HPCM does not induce vacuole formation in BAECs. 
 
Following BAEC exposure to HPCM (100%) from VacA+ and VacA- (VacA 
negative strain produced from the parental 60190 VacA+ strain through gene 
deletion) for 24 h, cell vacuolation was examined by vacuolation assay. BAECs 
incubated in either VacA- HPCM or E. coli conditioned media showed no 
vacuolation (Fig. 4.2.10 ii, iv). Cells incubated with VacA+ HPCM showed extensive 
vacuolation (Fig. 4.2.10 iii).  
 
4.2.11  VacA- HPCM has no effect on BAEC migration or tube 
formation. 
 
Following BAEC exposure to HPCM (25%) from VacA+ and VacA- strains 
for 24 h, cells were monitored for migration and tube formation. BAEC migration 
was reduced to 0.70±2.26 fold of control following incubation with VacA+ HPCM, 
whilst VacA- HPCM did not alter migration in comparison to untreated control (Fig. 
4.2.13 a). Similarly, BAEC tube formation was reduced to 0.41±0.01 of control with 
VacA+ HPCM, whilst VacA- HPCM had no effect (Fig. 4.2.13 b). In both 
experiments, E. coli conditioned media was included as a gram-negative bacterial 
control, and had no effect. 
 
 141 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2.10: Effect of different HPCM strains on BAEC vacuolation. Following 
BAEC exposure to 25% HPCM (VacA+ and Vac– 60190 strains) and E. coli 
conditioned media for 24 h, cells were examined by vacuolation assay. Black 
arrows indicate vacuoles. (i) Ctrl no conditioned media (ii) Vac- HPCM (iii) Vac+ 
HPCM (iv) E. coli conditioned media. Images are representative. 
 
 142 
Fig. 4.2.11: Effect of different HPCM strains on BAEC tube formation and 
migration Following BAEC exposure to 25% HPCM (VacA+ and Vac– strains) for 
24 h, cells were monitored for (a) Tube formation and (b) Migration. Histograms 
are averaged from three independent experiments ±SEM. E. coli- conditioned 
media included as gram-negative bacterial control. ***P≤0.005 versus control. 
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4.2.12 VacA- HPCM has no effect on BAEC proliferation. 
 
Following BAEC exposure to HPCM (25%) from VacA+ and VacA- strains 
for 4 days, cell proliferation was examined by FACS analysis and cell counts. FACS 
analysis showed a decrease in proliferation of BAECs incubated with VacA+ HPCM, 
while VacA- HPCM had no effect (Fig. 4.2.12a). 
Similarly, cell counts revealed proliferation was reduced to 0.65±0.01 fold of 
control following incubation with VacA+ HPCM, however VacA- HPCM had no 
effect (Fig. 4.2.12b). In both experiments E. coli- conditioned media was included as 
a gram-negative bacterial control, and had no effect relative to untreated control. 
 
4.2.13  VacA- HPCM has no effect on BAEC barrier function. 
 
Following exposure of sheared BAECs to HPCM (25%) from VacA+ and 
VacA- strains, cells were immunocytochemically monitored for ZO-1 localization. 
ZO-1 immunoreactivity exhibited a continuous, well-defined pattern of localization 
along the cell-cell border under control and VacA- conditions (Fig. 4.2.13 i-ii). 
Under VacA+ conditions however, ZO-1 membrane localization became highly 
discontinuous and jagged along the cell-cell border (Fig. 4.2.13 iii).  
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Fig. 4.2.12a: Effect of different HPCM strains on BAEC proliferation. 
Following BAEC exposure to 25% HPCM (VacA+ and VacA– strains) for 24 h, 
cells were monitored for proliferation by FACS analysis. Grey shaded area 
represents untreated control cells whilst black line represents conditioned media 
treated cells. E. coli- conditioned media included as gram-negative bacterial control. 
(i) 0% vs. VacA- (ii) 0% vs. VacA+  (iii) 0% vs. E. coli conditioned media. Curves 
are representative.  
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Fig. 4.2.12b: Effect of different HPCM strains on BAEC Proliferation. 
Following BAEC exposure to 25% HPCM (VacA+ and VacA– strains) for 24 h, 
cells were monitored for proliferation by cell counts. E. coli- conditioned media 
included as gram-negative bacterial control. Histograms represent fold change 
relative to control and are averaged from three independent experiments ±SEM. 
***P≤0.005 versus control. 
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Fig. 4.2.13: Effect of different HPCM strains on BAEC ZO-1 membrane 
localization. Following exposure of cyclically strained BAECs to 25% HPCM 
(VacA+ and Vac– strains) for 24 h cells were immunocytochemically monitored for 
ZO-1 localization. White arrows indicate plasma membrane localization of ZO-1. 
DAPI-stained nuclei are clearly visible. (i) 0% HPCM (ii) 25% VacA- HPCM (iii) 
25% VacA- HPCM. Images are representative. 
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4.2.14  VacA- HPCM has no effect on BAEC permeability  
Following exposure of sheared BAECs to 25% HPCM (cells are initially 
sheared to increase permeability so that change is more discernible) from VacA+ and 
VacA- strains, VacA- HPCM caused no increase in permeability over control. 
BAECs incubated with VacA+ HPCM increased permeability 1.127 fold. E. coli- 
conditioned media was included as a gram-negative bacterial control and had no 
effect (Fig. 4.2.14).  
 
4.2.15  VacA- HPCM has no effect on BAEC nitrite production. 
 
Following exposure of BAECs to 25% HPCM from VacA+ and VacA- 
strains, changes in sodium nitrite production were examined by DAN assay. 
Incubation of BAECs with VacA+ HPCM reduced sodium nitrite levels to 0.46±0.02 
fold of control. E. coli- conditioned media had no effect (Fig. 4.2.15). 
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Fig. 4.2.14: Effect of different HPCM strains on BAEC. Following exposure of 
sheared (10 dyne/cm2) BAECs to 25% HPCM (VacA+ and VacA– strains) for 24 h 
cells were cells were monitored for permeability. E. coli- conditioned media was 
included as gram-negative bacterial control. Histograms represent fold change 
relative to unsheared control and are averaged from three independent experiments 
±SEM. ***P≤0.005 versus control. §P≤0.005 versus VacA+. 
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Fig. 4.2.15: Effect of different HPCM strains on BAEC Permeability and 
Nitrite production Following BAEC exposure to 25% HPCM (VacA+ and VacA– 
strains) for 24 h, cells were monitored for Nitrite production. E. coli- conditioned 
media included as positive control, L-Name included as negative control. 
Histograms represent fold change relative to control and are averaged from three 
independent experiments ±SEM. ***P≤0.005 versus control. 
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4.2.16 SNAP recovers the VacA+ HPCM-mediated decrease in BAEC    
migration and tube formation. 
Following BAEC exposure to 25% HPCM (VacA+ and VacA-) for 24 h in 
the absence and presence of SNAP, cells were monitored for migration and tube 
formation. Exposure of cells to SNAP (1 µM) had no effect on migration relative to 
control, whilst VacA+ HPCM reduced migration to 0.75±0.011 fold of control. 
Exposure of BAECs to VacA+ HPCM in the presence of SNAP completely 
prevented the HPCM-dependent reduction in BAEC migration (Fig. 4.2.16 a). 
Furthermore, exposure of cells to VacA+ HPCM also reduced tube formation to 
0.44±0.02 fold of control, an effect that was completely prevented by treatment with 
SNAP (5 µM) (Fig. 4.2.16 b). VacA- HPCM was included in both experiments and 
had no effect on BAEC migration or tube formation. 
 
4.2.17 SNAP recovers the VacA+ HPCM-mediated decrease in BAEC 
proliferation- FACS Analysis. 
Following BAEC exposure to 25% HPCM (VacA+ and VacA-) in the absence 
and presence of SNAP (0.25 µM), cells were monitored for proliferation over 4 days 
by FACS Analysis. As previously shown, 25% VacA+ HPCM reduced proliferation 
relative to control, however inclusion of SNAP in VacA+ HPCM completely 
prevented the effect of HPCM on BAEC proliferation. VacA- HPCM had no effect 
on proliferation (Fig. 4.2.17). 
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Fig. 4.2.16 : Effect of SNAP on HPCM-induced changes in BAEC Migration 
and Tube Formation. Following BAEC exposure to 25% HPCM (VacA+ and 
VacA– strains) in the absence and presence of SNAP for 24 h, cells were 
monitored for (a) Migration and (b) Tube formation- by collagen based tube 
formation assay. Histograms represent fold change relative to control and are 
averaged from three independent experiments ±SEM. ***P≤0.005 versus control. 
§P≤0.005 versus VacA+. 
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Fig. 4.2.17: Effect of SNAP on HPCM-induced changes in BAEC proliferation. 
Following BAEC exposure to 25% HPCM (VacA+ and VacA– strains) for 24 h in 
the absence and presence of SNAP, cells were monitored for proliferation by FACS 
Analysis. Grey shaded area represents untreated control cells whilst black line 
represents HPCM and inhibitor treated cells. (i) 0% vs. 0% + SNAP (ii) 0% vs. 
VacA- + SNAP (iii) 0% vs. VacA+  (iv) 0% vs. VacA+ + SNAP. Curves are 
representative.  
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4.2.18 SNAP recovers the VacA+ HPCM-mediated decrease in BAEC 
proliferation- cell counts. 
 
Following BAEC exposure to 25% HPCM (VacA+ and VacA-) in the absence 
and presence of SNAP (0.25 µM), cells were monitored for proliferation over 4 days 
by cell counts. Exposure of cells to 25% VacA+ HPCM reduced proliferation to 
0.56±0.01 fold of control an effect which was completely prevented by the inclusion 
of SNAP. VacA- HPCM had no effect on proliferation (Fig 4.2.18). 
 
4.2.19 SNAP recovers the VacA+ HPCM-mediated decrease in BAEC 
barrier function. 
 
Following exposure of sheared BAECs to 25% HPCM (VacA+ and VacA-) 
for 24 h in the absence and presence of SNAP (1 µM), cells were 
immunocytochemically monitored for ZO-1 localization. Consistent with an intact 
endothelial barrier, ZO-1 immunoreactivity exhibited a continuous, well-defined 
pattern of localization along the cell-cell border under untreated conditions and in 
the absence or presence of SNAP and VacA- HPCM (Fig. 4.2.19 i-iii, v). Following 
VacA+ HPCM treatment however, ZO-1 membrane localization became highly 
discontinuous and jagged along the cell-cell border, an effect that was substantially 
prevented by treatment with SNAP (Fig. 4.2.19 v). 
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Fig. 4.2.18: Effect of SNAP on HPCM-induced changes in BAEC 
proliferation. Following BAEC exposure to 25% HPCM (VacA+ and VacA– 
strains) for 24 h in the absence and presence of SNAP, cells were monitored for 
proliferation by cell counts. Histograms represent fold change relative to control 
and are averaged from three independent experiments ±SEM. ***P≤0.005 versus 
control. §P≤0.005 versus VacA+. 
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Fig. 4.2.19: Effect of SNAP on HPCM-induced changes in BAEC ZO-1 
membrane localization. Following exposure of sheared BAECs to 25% HPCM 
(VacA+ and VacA– strains) for 24 h in the absence and presence of SNAP, cells 
were immunocytochemically monitored for ZO-1 localization. White arrows 
indicate plasma membrane localization of ZO-1. DAPI-stained nuclei are clearly 
visible. (i) 0% (ii) 0% + SNAP (iii) VacA– + SNAP (iv) VacA+  (v) VacA+ + SNAP 
(vi) Unsheared control (vii) Negative control. Images are representative. 
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4.2.20 SNAP recovers the VacA+ HPCM-mediated increase in BAEC 
permeability. 
 
Following exposure of sheared BAECs to 25% HPCM (VacA+ and VacA- 
strains) for 24 h, cell permeability was assessed by FD40 Dextran permeability 
assay. Exposure of cells to VacA+ HPCM increased permeability by 3.69±0.11 fold 
relative to sheared controls, an effect which could be prevented by the inclusion of 
SNAP (1 µM) (Fig 4.2.20). 
 
 157 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2.20: Effect of SNAP on HPCM-induced changes in BAEC 
permeability. Following BAEC exposure to 25% HPCM (VacA+ and VacA– 
strains) for 24 h in the absence and presence of SNAP, cells were monitored for 
for permeability. Histograms represent fold change relative to unsheared control 
and are averaged from three independent experiments ±SEM. *P≤0.5 versus 
control. **P≤0.05 versus control. ***P≤0.005 versus control. §P≤0.005 versus 
VacA+. 
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4.3 Discussion 
The endothelial cells lining the vascular system form an interface between 
bloodflow and underlying smooth mucle cell layers, providing a highly effective 
fluid and solute barrier. The endothelium is constantly exposed to any foreign matter 
that enters the blood stream, and its continued homeostasis is vital in preventing the 
development cardiovascular disease. Dysfunction of the endothelial layer is 
considered an early indicator in the onset of vascular occlusive pathologies such as 
atherosclerosis and intimal hyperplasia. While numerous traditional risk factors such 
as obesity, smoking and lack of exercise are associated with endothelial dysfunction, 
leading to atherosclerotic plaque formation, some non-traditional factors have also 
emerged such as elevated C-reactive protein levels (Schwedler et al., 2007), 
homocysteine levels (Caramia and Belardinelli, 2006), and bacterial infection. The 
latter is the focus of much experimental research, with many groups reporting 
associations for (Hoffmeister et al., 2001, Majka et al., 2002, Pieniazek et al., 1999, 
Zito et al., 1999) and against (Koenig et al., 1999, Pellicano et al., 2002, Whincup et 
al., 2000) the relationship. With respect to bacterial infection, no group have, to our 
knowledge, focused on cells of aortic or coronary artery origin. In addition, as it 
appears likely that the whole bacteria would be destroyed if it were to vacate the 
stomach, the role of bacterial secretions in cell function must also be explored. To 
address these matters, we have examined the effect of HPCM on BAEC function. 
 Initial investigations clearly demonstrated that exposure of BAECs to HPCM 
for 24 h dose-dependently induced vacuolation, significant re-distribution of actin 
bundles, and an apoptotic phenotype. Concomitantly, BAEC proliferation was 
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inhibited in a dose-dependent manner at sub-apoptotic concentrations (0-25%). 
These results mirror previous studies with H. pylori extracts on microvascular 
endothelial cells and HUVECs (Kalia et al., 2001, Kurosawa et al., 2002, Pearce et 
al., 2004, Jenkinson et al., 2002).  Further experiments also revealed a dose-
dependent reduction in BAEC tube formation and migration following 24 h 
incubation with HPCM (0-25%). Kalia et al., and others have reported similar 
results in microvascular endothelial cells (Jenkinson et al., 2002, Kalia et al., 2001), 
while opposing studies by Pearce et al., showed no effect of H. pylori extracts on 
HDMvEC or HUVEC migration (Pearce et al., 2004).  
 As previously mentioned (section 3.3), immunoreactivity of zonnula 
occludens-1 (ZO-1) has been successfully employed as an index of barrier integrity 
by our group and others (Bendfeldt et al., 2007, Colgan et al., 2007b). In our studies, 
ZO-1 localization was well defined and continuous along cell-cell junctions in 
control cells. However, following exposure of BAECs to 25% HPCM for 24 h, 
localization became jagged and discontinuous. These results are consistent with H. 
pylori disruption of tight junction assembly and barrier integrity and concur with the 
previous studies of Brisslert et al., which indicated that HPCM significantly 
increased recruitment and transendothelial migration of neutrophils in HUVECs 
(Brisslert et al., 2005).  
 Taken together, these results are indicative of a role for H. pylori secretions 
in an inflammatory process such as that associated with vascularocclusive 
remodelling and atherosclerosis. Loss of barrier function and dysregulation of 
endothelial cell function are central to the initiation and progression of 
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atherosclerotic lesion development (Simionescu, 2007). A number of H. pylori 
virulence factors have been described with the potential to cause these effects. The 
role of OMP’s from the bacterium in this regard has already been discussed (section 
3.3). Urease secreted by H. pylori is known to induce inflammatory responses 
(Enarsson et al., 2005) and upregulate iNOS expression (Fu et al., 1999). Both VacA 
and CagA have been implicated in altering host cell and barrier function (Amieva et 
al., 2003, Willhite and Blanke, 2004). Along with these virulence factors, there are 
numerous other secretions from H. pylori (sections 1.4.3.4- 1.4.3.6) whose plausible 
contribution to atherosclerosis have not been explored. However, in our studies 
bacterial conditioning of media proceeded for 24 h only. Studies by Schraw et al., 
have determined the secretion profile of the bacteria and show during this time 
period that VacA is the only major protein produced. Urease and Hsp B are also 
early secretions but occur after the 24 h timepoint (Schraw et al., 1999). Hence we 
examined the effect of VacA and Urease on BAEC cell function.  
 The enzyme Urease accounts for almost 10% of total H. pylori protein, and 
functions in converting urea in the stomach to ammonia, thereby neutralizing the 
acid surrounding the bacterium and facilitating gastric colonization. Apart from its 
role in inflammation (mentioned above), Fan et al., have shown a urease-dependent 
induction of apoptosis in gastric epithelial cells (Fan et al., 2000). These effects 
suggest the ability of urease to influence the progression of an atherosclerotic 
phenotype. For our studies we examined BAECs following treatment with 
unconditioned control media containing 10 µg/mL jack bean urease (known to 
display many of the same properties as H. pylori urease (Olivera-Severo et al., 
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2006)). Urease had no effect on any of the cell functions we studied, suggesting its 
lack of involvement in any of the HPCM-mediated events examined here. 
 As previously discussed (section 1.4.3.1), VacA is an autotransporter protein 
responsible for large vacuole formation in cultured mammalian cells. It functions by 
forming anion channels in the host cell plasma membrane, with resulting membrane 
depolarization (Szabo et al., 1999). In addition, VacA can enter cells and modulate 
mitochondrial permeability causing cytochrome C release (Willhite and Blanke, 
2004), reduce gastric epithelial barrier function (Pelicic et al., 1999), inhibit T-
lymphocyte proliferation and cytokine release (Gebert et al., 2004), and induce 
gastric epithelial apoptosis (Cover et al., 2003). Moreover, VacA- dependent 
regulation of the expression and function of cytoskeleton-associated Rho-GTPase 
family proteins has also been reported for gastric epithelial cells (Pai et al., 2000). In 
contrast, little information is available for the effects of H. pylori-derived VacA on 
endothelial cells. Kurosawa et al. reports that the H. pylori-dependent reduction in 
HUVEC proliferation, observed in parallel with induction of apoptosis, is seen with 
both CagA+/VacA+ double-positive and CagA-/VacA- double-negative strains. 
However, this is not conclusive evidence of a role of VacA in endothelial function, 
as the study suggests (Kurosawa et al., 2002).  
To further our understanding of VacA, we employed NPPB, an inhibitor 
known to selectively block the action of H. pylori-derived VacA (Szabo et al., 
1999). Treatment of BAECs with NPPB revealed a baseline inhibitory effect on 
proliferation and tube formation, observations previously reported for this inhibitor 
in similar studies (Manolopoulos et al., 2000, Rouzaire-Dubois and Dubois, 1998). 
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Importantly, NPPB had no effect on BAEC apoptosis as measured by AO staining- 
data not shown. Moreover, our data clearly showed that NPPB treatment of BAECs 
completely prevented HPCM-dependent reduction in proliferation, tube formation 
and migration. NPPB also completely prevents HPCM-dependent ablation of ZO-1 
membrane localization. While these findings suggest a role for VacA in these H. 
pylori-induced changes, the possibility of an alternative NPPB-inhibitable virulence 
factor(s) must be taken into account. For this reason our studies were extended using 
the VacA- mutant of our 60190 strain  (60190:v1) in which the VacA genes have 
been disrupted by insertational mutagenesis (Cover et al., 1994).  
VacA- HPCM had no effect relative to control on BAEC vacuolation, tube 
formation, migration, proliferation or ZO-1 membrane localization. The effect of 
HPCM on FD-40 Dextran flux across BAEC monolayers was also examined and it 
was found that VacA+ HPCM significantly increased flux, indicating increased 
permeability, whilst VacA- HPCM had no effect relative to control.  
 Sodium nitrite production was next examined, a marker of endothelial health 
and observed a VacA+ HPCM decrease in nitrite that was not present following 
exposure to VacA- HPCM. Taken together, these results suggest a direct role for 
HPCM-derived VacA in altering endothelial properties and function, possibly in a 
nitrite dependent manner. 
 In order to extend this premise further, BAEC cell functions following 
incubation with HPCM in the absence and presence of S-nitroso-N-acetyl 
pencillamine (SNAP) – a nitric oxide donor, were studies. Previous studies have 
shown that SNAP has the ability to increase endothelial cell migration (Kawasaki et 
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al., 2003), tube formation (Balasubramaniam et al., 2006), proliferation (Mottola et 
al., 2005) and permeability (Breslin et al., 2003). For control purposes therefore, 
concentrations of SNAP were used that were shown by these groups not to increase 
any of these cell properties and functions.  
 Our studies revealed that SNAP recovered the VacA+ HPCM-mediated 
decrease in BAEC migration, tube formation, proliferation and barrier function. This 
implies VacA decreases endothelial function in a NO-dependent manner. These 
results are consistent with the observations of Liuba et al., who observed impaired 
bioreactivity of endothelial NO following co-infection of apoE-knockout mice with 
Chlamydia pneumoniae and H. pylori (Liuba et al., 2003). In addition, our studies 
provide vital mechanistic data to support the hypothesis concerning H. pylori’s 
involvement in endothelial dysfunction. 
 In conclusion, among the non-traditional risk factors being proposed for 
cardiovascular disease, and in particular atherosclerosis, is the idea of pathogenic 
burden. The bacterium H. pylori is much studied in this role, and has been suggested 
to contribute to the initiation and progression of an atherosclerotic plaque through its 
effects on endothelial function. However, vascular endothelial cell models employed 
thus far are quite diverse, with little or no information available on molecular 
mechanisms involved, or on endothelial cells of aortic or coronary artery origin. In 
this study, a comprehensive examination of the effects of H. pylori conditioned 
medium on a broad range of cell properties in a well characterized aortic endothelial 
cell model (BAEC) was made. Our findings suggest H. pylori-derived factors play a 
complex role in an inflammatory process consistent with that typically associated 
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with atherosclerosis. Moreover, our experiments confirm the involvement of VacA 
(but not urease) in these events through a reduction in nitric oxide.  
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Chapter 5 
 
Modulation of HPCM-Dependent 
Changes in Endothelial Cell 
Properties by Laminar Shear Stress 
 166 
5.1 Introduction  
 
 
Blood flowing in the cardiovascular system exerts two main effects on the blood 
vessels namely cyclic strain and shear stress. Under normal physiological conditions 
the shear stress to which the endothelium is exposed remains a relatively constant 
value of 10-15 dyne/cm2. At these flow rates endothelial cell stability and survival is 
promoted and cells align in the direction of flow (Osborn et al., 2006). Moreover, 
the flow results the production of anti-thrombotic and vasodilatory factors (van 
Thienen et al., 2006), such as prostacyclin, NO, calcium thrombomodulin and tissue 
plasminogen activator. This provides a non-thrombogenic surface for blood flow and 
regulates vessel homeostasis along with immune and inflammatory reactions, 
resulting in an atheroprotective effect on the vessel wall (Yoshizumi et al., 2003).  
 Turbulent and low levels of shear stress have been shown to occur at 
curvatures in the blood vessel and in arterial branch ostia and bifurcations (Davies et 
al., 1995, Lehoux and Tedgui, 2003, Traub et al., 1999). Regions of perturbed shear, 
in conjunction with known risk factors for cardiovascular disease, can result in 
signal transduction events leading to endothelial dysfunction and initiation of 
atherosclerotic plaque formation (Chatzizisis et al., 2007). These processes are 
mediated by the action of NO, whose attenuation is one of the earliest biochemical 
changes preceding endothelial dysfunction.  
 Increasing evidence supports a role for H. pylori as a pro-atherogenic risk 
factor (Ando et al., 2006, Grabczewska et al., 2006, Kowalski et al., 2002). 
Moreover, our current findings point to a role for the bacterium in endothelial 
dysfunction, with VacA-dependent attenuation of the NO pathway apparently central 
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to the process. However, to our knowledge, no group has examined the effects of H. 
pylori- derived VacA on cells exposed to high and low levels of shear, where an 
atherosclerotic phenotype typically predominates. Since laminar shear in vivo results 
in an atheroprotective effect, we hypothesize that exposure of endothelial cells to 
physiological levels of laminar shear in vitro would abrogate the VacA+- dependent 
atherogenic effects on cell properties.  
 
In this chapter, the effects of HPCM on endothelial cell properties and function 
under shear conditions was examined.  
 168 
5.2 Results 
 
 
5.2.1 Laminar Shear alters BAEC morphology and cytoskeletal formation. 
 
Following BAEC exposure to laminar shear (10 dyne/cm2) for 24 h, cell 
morphology and cytoskeletal formation were examined by phase-contrast 
microscopy, and immunocytochemically by F-actin staining with rhodamine-
phalloidin. Laminar shear resulted in the realignment of BAECs in the direction of 
shear, as indicated by white arrow (Fig. 5.2.1 a ii), while F-actin staining revealed 
significant redistribution of actin bundles when compared to unsheared control (Fig. 
5.2.1 b i, ii).  
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Fig. 5.2.1: Effect of Shear on BAEC morphology and cytoskeleton. Following 
BAEC exposure to shear (10 dyne/cm2) for 24 h, cells were examined for (a) 
Morphology (b) Cytoskeletal rearrangement. White arrow indicates direction of 
shear. (a) Phase contrast (i) Ctrl (Unsheared) (ii) Sheared (b) Rhodamine-
Phalloidin (i) Ctrl (Unsheared) (ii) Sheared. Images are representative. 
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5.2.2 Laminar shear restores the VacA+ HPCM-mediated decrease in BAEC 
migration and tube formation.  
 
Following BAEC exposure to 25% HPCM (VacA+ and VacA-) under shear 
(0- 10 dynes/cm2) for 24 h, cells were monitored for migration and tube formation. 
Shearing at 10 dyne/cm2 increased baseline levels of both migration and tube 
formation. VacA+ HPCM decreased migration by 0.70±2.26 and 0.72±2.97 fold of 
0% control at 0 and 1 dyne/cm2, respectively, although shearing restored migration 
to baseline control levels seen at 10 dyne/cm2. VacA- HPCM and E. coli- 
conditioned media had no effects relative to 0% controls (Fig. 5.2.2 a).  
Similarly, VacA+ HPCM decreased tube formation by 0.41±0.01 and 
0.42±0.001 fold of 0% control at 0 and 1 dyne/cm2, respectively, and shearing 
restored migration to baseline control levels seen at 10 dyne/cm2. VacA- HPCM and 
E. coli- conditioned media had no effects relative to 0% controls (Fig. 5.2.2 b).  
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Fig. 5.2.2: Effect of HPCM and Shear on BAEC Migration and Tube 
Formation. Following BAEC exposure to 25% HPCM  (VacA+ and VacA– 
strains) under shear conditions (1 and 10 dyne/cm2) for 24 h, cells were monitored 
for (a) Migration and (b) Tube formation. E. coli- conditioned media was included 
as gram-negative bacterial control. Histograms represent fold change relative to 
unsheared 0% and are averaged from three independent experiments ±SEM. 
***P≤0.005 versus unsheared 0%. 
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5.2.3 Laminar shear restores the VacA+ HPCM-mediated decrease in BAEC 
proliferation- FACS Analysis.  
 
Following BAEC exposure to 25% HPCM (VacA+ and VacA- strains) under 
shear (0- 10 dynes/cm2) for 24 h, cells were monitored for proliferation by FACS 
analysis. VacA+ HPCM reduced BAEC proliferation in comparison to control 
following 1 dyne/cm2 shear for 24 h (Fig 5.2.3a). However, at 10 dyne/cm2 no 
decrease in proliferation was observed (Fig. 5.2.3b). VacA- and E. coli- conditioned 
media had no effect on proliferation at either shear intensity. 
 
5.2.4 Laminar shear restores the VacA+ HPCM-mediated decrease in 
proliferation- cell counts.  
 
Following BAEC exposure to 25% HPCM (VacA+ and VacA- strains) 
under shear (0- 10 dynes/cm2) for 24 h, cells were monitored for proliferation by cell 
counts. VacA+ HPCM reduced BAEC proliferation to 0.65±0.01 and 0.63±0.006 
fold of control following 0 and 1 dyne/cm2 shear, respectively. At 10 dyne/cm2, 
VacA+ HPCM had no effect on migration relative to sheared control. VacA- and E. 
coli- conditioned media had no effect on proliferation, regardless of shear intensity 
(Fig. 5.2.4).  
 
 173 
Fig. 5.2.3a: Effect of different HPCM strains and Low Shear on BAEC 
proliferation. Following BAEC exposure to 25% HPCM (VacA+ and Vac– strains) 
and 1 dyne/cm2 shear for 24 h, cells were monitored for proliferation by FACS 
Analysis. Grey shaded area represents untreated control cells whilst black line 
represents conditioned media treated cells. (i) 0% vs. VacA- (ii) 0% vs. VacA+  (iii) 
0% vs. E. coli. Histograms are representative. 
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Fig. 5.2.3b: Effect of different HPCM strains and High Shear on BAEC 
proliferation. Following BAEC exposure to 25% HPCM (VacA+ and Vac– strains) 
and 10 dynes/cm2 shear for 24 h, cells were monitored for proliferation by FACS 
Analysis. Grey shaded area represents untreated control cells whilst black line 
represents conditioned media treated cells. (i) 0% vs. VacA- (ii) 0% vs. VacA+  (iii) 
0% vs. E. coli. Histograms are representative. 
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Fig. 5.2.4: Effect of HPCM and Shear on BAEC Proliferation. Following 
BAEC exposure to 25% HPCM  (VacA+ and VacA– strains) under shear conditions 
(1 and 10 dyne/cm2) for 24 h, cells were monitored for proliferation by cell counts. 
E. coli- conditioned media was included as gram-negative bacterial control. 
Histograms represent fold change relative to unsheared 0% and are averaged from 
three independent experiments ±SEM. ***P≤0.005 versus unsheared 0%. 
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5.2.5  Laminar shear restores the VacA+ HPCM-mediated decrease in sodium 
nitrite production. 
  
Following BAEC exposure to 25% HPCM (VacA+ and VacA-) under shear 
(0- 10 dynes/cm2) for 24 h, cells were monitored for sodium nitrite production by 
DAN assay. Shearing at 10 dyne/cm2 increased baseline levels of sodium nitrite. 
VacA+ HPCM decreased sodium nitrite levels to 0.46±0.02 and 0.39±0.02 fold of 
0% control at 0 and 1 dyne/cm2, respectively, although shearing restored sodium 
nitrite levels to baseline control levels seen at 10 dyne/cm2. VacA- HPCM and E. 
coli- conditioned media had no effects relative to 0% controls (Fig. 5.2.5).  
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Fig. 5.2.5: Effect of HPCM on BAEC Nitrite production Following BAEC 
exposure to 25% HPCM  (VacA+ and VacA– strains) under shear conditions (1 and 
10 dynes/cm2) for 24 h, cells were monitored for sodium nitrite production by 
DAN assay. E. coli- conditioned media included as gram-negative bacterial 
control, L-Name included as negative control. Histograms represent fold change 
relative to unsheared 0% and are averaged from three independent experiments 
±SEM. ***P≤0.005 versus unsheared 0%.. 
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5.3 Discussion 
 
 
The shearing effect exerted on the endothelial layer by blood flowing through the 
cardiovascular system results in the production of many anti-thrombotic and 
vasodilatory factors central to the maintenance of vessel homeostasis (van Thienen 
et al., 2006). One such factor is NO, whose production is stimulated by laminar 
shear-dependent ion channel activation in endothelial cells (Olesen et al., 1988). In 
addition, shear controls endothelial cell properties and function via transduction of 
signals to the cell through transmembrane structures classed as mechanotransducers 
(Chien, 2007) (i.e. integrins, ion channels, G-proteins and receptor tyrosine kinases). 
In this manner, healthy endothelial function is promoted.  
 In regions of the vasculature such as artery bifurcations or vessel curvature, 
normal laminar shear is perturbed and turbulent. As a result, NO production is 
lowered, control over endothelial function is lessened, and cellular alignment 
prevented, resulting in weakened cell-cell contacts (Gimbrone, 1999b). Moreover, 
an inflammatory phenotype dominates; meaning molecules present in the 
bloodstream can interact with the vessel wall in a manner that is not possible at other 
locations in the vasculature.  
 It has been suggested that the bacterium H. pylori plays a role in the initiation 
and development of an atherosclerotic plaque (Grabczewska et al., 2006, Kowalski 
et al., 2002), and may do so by exacerbating the pro-atherogenic effects associated 
with arterial bifurcations/vessel curvature.  To date, no studies have looked at the 
effect of H. pylori under shearing conditions on cells of vascular origin. To address 
this, we have employed a robust and well characterised laminar shear model (Asada 
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et al., 2005, Dardik et al., 2005, Ley et al., 1989), to examine BAEC function in the 
presence of HPCM. 
 Our initial findings showed in accordance with Galbraith et al., that the shear 
stress-induced spatial reorganization of the actin cytoskeleton occurs after 24 h shear 
for realignment of endothelial cells (Galbraith et al., 1998). Moreover, cells exposed 
to low levels of shear and VacA+ HPCM, showed marked decreases relative to 
control in migration and tube formation that were not present at high levels of shear. 
In addition, we saw a marked increase in both cell functions following 10 dyne/cm2 
shear for 24 h, as previously shown by Wu et al., and Sprague et al., for migration 
(Sprague et al., 1997, Wu et al., 1995) and our group for tube formation (Von 
Offenberg Sweeney et al., 2005). Similarly, the decrease in BAEC proliferation 
following VacA+ HPCM treatment for 4 days at low shear was not present at high 
shear. Interestingly, no significant difference in proliferation was observed between 
low and high shear controls. This is in contrast to studies by Levesque et al., who 
demonstrated a dose-dependent reduction of endothelial cell proliferation with 
increasing laminar shear stress (Levesque et al., 1990) after 48 h.  
 In the previous chapter, nitrite production- a marker of endothelial function, 
was examined. Here, a DAN assay was once again employed to study nitrite 
production in response to shear and it was found that the decrease in nitrite 
following incubation with VacA+ HPCM at low shear was not present at high shear. 
In agreement with previous studies (Misko et al., 1993), a marked increase in nitrite 
levels following shear was observed.  
 These results suggest that at high levels of shear HPCM has little or no effect 
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on BAEC function, consistent with our knowledge that shear promotes an athero-
protective phenotype. For example, normal laminar shear promotes the release of 
factors from endothelial cells that inhibit coagulation, migration of leukocytes and 
SMC proliferation, whilst also promoting cell survival (Traub and Berk, 1998). At 
low levels of shear such as those found at arterial bifurcations/curvature, incubation 
with VacA+ HPCM causes endothelial dysfunction similar to that found in unsheared 
cells. Furthermore, the dysfunction coincides with a decrease in production of 
sodium nitrite, once again implicating HPCM with endothelial dysfunction in a 
nitrite-dependent manner. 
 However, the manner by which VacA reduces NO production has not yet been 
examined. It is possible that an indirect relationship exists between the two. For 
example, laminar flow opens K+ and Cl- ion channels, hyperpolarizing the cell and 
increasing the driving force for Ca2+ entry and NOS III activation. As previously 
discussed, VacA forms vacuoles by forming anion selective channels. Due to 
increased chloride conduction through these channels, intraluminal chloride 
concentrations are increased and vacuolar ATPase activity rises to compensate, 
resulting in an upsurge in proton pumping and a reduction in intraluminal pH. Here, 
it was shown that at low shear, NO production is lowered by VacA+ HPCM, possibly 
due to the action of VacA increasing intraluminal chloride and vacolar ATPase 
concentrations, thus preventing the hyperpolarization of the cell necessary to 
activate the NOS III enzyme. Moreover, this may explain why VacA appears to have 
no effect at high shear rates- the increased opening of ion channels by shear results 
in a massive Ca2+ influx, quickly hyperpolarizing the cell, resulting in NO and 
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cGMP production- the latter of which inhibits further calcium entry into the cell. 
Here, the action of VacA may be prevented, as the large increase in chloride 
conduction due to opening of ion channels cannot be counterbalanced by the action 
of vacuolar ATPase, thus preventing the formation of vacuoles. It should be noted 
that this is speculative, but experiments examining whether VacA prevents 
hyperpolarization could provide some evidence for the theory.  
 
 
 
 
 
Fig. 5.3.1: The action of VacA and NO. (a) VacA binds to the cell and inserts into 
the plasma membrane, forming an anion-selective channel of low conductance. The 
toxin channels are slowly endocytosed and eventually reach late endosomal 
compartments, increasing their permeability to anions with enhancement of the 
electrogenic vacuolar ATPase (v-ATPase) proton pump. In the presence of weak 
bases, osmotically active acidotropic ions will accumulate in the endosomes. This 
leads to water influx and vesicle swelling, an essential step in vacuole formation (b) 
Laminar flow opens specialised ion channels within the endothelial cell membrane 
such as Ca2+- activated K+ channels. This hyperpolarises the cell, increasing the 
driving force for Ca2+ entry and activating NOS III (eNOS) and hence NO 
production. Images (a) (Montecucco and Rappuoli, 2001) (b) (Klabunde R. E., 2007) 
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 In conclusion, it was shown that high levels of shear can prevent the VacA 
HPCM-mediated dysfunction in endothelial cells in vitro. Low levels of shear, such 
as those found at arterial branch points/curvatures, were not protective. This data 
highlights the possible role of H. pylori in endothelial cell dysfunction at arterial 
branch points and curvatures.  
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Chapter 6 
Final Summary 
 
 
 
 
 
 
 
 
 
 
 184 
6.1 Final Summary 
 
Cardiovascular disease is the number one cause of death globally, accounting for 
approximately 16.7 million deaths annually (World Health Organisation). It refers to 
any abnormal condition characterized by the dysfunction of the heart or blood 
vessels, and includes coronary heart disease, cerebrovascular disease, hypertension, 
rheumatic and congenital heart disease and heart failure. If the current trends in 
health continue, it is predicted that by 2015, 20 million people will die each year 
from CVD. To this end, improving treatments and identifying risk factors of the 
disease have become crucial, and are the focus of much study.  
 From such work, the importance of the endothelium has been identified in 
the initiation and progression of CVD (Pechanova and Simko, 2007), and in 
particular, the paradigm for our study, endothelial dysfunction leading to 
atherosclerosis. The endothelial cells lining the innermost layer of the vasculature 
are constantly exposed not only to any foreign matter in the bloodstream, but also to 
the strain and shear of blood flow. The laminar shearing effect of blood flow is 
responsible for stimulating the production of numerous endothelial factors vital to 
the maintenance of vessel homeostasis, such as those necessary for vasodilation and 
vasoconstriction (Gori et al., 2007). In addition, normal endothelial functions 
include mediation of coagulation, platelet adhesion, immune function, and control of 
volume and electrolyte content of the intra- and extra-vascular spaces (Strukova, 
2006). Importantly, shear also regulates endothelial cell functions through 
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mechanotransducers such as integrins, ion channels, G-proteins and receptor 
tyrosine kinases (White and Frangos, 2007).  
Loss of control over these processes, resulting in endothelial dysfunction, is 
considered pivotal to the initiation of atherosclerosis, and has been shown to occur at 
arterial bifurcations/curvatures (Cunningham and Gotlieb, 2005). Here, perturbed 
shear predominates, reducing cellular production of homeostatic factors such as 
nitric oxide, resulting in weakened cell-cell contacts, lessened cell functional 
control, and upregulation of pro-inflammatory molecules. When these events occur 
in the presence of CVD risk factors, initiation of an atherogenic plaque may ensue 
(Malek et al., 1999).  
There are many traditional risk factors for CVD, including high cholesterol 
and blood pressure, obesity and smoking. Moreover, research has also identified 
many non-traditional factors such as elevated C-reactive protein levels (Schwedler et 
al., 2007), homocysteine levels (Caramia and Belardinelli, 2006), and bacterial 
infection. In particluar, the bacterium H. pylori has been identified in such a role, 
with many groups supporting the association (Hoffmeister et al., 2001, Majka et al., 
2002, Pieniazek et al., 1999, Zito et al., 1999). To our knowledge however, no group 
has examined the effect of the bacterium or its secretions on cells of aortic or 
coronary origin, where a vascular occlusive pathology typically manifest. In order to 
address this our work has focused on the effects of H. pylori OMP and conditioned 
media on BAEC in the presence and absence of physiologically relevant levels of 
shear.  
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One of the major obstacles facing scientists examining a role for H. pylori in 
atherosclerosis is establishing a way that the bacteria can enter the blood stream and 
interact with the vessel wall. A 2003 paper by Semino Mora et al., examining the 
location of H. pylori in the stomach provided insight on this. It was shown that the 
bacteria can leach from the lumen of the stomach into epithelial cells and the lamina 
propria (Semino-Mora et al., 2003), the latter of which contains gastric mucosal 
blood capillaries (Fig. 6.1.1). Here the bacterium could pass via diapedesis through 
the capillary wall and into the main circulatory system, with the ability of H. pylori 
to weaken epithelial cell-cell contacts supporting this action (Amieva et al., 2003, 
Krueger et al., 2007, Papini et al., 1998). In addition, a 2006 study by the same 
group reported that H. pylori can be found on the erythrocytes in capillaries and 
post-capillary venules in the gastric mucosa of humans and Rhesus monkeys. This 
association was mediated by binding of the SabA OMP adhesion to erythrocytes 
(Aspholm et al., 2006). The concept of bacterial leaching into the circulatory system 
is not alien. Periodontal infection of a chronic nature has frequently been shown to 
leach into the bloodstream and has even been implicated in atherosclerosis and CAD 
(Desvarieux et al., 2005, Epstein, 2002). Further to the theory of leaching, a number 
of studies have confirmed cross-reactivity between anti-H. pylori antibodies and 
blood vessel antigens. Franceschi et al., reported that anti-CagA antibodies cross-
reacted with antigens of both normal and atherosclerotic blood vessels by 
immunohistochemistry (Franceschi et al., 2002) while Guo et al., showed anti-H. 
pylori antibodies cross-react with some antigens of human erythrocyte membrane 
(Guo et al., 2007). This data points to the presence of the bacterium in the 
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bloodstream, and thus a potential for it to be transported throughout the vasculature, 
possibly through an erythrocyte interaction.  
As already mentioned, our premise encompasses the ability of H. pylori to 
enter the bloodstream and interact with the vessel wall, particularly at regions of 
perturbed/turbulent flow where the net shearing effect on the endothelium is 
lessened. It may be more likely however, that bacterial secretions from the stomach 
are involved in these events, as the immune system would rapidly detect and remove 
the whole bacterium from circulation. This hypothesis seems possible, as one such 
bacterial fraction- LPS, has been shown to elicit only a weak immune response by 
mimicking Lewis blood group antigens (Appelmelk et al., 1996). Moreover, the 
relative size of a secreted protein to the whole bacteria may mean it avoids detection 
in the bloodstream long enough to interact with the endothelium. For these reasons, 
we focused on OMP and secretory fractions of H. pylori in our studies.  
 Our experiments were carried out using the H. pylori 60190 human strain. It 
is associated with increased toxicity due to its CagA and VacA positivity, and is 
commonly used in many studies (Ganten et al., 2007, Ohno and Murano, 2007, 
Schwartz and Allen, 2006). Many different H. pylori strains have been used for 
experimental purposes, however cytotoxin-expressing strains correlate with 
increased pathogenicity and long-term gastric colonization. For example, Al-
Marhoon et al., report CagA+ strains induces greater levels of prostaglandin E2 than 
CagA- (Al-Marhoon et al., 2004), Pillinger et al., observed CagA+ strain 147A 
stimulates gastric epithelial cell MMP-1 secretion when compared to CagA- Tx30a 
strain (Pillinger et al., 2007), and increased thrombin generation with VacA+ strains  
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Fig. 6.1.1: H. pylori, from transmission to atherosclerosis. (a) Helicobacter pylori 
can be transmitted through person-to-person contact, contaminated drinking water, 
from animals such as cats or pigs, through the use of endoscopy techniques to 
examine gastric disorders. Following ingestion the bacterium progresses to the 
stomach; (b) The bacterium, leaches from the lumen of the stomach into epithelial 
cells and the lamina propria, where it may enter the capillaries; (c) H. pylori travels 
in the blood stream to arterial bifurcations, where it may interact with the 
endothelium. (Images (a) (EnchantedLearning, 2006) (b) (Tortora, 1996) (c) (Nott, 
2006)) 
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was shown by Suzuki et al. (Suzuki et al., 2005). Thus, a host of strains have been 
employed in previous studies; however, we chose the 60190 strain due to the large 
quantity of data available on its effects and also due to the availability of its VacA- 
mutant 60190:v1. 
Our initial work focused on an OMP fraction isolated from H. pylori strain 
60190, which we subsequently found to have little effect on endothelial function. An 
increase in BAEC tube formation and decrease in migration was observed, with a 
number of hypothesizes possibly explaining these opposing effects (Section 3.3). 
Our next series of experiments centered on bacterially conditioned media, with 
marked changes in cell function observed. Moreover, a role for VacA in this 
dysfunction was elucidated with data suggesting a VacA-dependent NO-reduction. 
Our final chapter explored the premise that H. pylori and in particular VacA, acts in 
regions of turbulent/perturbed shear to alter cell function. This would appear to be 
the case, with high shear apparently protecting against the NO-reducing effects of 
HPCM, albeit via an unknown mechanism. In order to further explore the latter, it is 
first necessary to understand the pathways through which NO impacts on cell 
properties and functions. 
 NO influences the cell-death programme of endothelial cells through 
mediation of S-nitrosylation of caspase-3, -8 and -9, resulting in the inactivation of 
each caspase (Kim et al., 2000, Torok et al., 2002) and hence, an anti-apoptotic 
effect (Hida et al., 2004). Importantly, H. pylori VacA induces apoptosis in gastric 
cells through activation of caspase-8 and 9 (Manente et al., 2007). Endothelial 
migration is increased following exposure to NO, via NO-mediated activation of the 
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PI3K/Akt pathways (Kawasaki et al., 2003). While no study has examined the effect 
of VacA specifically on the migratory pathway, PI3K activation by H. pylori has 
been shown on macrophage (Allen et al., 2005), and Il-6 induction by H. pylori 
requires TLR4-dependent NF-kappaB activation and mitogen- and stress-activated 
PI3K-triggered phosphorylation events (Pathak et al., 2006). This data suggests H. 
pylori could influence PI3K activation/inactivation in endothelial cells, possibly 
influencing the cells migratory phenotype. Both proliferative and angiogenic 
endothelial cell phenotypes are known to be influenced positively by NO, through 
VEGF/NO mediated activation of the MAPK pathway (Parenti et al., 1998, Zheng et 
al., 2006), although Ziche et al., suggests basic fibroblast growth factor (bFGF) in 
concert with NO may also be involved (Ziche et al., 1997). Interestingly, VacA has 
been shown to activate the MAPK pathway in epithelial cells (Nakayama et al., 
2004), and in contrast to our findings, stimulate proliferation of gastric cancer cells 
in this manner (Chen et al., 2006).  Moreover, inhibition of T-cell activation and an 
increase in prostaglandin production through induction of cyclooxygenase-2 in 
gastric cells have also been observed in a VacA/MAPK dependent manner 
(Boncristiano et al., 2003, Hisatsune et al., 2007). Whilst these studies do not 
correlate with our own, all were carried out in gastric cells, not in aortic endothelial 
cells, perhaps accounting for the opposing effects on proliferation. Finally, eNOS 
has been shown to play a role in a VEGF-induced acute vascular permeability 
increase (Fukumura et al., 2001), possibly in a MAPK dependent manner. Notably, 
Caputo et al., have demonstrated a VacA dependent up-regulation of VEGF 
expression in gastric cells (Caputo et al., 2003). Taken together these studies point to 
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a strong role for H. pylori in stimulating a VEGF/NO up-regulation in gastric cells. 
However, evidence from Liuba et al., and now our group, suggests that NO 
production in endothelial cells, coronary and aortic respectively, is reduced by H. 
pylori (Liuba et al., 2003). As VEGF is often implicated in NO production and vice 
versa (Zheng et al., 2006), it seems likely that VEGF may also be down-regulated by 
H. pylori in endothelial cells. This would further contribute to the decreases we have 
observed in BAEC migration, tube formation, proliferation and nitrite production. 
An experiment examining VEGF expression in BAEC’s following HPCM treatment 
may yield a definitive answer as to whether an indirect relationship between VacA 
and NO exists through VEGF.  
 While the association between H. pylori and NO appears promising, it would 
be remiss not to discuss other factors, which in association with VacA could induce 
the responses we have observed. Of particular note are the class of single membrane-
spanning, non-catalytic Toll-like receptors (TLRs). TLRs are a form of pattern 
recognition receptor (PRR) that recognize structurally conserved molecules that are 
broadly shared by pathogens and are termed pathogen-associated molecular patterns 
(PAMPs). Following activation of TLRs by PAMPs, an immune response is 
triggered resulting in production of inflammatory cytokines. Numerous groups have 
examined whether H. pylori induces TLR activation, resulting in downstream 
cytokine expression. Uno et al., observed in gastric cells that H. pylori LPS results in 
TLR2 activation through TLR4 signaling propagated through extracellular signal-
regulated kinase (ERK) and NFkappaB activation (Uno et al., 2007).  In addition, 
iNOS expression and resulting NO production was increased in cells following LPS 
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exposure. Interleukin-8 induction via TLR2 and MAPK pathway following exposure 
to H. pylori heat-shock protein 60 was shown by Zhao et al., in human monocytes 
(Zhao et al., 2007). Most notably, Smith et al. observed a H. pylori and TLR2 
induction of syndecan-4 expression in an NFkappaB-dependent manner. Syndecans 
are a family of trans-membrane heparin sulfate proteoglycans (HSPG) that have are 
known to affect a variety of biological functions, including the regulation of growth 
factor signaling, adhesion, tumourigenesis, and inflammation. These results 
indicated that the interaction between H. pylori and TLRs has many downstream 
effects, including iNOS induction and syndecan expression, which may account for 
the effects we have seen in BAECs. However, this seems unlikely as no experiments 
have been carried out examining the bacterium’s effect on cellular functions and 
moreover, no studies have been conducted in endothelial cells of a coronary or aortic 
nature. What does appear plausible based on the aforementioned studies is a TLR- 
mediated interaction between H. pylori and NO, similar to the role we have 
proposed for VEGF. To confirm/disprove this theory, a series of experiments 
examining firstly, TLR activation in endothelial cells in response to H. pylori and 
secondly, whether blocking TLR signal transduction has any effect on the previously 
shown decrease in NO expression, following incubation with H. pylori.  
 Many aspects of H. pylori’s interaction with the endothelium, and more so its 
putative role in atherosclerosis, remain unresolved. However, a number of studies 
could be undertaken to clarify these issues. In our own work, it was initially 
examined whether OMPs had any effect on BAEC function, and opposing changes 
in cell migration and tube formation were found. As previously mentioned, 
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experiments examining the activation profile of the integrins involved in migration 
over time and isolation/testing the functions of individual OMP’s in an in vivo model 
should clarify this issue. Furthermore, as this is an total OMP fraction, isolating 
specific OMPs with known effects- such as SabA, OipA, HopA or LPS and testing 
their effects on cell migration/tube formation could pinpoint which (if any) is 
responsible for the observed endothelial dysfunction. Our second set of studies 
sought to determine whether H. pylori conditioned media altered BAEC function. 
The decrease in BAEC proliferation, as measured by cell counts and FACS analysis, 
proved particularly robust, and identification of what stage of the cell cycle HPCM 
arrests/slows growth would extend our knowledge on this subject. To this end, 
FACS analysis can be employed to examine markers specific to each phase of 
proliferation. In addition, mechanistic data from the pathways through which HPCM 
exerts its effects on cell function would contribute significantly to our research. For 
example, Real-time PCR or Western blotting could be used to examine altered 
expression/activation of MAPK following exposure to HPCM. This would provide 
information into how decreased proliferation/angiogenesis may be occurring, and 
lead on to experiments determining how binding of VacA with its receptors on 
BAECs results in dysregulation of the pathway. In our final chapter, it was 
investigated how shear, NO and H. pylori can influence endothelial function. While 
our shear model has been used and validated previously (Colgan et al., 2007b, 
Pearce et al., 1996), conducting our experiments in a perfused capillary system 
would introduce another dimension to our work with pulsatile shear, whilst also 
confirming our laminar studies. The perfused transcapillary culture apparatus 
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(Cellmax® Artificial Capillary System) consists of an enclosed bundle of 50 semi-
permeable PronectinTM-coated polypropylene capillaries through which medium 
from a reservoir is pumped at a chosen flow rate. By electronically altering the flow 
rate, varying pulsatile flow rates and hence pulse heights (pressure) can be achieved 
in this system. A schematic is shown in Figure 6.1.2.  
  
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.2 Schematic of the Cellmax® Artificial Capillary System: As the gear 
pump rotates, the motor shaft forces the pump pins to depress the pump tubing on 
the capillary module, thereby forcing culture media to flow in a pulsatile fashion 
through the gas-permeable silicone flow path tubing and through the capillary. By 
altering the flow rate using an electronic control unit housed outside the humidified 
incubator, varying pulsatile flow rates and hence pulse heights (pressure) can be 
achieved in this system. (Spectrum Laboratories, Calif., USA) 
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Endothelial dysfunction in conjunction with other cardiovascular risk factors, 
are hallmarks of atherosclerotic plaque formation. Another early indicator of a pro-
atherogenic endothelium is inflammation. To extend our hypothesis on the role of H. 
pylori (and in particular VacA) in atherosclerosis the presence of inflammatory 
markers could be assessed following treatment. These may include C-reactive 
(Libby, 2002) and adhesion molecules such as ICAM, VCAM, P-selectin and E- 
selectin (all of which can be monitored by western blotting and/or FACS analysis). 
In addition to bacterial fractions, another natural progression of our work 
could involve co-culturing of whole H. pylori with endothelial cells. In this manner, 
many aspects of the bacteria could be focused on that cannot be examined by 
bacterial fractions. A good example is CagA; it is not secreted into the extracellular 
matrix, but instead requires “docking” with host cell receptors with subsequent 
injection of the cytotoxin. Moreover, the ability of the bacterium to adhere to the 
endothelium under high or low shearing conditions could be elucidated. In this 
regard, low shearing rates, such as those found at arterial bifurcations/curvature 
could be predicted to enhance the ability of H. pylori to adhere to the endothelium.  
While H. pylori has been implicated in cardiovascular disease, the bacteria 
Chylamidia pneumonia, has also been studied within this context. Both bacteria have 
been found in atherosclerotic plaques and are implicated in the initiation and 
progression of atherosclerosis (Witherell et al., 2003). However, as with H. pylori 
little or no data is available pertaining to its impact on endothelial function. A series 
of experiments such as those carried out by our group could easily be performed 
with conditioned media from both bacteria combined. Better still, a co-culture of 
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both bacteria with endothelial cells and subsequent examination cell function could 
increase our knowledge in this area.   
Finally, all of these future studies are based on in vitro models. Ultimately, to 
prove these concepts an in vivo model must be employed. Perhaps the best place to 
begin is by elucidating and recording the manner in which H. pylori leaches through 
the gastric niche and enters the circulatory system. A 1995 study by Contag et al., 
has provided the groundwork for such an experiment (Contag et al., 1995). In this 
study, three strains of Salmonella were bioluminescently labeled via transformation 
with a plasmid conferring constitutive expression of bacterial luciferase. 
Subsequently, detection of photons transmitted through tissues of animals infected 
with bioluminescent Salmonella allowed visualization of the bacteria localized to 
specific tissues through the IVIS50 system (Xenogen Corporation, Alameda, CA). A 
similar study could be employed to track H. pylori in real-time following feeding of 
infected chow to a mouse. Additionally, the experiment could be performed on ApoE 
knockout mice that are prone to developing atherosclerotic plaques to monitor whether 
the bacteria localizes to arterial bifurcations and interacts with the endothelium. This 
becomes particularly important in the light of papers for (Liuba et al., 2003) and 
against (Mach et al., 2002) the association of the bacterium and atherosclerosis in 
mice.  
In conclusion, it was demonstrated that the VacA cytotoxin from Helicobacter 
pylori effects endothelial function in a pro-atherogenic manner, through reduced nitric 
oxide production. Moreover, it was shown that at high shear rates the endothelium was 
athero-protective and prevented these effects. Concomitantly, decreasing migratory and 
increasing tube formation phenotypes in endothelial cells following exposure to H. 
pylori OMP was observed. Whilst these experiments point to a distinct role for the 
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bacterium in atherosclerosis, much remains to be elucidated both in vitro and in vivo. 
However, our data represent a robust starting point. While the overall clinical relevance 
of such studies remains to be seen, undisputed identification of another risk factor for 
cardiovascular disease is paramount in improving its treatments and reaching the 
ultimate goal of a cure. It is the author’s opinion that, as with many diseases, the onus 
is on each individual to avoid the risk factors of CVD, and maintain a healthy lifestyle. 
For factors that cannot be controlled by exercise or diet, such as our proposed risk (H. 
pylori), a vaccine against the disease could be administered at a young age, similar to 
the MMR vaccine. Research into such products is approaching fruition. Until then 
eradication therapies will continue to dominate and the bacteria will persist and thrive in 
the 10% of developed and 90% of developing countries.  
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